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Low cardiorespiratory fitness is a crucial risk factor for premature death and a plethora
of health threats. It is determined by measuring the maximal volitional oxygen consump-
tion (V̇O2peak) in incremental cardiopulmonary exercise tests. The interpretation of an
individual’s V̇O2peak is only meaningful if sex-specific and age-specific reference values
are considered. The primary goal of this study was to create reference values for V̇O2peak
based on cardiopulmonary exercise tests using cycle ergometry.
Methods
The data were acquired in the course of primary preventive health screenings. Overall,
9,354 German white-collar workers (6,063 men, 3,291 women) aged 25 to 69 years who
performed cycle ergometry-based incremental exercise tests were included in the analysis.
Three study centres recorded the data in a central database (Prevention First Registry)
for an inquiry period between 2001 and 2015. Quantile regressions were used to cre-
ate nomograms and an interactive web application was developed (www.uks.eu/vo2peak).
Apparent and external validations of the regression fits were performed. The generalis-
ability of this sample was assessed by comparing five characteristics to a study which was
representative of the German population. Exercise test modalities were not recorded in
the full dataset but were acquired retrospectively for a random sample with an a priori
calculated sample size of 252 participants.
Results
An estimated proportion of 97% of the recorded exercise tests was continued until exertion.
The reference values showed a particularly high validity for the age groups from 30 to
64 years. 3/5 characteristics in men and 4/5 characteristics in women of this sample
were significantly different from the German population, indicating a selection of healthy
participants.
Conclusions
The reference values presented by this study are based on one of the most extensive
databases in this field. They can be used for participants of cycle ergometry-based exercise




Eine niedrige kardiorespiratorische Fitness ist ein entscheidender modifizierbarer Risiko-
faktor für vorzeitiges Versterben sowie eine Vielzahl von weiteren Gesundheitsgefahren.
Sie wird bestimmt, indem die maximal willkürliche Sauerstoffaufnahme (V̇O2peak) bei
einer spiroergometrischen Untersuchung gemessen wird. Die individuelle V̇O2peak ist
jedoch nur aussagekräftig, wenn sie mit geschlechtsspezifischen und altersspezifischen
Referenzwerten verglichen wird. Das primäre Ziel dieser Arbeit war die Erstellung von
Referenzwerten für die V̇O2peak, welche im Rahmen von Spiroergometrien mit Fahrrad-
ergometern erhoben wurden.
Methoden
Die Datenerhebung erfolgte im Rahmen von präventivmedizinischen Untersuchungen bei
denen eine Spiroergometrie mit Fahrradergometern durchführt wurde. Insgesamt wurden
9,354 Teilnehmer (6,063 Männer, 3,291 Frauen) im Alter von 25 bis 69 Jahren in die
Analyse eingeschlossen. Die Teilnehmer waren vor allem Büroangestellte mit einem bewe-
gungsarmen Arbeitsumfeld. Untersuchungen aus drei deutschen Zentren wurden in einer
zentralen Datenbank (Prevention First Registry) gespeichert. Quantilregressionen wur-
den berechnet um Nomogramme zu erstellen und eine Webapplikation wurde entwickelt
(www.uks.eu/vo2peak). Apparente und externe Validierungen der Quantilregressionen
wurden durchgeführt. Fünf Merkmale dieser Studienpopulation wurden mit einer für
Deutschland repräsentativen Studie verglichen um die Repräsentativität der Ergebnisse
zu untersuchen. Die Testmodalitäten der Spiroergometrien wurden nicht in der zentralen
Datenbank gespeichert und wurden deshalb für eine Zufallsstichprobe mit einer a priori
berechneten Fallzahl von 252 Teilnehmern erhoben.
Ergebnisse
Bei einem geschätzten Anteil von 97% der Teilnehmer wurden Ausbelastungskriterien
erfüllt. Die Referenzwerte zeigten eine besonders hohe Validität für die Altersgruppen
von 30 bis 64 Jahre. 3/5 Merkmale bei Männern und 4/5 Merkmale bei Frauen dieser
Studienpopulation zeigten signifikante Unterschiede zur deutschen Bevölkerung. Dies
deutet auf eine Selektion von gesunden Teilnehmern hin.
Schlussfolgerung
Die Referenzwerte dieser Studie basieren auf einer der umfangreichsten bisher publizierten
Datengrundlagen in diesem Feld. Sie können für Teilnehmer von fahrradergometrischen
Spiroergometrien im Alter von 25 bis 69 Jahren verwendet werden, die einer Bevölkerungs-
gruppe angehören, welche vergleichbar mit dieser Studienpopulation ist.
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1 Rationale and objectives
Cardiorespiratory fitness (CRF) is the ability of a person to perform physical activity for
a prolonged period of time [53, p. 72]. During physical activity, the cardiorespiratory
system reacts with an increased heart rate and breathing rate, which is necessary to
supply the additional amount of oxygen. This is needed to sustain increased energetic
requirements through the oxidation of metabolic substrates.
A comprehensive body of evidence shows that low endurance capacity is an important
risk factor for a plethora of health threats such as cardiovascular diseases and premature
death [35, 61, 41]. This means that the risk of dying and the risk of cardiovascular diseases
is higher in persons with low endurance capacity. Besides cardiovascular diseases and all-
cause mortality, CRF is also associated with diabetes mellitus [5, 77], some types of cancer
[60] and - to a lower extent - with psychiatric diseases like depression or dementia [21].
CRF is a strong predictor for health threats in later life and its predictive power is
comparable to well-accepted risk factors such as tobacco smoking or arterial hypertension.
Kim et al. (2007) [33] stated that, “Exercise capacity is known to be one of the most
important predictors of death for men and women alike.” However, despite the high
predictive power, cardiovascular risk calculators like PROCAM [4]∗, European SCORE
[12]†, Framingham [13] or JBS3 [28]‡ do not consider CRF for risk estimation. The
American Heart Association (AHA) emphasised in 2016 that this is a major drawback
and that it is crucial to consider CRF for cardiovascular risk predictions [58].
The assessment of CRF in primary preventive health examinations is crucial and the
value of CRF in preventive medicine goes beyond the mere prediction of future health
threats. As physical exercise increases CRF [39], it is assumed to be a modifiable risk
factor. Participants of preventive health examinations are hence able to impact their
future health by performing physical activity regularly. The AHA emphasised that CRF
is an essential modifiable factor that should be addressed to reach the AHA’s 2020 goals
of improving the cardiovascular health of US-Americans [40].
The most common approach for determining CRF is by performing incremental cardiopul-
monary exercise testing (CPET) and measuring the participant’s oxygen uptake. During
CPET, the participant performs a physical activity of increasing intensity which leads
to increased requirements for oxygen. The participant tries to maintain the increased
physical activity until the maximal volitional intensity is achieved. At this point of the
exercise test, the oxygen uptake of the participant is assessed. If the intensity performed
in the exercise test is close to the true exercise capacity of the participant, the determined
∗PROCAM = Prospective Cardiovascular Münster study
†SCORE = Systematic Coronary Risk Evaluation
‡JBS3 = Joint British Society 3
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oxygen uptake is then stated to be the maximal oxygen uptake. The maximal oxygen
uptake is widely considered to be the gross criterion of CRF [44, 59].
Gas exchange measurement during CPET usually determines the oxygen uptake of a par-
ticipant as the difference between the volume of oxygen inhaled and exhaled per time
unit. The result of this calculation is the volumetric flow rate (V̇O) of oxygen which is in-
corporated by the participant∗. According to the American Thoracic Society’s statement
on cardiopulmonary exercise testing (2003), there are two notations of the highest oxygen
uptake measured using CPET [1]. V̇O2max is considered to express the oxygen uptake
in the case that the participant maintained the incremental exercise until the maximal
volitional intensity. Maximal effort can be assumed based on end criteria measured during
the exercise test. On the other hand, V̇O2peak denotes the oxygen uptake if it is not clear
whether the participant performed the exercise test until maximal exertion. However,
there is no strict distinction between the usage of V̇O2max and V̇O2peak, and both terms
are often used interchangeably. Therefore, the present study uses V̇O2peak to denote the
highest oxygen uptake during CPET irrespective of whether end criteria were considered
or not.
As mentioned above, a high CRF seems to be essential for improving cardiovascular health.
However, the definition of what exactly can be defined as a high CRF is not apparent.
CRF is known to be strongly dependent on sex and age [23, 50]. Other factors such as
physical activity or tobacco smoking are also known to have an impact, which is why
there is a wide inter-individual variability of CRF [50]. Considering the substantial role
that sex plays as well as the decline of CRF associated with increasing age, it is critical
to interpret the individual CRF of a CPET participant in the light of sex- and age-
specific reference values from a comparable population. According to Kim et al. (2007),
“defining normative values for EC [exercise capacity] is of utmost importance in accurate
risk prediction after stress testing” [33]. Based on this, the primary and secondary goals
of the present analysis were:
Primary goals
1. Primary goal 1: To calculate percentile reference values for peak oxygen
uptake.
2. Primary goal 2: To visualise reference values as nomograms and as an inter-
active web application.
∗V̇O = volume of oxygen per time unit = δV
δt
, measured in litres of oxygen per minute
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Secondary goals
1. Secondary goal 1: To perform external validation of the reference values. The
population used for external validation should be different from the population
in which the reference values are calculated.
2. Secondary goal 2: To compare this study sample with the German population
in order to detect selection bias.
3. Secondary goal 3: To perform an exploratory multivariable analysis aiming
to find predictors for peak oxygen uptake.
In the following, the role of CRF in preventive medicine, the measurement of CRF using
CPET and present reference values for peak oxygen uptake are outlined in chapter 2. The
data source, test modalities and statistical methods of the present study are described
in chapter 3. The results including reference values, visualisations as nomograms and
an explorative multivariable analysis are displayed in chapter 4. Finally, the results are
discussed in chapter 5 and conclusions are drawn in chapter 6.
3
2 Background
This chapter reviews the current literature on the association between cardiorespiratory
fitness and health-related outcomes (section 2.1) followed by the value and the general
framework of incremental exercise testing in primary preventive health examinations (sec-
tion 2.2). Section 2.3 describes the methodological principles of the measurement process
using incremental exercise tests. In section 2.4, existing reference values for peak oxygen
uptake and quality standards of the measurement are reviewed.
2.1 Cardiorespiratory fitness as a risk factor
Low CRF is a risk factor for premature all-cause mortality and cardiovascular disease. A
comprehensive body of scientific evidence supports an inverse dose-response relationship,
meaning that the higher a person’s CRF, the lower the person’s risk of cardiovascular
disease [53, 33]. Besides, other health problems such as neoplasia, metabolic or neurode-
generative diseases have been shown to be inversely associated with CRF. The evidence
can be derived from meta-analyses as well as comprehensive prospective studies. Sev-
eral studies have reported adjusted effects supporting the assumption that low CRF is a
risk factor which is independent of widely accepted risk factors. The effects of CRF on
cardiovascular disease and mortality have been recognized as decidedly strong. CRF is
therefore regarded as one of the most important independent predictors of cardiovascular
disease and all-cause mortality [33].
Kodama et al. (2009) performed a systematic review and meta-analysis of observational
cohort studies that addressed the question of CRF being a predictor for cardiovascular
disease [35]. Overall, 33 studies were eligible for the analysis including 102,980 subjects
for analysis of all-cause mortality and 84,323 subjects for analysis of cardiovascular dis-
ease. Mean age at baseline of the included studies was 37 to 58 years. The meta-analysis
revealed that an increase of maximal cardiorespiratory fitness decreased the risk for car-
diovascular disease (risk ratio [RR] 0.85, 95% confidence interval [CI] 0.82 to 0.88 for an
increase of maximal aerobic capacity by one MET∗) and the risk of all-cause mortality
(RR 0.87, 95% CI 0.84 to 0.90 for an increase of maximal aerobic capacity by one MET).
Another meta-analysis was performed by Löllgen et al. (2009), who analysed the asso-
ciation between physical activity and all-cause mortality [41]. In total, 38 prospective
cohort studies including information on the intensity of physical activity were included
in the analysis. Highly active subjects had a lower risk to die compared to subjects with
∗CRF can be described by metabolic equivalents (METs). 1 MET is assumed to be the oxygen consump-
tion under resting conditions which is assumed to be 3.5 mLO2/min/kg. < 3 METs indicate low-intensity
physical activity and ≥ 6 METs indicate vigorous-intensity physical activity.
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low activity levels (men: RR 0.78, 95% CI 0.72 to 0.84, women: RR 0.69, 95% CI 0.53 to
0.90).
Shah et al. (2016) conducted a comprehensive cohort study and observed that the CRF
of younger adults (18 to 30 years) was also a predictor of health outcomes in later life
[61, 11]. They observed 4,872 participants of exercise tests for a median follow-up period
of 27 years. One additional minute of exercise test duration at baseline reduced the
hazard of death by 15% (hazard ratio 0.85, 95% CI 0.80 to 0.91). The authors assumed
that CRF was an independent risk factor and was not mediated by other well-known
risk factors such as coronary artery calcification. This assumption was supported by
their adjusted analysis which considered confounding and effect modification by major
risk factors. Furthermore, the authors could not find an association between CRF and
coronary artery calcification at each follow-up measurement and hence suggested that
coronary artery calcification did not mediate the protective effects of high CRF.
Aside from all-cause mortality and cardiorespiratory events, a low CRF was a risk factor
for other health-related outcomes such as metabolic diseases [77], neoplasia [60], neurode-
generative diseases [21] or, with smaller effect size, affective disorders [51].
Zaccardi et al. (2015) described the association between CRF and type 2 diabetes mel-
litus [77]. The authors conducted a meta-analysis of prospective studies as well as their
own prospective cohort study with a follow-up period of 23 years. 92,992 subjects were
analysed in the meta-analysis including 8,564 cases with type 2 diabetes mellitus. Higher
CRF was associated with a lower risk for type 2 diabetes mellitus (RR 0.95, 95% CI 0.93
to 0.98 per increased MET) in the meta-analysis.
Schmid & Leitzmann (2015) performed a meta-analysis of the association between CRF
and total cancer mortality [60]. They considered six prospective studies, which included
71,654 subjects with a median follow-up period of 16 years, resulting in 2,002 total cancer
mortality cases. CRF was measured using maximal or submaximal exercise tests. All
included studies presented risk estimates that were adjusted for age and smoking status.
The meta-analysis showed a strong, inverse association when the groups with highest and
lowest CRF were compared (RR 0.55 95% CI 0.47 to 0.65).
The impact of physical activity on neurodegenerative diseases was studied by Hamer &
Chida (2009) [21]. In their meta-analysis, the authors extracted data from 16 prospective
cohort studies, including 163,797 participants with 2,731 dementia or Alzheimer’s disease
patients and 488 patients with Parkinson’s disease. CRF was not measured directly in
the included studies, but self-reported physical activity was used as the predictor. When
subjects with the highest and the lowest physical activity were compared, Alzheimer’s
disease was found less often in the group with higher physical activity (RR 0.55, 95% CI
0.36 to 0.84). Other associations showed lower effects measures or non-significant results.
Another association was analysed by Papasavvas et al. (2016) [51], who found a modest
correlation (correlation coefficient -0.16 95% CI -0.21 to -0.10) between the severity of
depression and CRF in their meta-analysis.
In summary, there is substantial evidence for an association between CRF and cardiovas-
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cular disease as well as CRF and premature all-cause mortality. The associations were
observed in prospective studies, meta-analysis and were validated in external popula-
tions. Hence, it is likely that there is a causal relationship between CRF and these health
threats. It should also be emphasised that the effect sizes of these relationships are very
high and comparable with other major risk factors such as tobacco smoking or dyslipi-
daemia. Therefore, CRF is a decisive modifiable risk factor which should be targeted by
preventive medicine. Furthermore, adjusted analyses support the assumption that CRF
is a risk factor that is independent of other major risk factors. Aside from cardiovascu-
lar disease and mortality, plenty of health threats are inversely associated with CRF. To
conclude, CRF might be an essential target in the prevention of cardiovascular disease,
mortality and other critical health threats.
2.2 Exercise tests in preventive medicine
This section outlines the general framework of CPET and the value of CPET in preventive
medicine. Furthermore, the effort to increase CRF, which is a primary goal of preventive
medicine and one of the important rationales to measure V̇O2peak, is outlined.
General framework of exercise tests
CPET and the measurement V̇O2peak should be embedded into a more comprehensive
assessment to rule out preexisting diseases that might affect patient safety [53, 1, 71].
This assessment includes anamnesis, resting electrocardiogram, blood pressure as well as
the measurement of anthropometric characteristics and laboratory values such as carbon
hydrate and lipid metabolism. During CPET, there is usually a recording of heart rate,
blood pressure and the assessment of subjective symptoms. Blood pressure and exercise
electrocardiogram are recorded to detect pathological reactions of the circulatory system
and terminate CPET if appropriate. Subjective symptoms may either be the rating of
perceived exertion (e.g. by Borg Scale, [53]), localised pain or angina pectoris. Taking
capillary blood samples is also common to measure lactate levels at a given work rate.
Based on lactate thresholds, precise recommendations for physical exercise can be con-
ducted. A number of organisations have published extensive guidelines for CPET and its
framework such as the ACSM (2014) [53], ATS/ACCP (2003) [1], AHA (2010) [7] and in
German by Trappe & Löllgen (2000) [67] or DGSP∗ (2007) [15].
Exercise prescription
In chapter 2.1, evidence was presented to show that CRF is a substantial risk factor for a
number of health threats. Garber et al. (2011) stated in their ACSM position that, “The
scientific evidence demonstrating the beneficial effects of exercise is indisputable” [18].
∗Deutsche Gesellschaft für Sportmedizin und Prävention
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From a public health perspective, it is interesting how CRF can be improved and whether
and to what extent an improvement in CRF leads to a lower occurrence of adverse events.
Therefore, a short overview of cardiopulmonary exercise and its health implications is
outlined in the following.
CRF is largely dependent on physical activity and physical exercise. Improved fitness
as a response to progressive exercise is a basic principle of training theory [16]. This
was shown in a meta-analysis by Lin et al. (2015) [39], who used 27 studies of men and
25 studies of women. The exercise arrangements were different in the analysed studies
including moderate and vigorous training. The mean overall response of relative V̇O2peak
was quantified at 5.4 mLO2/min/kg (95% CI 4.3 to 6.5) in men and 3.2 mLO2/min/kg
(95% CI 2.6 to 3.9) in women. The effect of exercise was stronger in subjects with a
sedentary lifestyle compared to subjects with an active lifestyle, and it also increased
with exercise duration per week. The authors also observed that exercise leads to desired
effects on lipid and glucose metabolism. Those findings were confirmed by a meta-analysis
of Huang et al. (2016) [24], who conducted a meta-analysis of older adults with a mean
age of 68 years.
The ACSM’s recommendations for cardiorespiratory endurance exercise in healthy indi-
viduals depend on the intensity of exercise [18, 53]. When moderate intensity is performed,
30 minutes per day on five days a week are recommended. Exercise with vigorous inten-
sity should be performed on three days a week for 20 minutes per day. The intensity of
endurance exercise should be defined based on heart rate reserve (HRR) or on V̇O2peak re-
serve (V̇O2R)
∗. Using the oxygen uptake method, moderate exercise is defined as V̇O2rest
plus 40% to < 60% of V̇O2R and vigorous exercise at V̇O2rest plus 60% to < 90% of V̇O2R.
Persons with diseases such as heart failure, or athletes with high CRF are likely to benefit
from different training arrangements which can be found in [53, p. 161] and [18].
To conclude, it is clear that cardiorespiratory fitness is a substantial independent risk
factor. However, CRF is critically dependent on cardiorespiratory exercise and training
[37, 18]. It is reasonable to measure CRF by acquiring V̇O2peak in preventive medicine
to assess the participant’s risk and in order to arrange endurance exercise systematically.
For the interpretation of a participant’s V̇O2peak as well as for exercise prescription, sex-
specific and age-specific reference values based on a comparable population are essential.
2.3 Measurement of peak oxygen uptake
This chapter outlines the measurement tools needed to assess V̇O2peak. Different types of
ergometers, test protocols, and end criteria are summarised. A special focus is placed on
how the results of CPET are affected by its test modalities.
∗Heart rate reserve is defined as HRR = HRmax − HRrest, where HRmax denotes the maximal heart rate
and HRrest denotes heart rate at rest. V̇O2peak reserve is calculated as V̇O2R = V̇O2peak−V̇O2rest, where
V̇O2peak denotes maximal oxygen comsumption and V̇O2rest denotes oxygen consumption at rest [53, p.
170].
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Cardiopulmonary exercise tests
There are several test arrangements that aim to assess V̇O2peak. Open circuit spiroergom-
etry that is performed until maximal effort of the participant is a standard setting and has
been described as the gold standard in measuring V̇O2peak [1, 7, 53]. Spiroergometry is the
measurement of gas exchange during physical activity that is performed on an ergometer.
Gas exchange is measured by wearing an airtight mask with a built-in pneumotachograph,
which is a low-resistance valve through which respiration is conducted. V̇O2 is obtained
using respiratory rate, tidal volume and the composition of inhaled and exhaled gas. Re-
cent spiroergometry systems provide a breath-by-breath analysis of the composition of
gas. In order to measure maximal oxygen uptake, the work rate is increased over time
until the maximal volitional work rate of the participant is finally achieved. V̇O2peak
is then calculated as the average V̇O2 of the final exercise period in order to decrease
noise. Past studies have suggested using an average over at least the final 30 seconds
of the exercise test [50, 1]. In some settings, CPET cannot be performed until exertion.
In that case, exercise is performed until a predefined termination point and V̇O2peak is
extrapolated based on e.g. heart rate at a given work rate using prediction equations.
Such submaximal testing is an option if maximal testing is not safe for patients with
preexisting cardiovascular disease [53]. However, the focus of the following is on maximal
exercise tests, as those were used in the present study.
Type of ergometer
Graded exercise testing requires that the participant performs a standardised dose of
work. Two options that were applied frequently in past studies are cycle ergometers
and treadmills [53, 1, 71]. Some characteristics and differences of cycle and treadmill
ergometers are summarised below.
The work rate is adjusted differently in cycle and treadmill ergometers. In treadmills,
this is usually done using speed and elevation of the device, whereas in cycle ergometers,
the resistance is modified. In electronically broken cycle ergometers, the work rate can
be adjusted very accurately by controlling the resistance of the device. When treadmill
ergometers are used, on the other hand, the work rate can only be estimated based on
the speed and weight of the subject.
There is a substantial difference in the assessed V̇O2peak between cycle and treadmill
ergometers. V̇O2peak was estimated to be 5 to 10% higher when measured on treadmill
ergometers [1, p. 218]. The difference between both ergometer types was even greater in
two studies of the same population using both types of ergometers. A 35 year-old man
showed a median relative V̇O2peak of 42 mLO2/min/kg using treadmill ergometers and
30 mLO2/min/kg using cycle ergometers [30, 31]. It was assumed that these differences
occur because CPET on cycle ergometers is often terminated due to local muscle fatigue.
Additionally, a larger number of muscles are active in treadmill tests, which increases O2
consumption. Because of the large difference between cycle and treadmill ergometer, it is
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essential to be informed about the type of ergometer that was used for reference values.
Another difference in ergometers concerns additional testing during the exercise test like
electrocardiograms or drawing capillary blood samples. It is more feasible and there are
less artefacts when cycle ergometers are used because the whole body of the subject is
in motion on treadmill ergometers. To address this issue, it is becomes necessary to
use specific test protocols to treadmill ergometers. When capillary blood samples and
treadmill ergometry are desired, discontinuous protocols are often applied and the blood
samples are drawn during phases without exercise.
In conclusion, ATS/ACCP Guidelines recommend cycle ergometers as the preferred mode
of exercise [53]. In order to increase external validity, treadmill or field test may be desired,
nevertheless.
Protocols of incremental exercise tests
Exercise tests are usually based on an incremental work rate. The ATS/ACCP guidelines
(2003) [1, p. 224] describe four different general types of CPET protocols. The protocols
are particularly defined by the amount of increment per time unit.
1. In progressive or continuous incremental protocols (also: “ramp protocol”), the
work rate is adjusted in short periods of time or continuously.
2. In multistage incremental protocols, the work rate is constant for a defined period
of time (e.g. three minutes) and increased when the time period is over.
3. In protocols using constant work rate, the work rate is constant over a period of
usually < 30 minutes.
4. In discontinuous protocols, the work rate is constant over a period of time (e.g.
three minutes), then a resting period is inserted after which an increased work rate
is applied. This type of protocol is sometimes necessary when lactate measurements
from capillary blood samples are desired and treadmill is the preferred mode of
physical activity.
In clinical practice, however, plenty of versions of the protocols mentioned above are used.
The ATS/ACCP guidelines (2003) [1, p. 224] provide an overview of the most common
protocols.
The amount of increments per time has to be selected carefully and has to be adjusted
to the participant’s level of fitness. An increase in work rate leads indeed to an increased
oxygen consumption, but the oxygen consumption increases with some delay. Therefore,
a rapid increase in work rate might lead to inaccurate results in gas exchange measure-
ment. According to ATS/ACCP guidelines (2003), increments should be between 5 to
25 Watt/minute [1]. This should yield a period of 8 to 12 minutes for CPET, overall.
By the use of predicted V̇O2peak, the increase in work rate can be adjusted to achieve an
estimated overall time of 10 minutes [1, p. 225].
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Termination of exercise tests
The exercise test should be continued until the participant reaches the maximal volitional
effort. This is required because V̇O2peak cannot be interpreted as the highest volitional
oxygen uptake if CPET was terminated due to other reasons. In order to quantify the
participant’s effort, several measures have been used. Midgley et al. (2007) [45] reviewed
and commented end criteria for maximal effort that were used in past studies. Some of
the commonly used criteria were based on the slope of V̇O2 during incremental exercise,
the heart rate, the respiratory exchange ratio (RER = V̇CO2
V̇O2
) or blood lactate level. The
most common criteria of the reviewed studies are displayed in table 2.1.
Table 2.1: End criteria for maximal effort in exercise tests.
Criterion Value used
Heart rate ≥ 90% of APMHR
RER ≥ 1.1
Blood lactate ≥ 8 mmol/L
V̇O2 plateau ≤ 150 mLO2/min
Note: APMHR = age-predicted maximal
heart rate
RER = respiratory exchange ratio
Table modified according to Midgley et al.
(2007) [45]
The estimation of the age-predicted maximal heart rate (APMHR) can be useful as an end
criterion, but several calculation methods have been used. Common estimation methods
have been APMHR = 220 - age in years or the less rigorous equation APMHR = 200
- age in years [59, 15]. The latter criterion might be more suitable for cycle ergometry
since the exercise test is usually terminated earlier compared to treadmills (section 2.3).
A more data-driven approach was published by Tanaka et al. (2001) [66], who performed
a meta-analysis of studies with an overall sample size of 18,712 participants. The linear
regression model APMHR = 208 - 0.7 ∗ age in years showed a high goodness-of-fit and a
correlation coefficient of r = -0.9.
In addition to end criteria for maximal effort, there are health-related contraindications
for the continuation of the exercise test [53, p. 87] such as i) symptoms of hypoxia (e.g.
dyspnoea, angina pectoris, cyanosis) ii) unphysiological response of blood pressure or
heart rate (decreasing blood pressure or heart rate despite increasing work rate, excess of
blood pressure) or arrhythmia in the electrocardiogram.
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2.4 Reference values for peak oxygen uptake
It is essential to compare the individual results of exercise testing with reference values
that are drawn from a comparable population and are stratified by at least age and sex
[33]. This is due to the strong impact of sex and age on the CRF. Exercise test results
are only diagnostically conclusive if sex-specific and age-specific reference values from a
comparable population are considered [1, 7, 50].
Several attempts have been made to produce reference values for CPET. Kim et al. (2007)
[33] summarised eleven studies that provided reference values for exercise capacity and
conducted an external validation of the models. The authors had access to CPET results
of 13,089 men and 9,177 women and were able to assess the subsequent deaths of the study
subjects using Social Security Death Index for a median follow-up time of five years. The
authors concluded that all reference values were more or less accurate for the prediction
of premature all-cause mortality. This was done by classifying the individual results of a
CPET participant in relation to the reference values. Low V̇O2peak in comparison to the
reference values was then used as the predictor of premature all-cause mortality. Reference
values that were adjusted for age and sex, nevertheless, performed better compared to
simple cut-off values. The best predictions of death for men and women were based on a
Veterans Affairs cohort [46] and the St. James Take Heart Project [20], respectively.
Paap and Takken (2014) performed a systematic review of studies that presented reference
values for V̇O2peak in adults [50]. The key points of this review are be summarised below:
Overall, 35 studies from 1985 to 2013 were included in the analysis. In the reviewed stud-
ies, the sample size ranged from 25 to 2,263 and the age from 4 to 95 years, respectively.
23/32 (71.9%) studies with a reported design were prospective, and 17/32 (53.1%) were
population-based. The study design was unclear in three studies. Most studies were con-
ducted in European and North American countries, resulting in predominantly Caucasian
participants. The authors described the need of reference values especially for South
American, Middle Eastern, African and Asian populations. 22/35 (62.9%) studies used
only cycle ergometers, 12/35 (34.3%) studies only treadmill ergometers and 1/35 (2.9%)
study used both ergometers. The reviewed studies used different CPET protocols. The
most prevalent protocols were multistage or ramp protocols, but different individualised
protocols were also present. Most studies (21/32; 65.6%) used either breath-by-breath or
mixing chamber systems with an at least 30-second time-averaging of V̇O2 of the final
exercise test period to determine V̇O2peak. Only 7/23 (30.4%) studies with reported time
averaging used < 30 seconds. Tobacco smokers were excluded by 7/29 (24.1%) studies in
which smoking status was reported, and only one study took smoking status into account
in the analysis. The authors created a rating system based on ATS/ACCP guidelines for
exercise testing [1] to grade the quality of each reviewed study. They listed 14 dichoto-
mous criteria (yes/no) and coded yes as 1 and no as 0. Studies with ≥ 10 points were
considered “high quality”, 7 to 9 “moderate quality” and < 7 “low quality”. Some of
those criteria were also used to assess the quality of the present study (table 5.1). The
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3. Community-based sampling of the study population
4. The number of study subjects is at least as high as calculated in the sample
size estimation
• Characteristics of CPET
5. Measurement of gas exchange data and VO2peak is averaged over time to avoid
noise (preferably ≥30 seconds intervals)
6. CPET was performed using breath-by-breath or mixing chamber analysis ac-
cording to ATS/ACCP guidelines [1]
7. Quality control was performed according to ATS/ACCP guidelines [1]
• Important background reported
8. Level of physical activity reported
9. Exercise testing protocol described
• Data analysis and reporting
10. External validation of the statistical model
11. Adequate fitting of the regression model was performed
12. Analysis was stratified by racial group
13. Smokers were excluded
14. Confidence limits were given for descriptive statistics
The study that scored the most points (11) was conducted by Itoh et al. (2013) [26]. The
publication of Edvardsen et al. (2013) [17] scored 10 points. For this reason, these two
studies are summarised below:
Itoh et al. (2013) performed a prospective, community-based, multi-centre study in Japan.
The allocation of study subjects into groups was randomised. The final sample consisted
of 749 healthy Japanese participants aged 20 to 78 years. The authors excluded smokers,
subjects with a body mass index (BMI) of < 17.6 kg/m2 or BMI > 28.6 kg/m2, subjects
who exercise regularly (> 2 times per week), subjects with cardiopulmonary pathologies
and more. The measurement was done using treadmill and cycle ergometers, and ramp
protocols were applied. VO2peak was calculated as the average of the last 30 seconds of
exercise. RER was measured, and subjects with poor effort (RER < 1) were excluded from
12
2.4. REFERENCE VALUES FOR PEAK OXYGEN UPTAKE 2. Background
the analysis. Differences in protocol and cycle versus treadmill ergometer were compared.
Multiple linear regression was used to model the effects of age, sex and the type of test
protocol. The results were displayed as two-dimensional line charts and scatter plots.
The analysis using linear ordinary least square regression, however, was a limitation of
this study because it only allows the estimation of conditional means and not percentiles.
This approach does not consider the distribution of VO2peak for a given age and sex. A
further limitation was the extensive exclusion of participants which lead to a final study
population which was constructed artificially and might decrease external validity. The
authors obviously wanted to derive reference values from healthy healthy individuals, who
did not exercise on a regular basis or have any potetial risk factors.
A study performed by Edvardsen et al. (2013) [17] was based on a multi-centre, population-
based random sample from Norway. The final sample size after exclusion of study subjects
with poor effort (RER < 1.10 or Borg score < 17) was 759 men and women aged 20 to 85
years. Smokers were not excluded in this study. CPET was performed only on treadmill
ergometers. Gas exchange measures were reported as the mean VO2 of the final 30 sec-
onds of the exercise test. The reference values were also presented as the result of linear
ordinary least square regression, and no percentiles were reported.
The results of two recent studies that were based on a large sample were not included in
the systematic review of Paap and Takken [50]. Kaminsky et al. (2015) and Kaminsky
et al. (2017) [30, 31] presented the results of the “Fitness Registry and the Importance
of Exercise National Database (FRIEND)” database. The database was based on CPET
data from several laboratories in the USA. Men and women who participated in an exercise
programme or research study at the age of 20 to 79 years were eligible for the study.
Percentile values of treadmill [30] as well as cycle [31] ergometer were published. Kaminsky
et al. (2015) [30] recorded CPET results from eight laboratories in the time frame from
2014 to 2015. Treadmill ergometers were used, and individuals who achieved exertion
(RER > 1.0) were included in reference values. Overall, 7,783 subjects (4,611 men, 3,172
women) were eligible for the analysis. On the other hand, Kaminsky et al. (2017) [31]
published reference values based on CPETs using cycle ergometers. 4,494 subjects (1,717
men, 2,777 women) from ten laboratories participated in data acquisition between 2014
to 2016. Exertion was assumed if RER > 1.1.
Reference values based on a German sample were also derived. Koch et al. (2009) [34]
conducted a population-based study in Pomerania, a north-eastern region of Germany.
A representative sample of 3,300 subjects was drawn from the whole population (n =
212,157). Of those 3,300, 1,708 subjects agreed to participate in CPET on a cycle er-
gometer. The volunteers were younger, healthier and tobacco smoking was less prevalent
compared to the Pomeranian population. This might be an indicator of selection bias.
The selection of healthy participants might lead to increased reference values. A rigorous
exclusion of cases such as smokers, obese subjects and subjects with cardiac arrhythmia
led to a final sample size of 534 (253 men and 281 women). CPET was performed using
a stepwise protocol on cycle ergometers with an increment of 16 W/min. The analysis
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was done using quantile regression with maximal oxygen uptake as dependent and age as
independent variables. Age was modelled as a categorical factor and was adjusted for sex
and BMI. Regression coefficients and plots with normal ranges were supplied.
To conclude, several attempts have been made to create reference values. The quality of
the existing reference values was diverse. Nevertheless, reference values were valuable for
the prediction of all-cause mortality.
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3 Material & Methods
The material and methods of the present study are outlined in this chapter. Section
3.1 describes the study design as well as the composition and structure of this study’s
participants. Furthermore, it summarises the general set-up of data acquisition. The
measurement of V̇O2peak is described in section 3.2. Data management and the construc-
tion of the final datasets is described in section 3.3. Lastly, the methods to assess the
generalisability of this sample, and the statistical methods are outlined in the sections
3.4, and 3.6.
3.1 Study design and participants
General framework
The data acquisition of the present study was conducted by Prevention First®, a quality
network of institutions offering primary preventive health screenings. There were three
study centres in the German cities Rüdesheim, Frankfurt and Munich. Data acquisition
ended at all three sites in 2015 but started in different years. Rüdesheim was the first
centre to systematically record the data in 2001, followed by Frankfurt in 2006 and Munich
in 2008.
Study design
This was a cross-sectional, registry-based study analysing routine files recorded in the
course of primary preventive health screenings.
Participants
A proportion of 95% of all recorded CPET participants of this study was acquired in the
course of workplace health promotion programmes. More than 100 local companies such
as mid-sized companies, banks, insurance companies or business consulting participated
in these programmes. The individuals in this group were predominantly white-collar
workers with office jobs and a sedentary working environment. The other 5% of the
recorded individuals comprised persons with private health insurance or persons who
purchased the health screening as direct payers.
Inclusion criteria and exclusion citeria
All participants underwent pre-exercise evaluation before qualifying for participation in
CPET. According to ACSM guidelines [53, p. 40], medical history, physical examination
and laboratory tests were applied. Subjects who did not meet clinical exclusion criteria
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(e.g. hypertensive emergency, acute infection) and who were free of acute complaints
subsequently performed CPET with the goal of maintenance until exertion. If exclusion
criteria were present, CPET was offered at a later time. Experienced test instructors
and physicians supervised CPET. table 3.1 outlines inclusion and exclusion criteria of
the present study. Some participants contacted Prevention First® more than one time,
but for this cross-sectional analysis, only the first contact of a participant and Prevention
First® was considered.
Table 3.1: Inclusion and exclusion criteria of the present study.
Inclusion criteria Exclusion criteria
•Men and women aged 25 to 69 years •Age < 25 or age ≥ 70 years
•First contact of the participant and Pre-
vention First®
•Follow-up examinations of the participant
and Prevention First®
•Participants of workplace health promo-
tion programmes, members of private
health insurance or direct payers
•Persisting contraindications for CPET
such as acute myocardial infarction or
unstable angina pectoris. For a compre-
hensive list, see [1, p. 227]
•Participation in preventive health screen-
ings including CPET at Prevention First®
in Rüdesheim, Frankfurt or Munich
•Participants who did not agree with the
use of personal data for scientific purposes
or did not provide informed consent
•Missing value in one of the characteristics
i) age or ii) peak oxygen uptake or iii)
study centre (location of data acquisition:
Rüdesheim, Frankfurt or Munich)
Ethics approval and informed consent
Participants who agreed with the use of their personal data for scientific purposes and
provided informed consent (appendix A.4) were considered for this study. Their CPET
results and pre-exercise evaluations were recorded in a computerised database.
According to the AGENS∗ guidelines for secondary data analysis, ethical approval was not
needed as this was a secondary data analysis using routine files [3, p. 3]. The participant’s
data were pseudonymised before data analysis, and there was no particular treatment of
participants who were analysed in this study.
∗AGENS = Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten der Deutschen Gesellschaft für
Sozialmedizin und Prävention (DGSMP) und der Deutschen Gesellschaft für Epidemiologie (DGEpi)
16
3.2. MEASUREMENT OF SAMPLE CHARACTERISTICS 3. Material & Methods
3.2 Measurement of sample characteristics
Primary outcome measures: peak oxygen uptake
This study determined CRF as the highest volitional oxygen consumption during CPET.
The consumption of oxygen was assessed as a volumetric flow rate (V̇O2 =
δV
δt ). End
criteria of the exercise test were not recorded in the main dataset but were acquired
retrospectively for a random sub-sample (section 3.3). Therefore, the term V̇O2peak rather
than V̇O2max was used to describe the highest oxygen uptake during CPET. This was in
concordance with the recommendations of CPET guidelines [1]. V̇O2peak was assessed
as an absolute value (absolute V̇O2peak measured in LO2 per minute) and relative to the
participant’s body weight in kilograms (relative V̇O2peak measured in mLO2 per minute
per kilogram of body weight). V̇O2peak was defined as the mean V̇O2 of the last 10 seconds
of the exercise test. Such averaging was recommended to avoid noise and artefacts of
measurement [1, 50].
Further sample characteristics
The sample characteristics were acquired in the course of the pre-exercise evaluation prior
to the exercise test. The age of the participants was recorded in years. Tanita TBF 410
(Tanita, Tokyo, Japan) body composition analysers were used to assess body weight and
to estimate body fat via bioelectrical impedance analysis. Body fat was also estimated
by measuring skinfold thickness using Lange Skinfold Calipers (Beta Technology, Cam-
bridge, Maryland, USA). Skinfold thickness was measured at three sites according to
Jackson Pollock (1985) [27] (men: chest, abdomen, thigh; women: triceps, suprailium,
thigh). Blood pressure was acquired after the participant rested in a sitting position for
at least 5 minutes. Manometric blood pressure gauges by BOSO (Jungingen, Germany)
were used, and the average of two consecutive measurements was recorded to the nearest
2 mmHg. Overweight, obesity, and hypertension were defined according to the World
Health Organization (WHO) (overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥ 30 kg/m2,
hypertension: either systolic blood pressure ≥ 140 mmHg, or diastolic blood pressure ≥
90 mmHg [76, 74]). Participants were instructed not to eat on the morning prior to their
exercise test in order to draw fasting blood samples. The analyses of the blood samples
were performed by two accredited laboratories (study centres Rüdesheim and Frankfurt:
Labor Dr. Riegel, Wiesbaden, Germany; study centre Munich: Synlab, Augsburg, Ger-
many). Dyslipidaemias were defined according to guidelines by the ESC/EAS∗ [9, table
10]. Elevated low-density lipoprotein (LDL) cholesterol was defined as fasting LDL choles-
terol levels ≥ 115 mg/dL, reduced high-density lipoprotein (HDL) cholesterol was defined
as HDL cholesterol ≤ 40 mg/dL, elevated triglycerides were defined as triglycerides ≥
150 mg/dL. Diabetes mellitus was defined according to the WHO as either fasting blood
∗European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
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glucose levels ≥ 126 mg/dL or glycated haemoglobin (HbA1c) ≥ 6.5% [57].
Exercise test modalities
Open circuit spiroergometry using cycle ergometers was performed to apply an incre-
mental workload to the participant. The CPET protocol was selected according to the
requirements of each measurement and was adapted to the estimated level of fitness of
the participant. Multi-stage protocols were used if capillary blood samples for measuring
blood lactate levels were drawn and ramp protocols were used if no capillary blood sam-
ples were drawn. The duration of CPET was intended to be 4 to 6 stages of 3 minutes
each in multistage protocols or 12 to 18 minutes in ramp protocols. The increments in
work rate were selected by an experienced CPET instructor or physician before the CPET
according to the participant’s level of fitness to fulfil these conditions. Before the first
application of a workload, the participant pedalled with no resistance for 3 minutes.
Gas exchange was measured with breath-by-breath analysis using the Ganshorn Power-
cube system (Ganshorn Medizin Electronic GmbH, Niederlauer, Germany). Ganshorn
LF8 V8.5 software and the previous versions were used for analysis of the results. Cal-
ibration of the gas exchange measurement system was performed daily in concordance
with the manufacturer’s instructions, and approximately 3 to 4 CPETs were performed
per day using the same calibrated system. Cycle ergometers were calibrated once a year
and met the German directives for medical devices. At all study centres, quality control
was performed according to a DIN EN ISO 9001 certified quality management system.
If there were no contraindications during the exercise test [53, p. 87], the increments
of work were continued until the maximal volitional work rate was achieved. Blood
lactate levels, RER, and maximal heart rate were recorded to get information about
the participant’s effort. Adequate exertion was assumed if one of the end criteria was
achieved: i) blood lactate levels ≥ 8 mmol/L or ii) RER ≥ 1.10 or iii) maximal heart
rate ≥ 90% of the age-predicted maximal heart rate ([45], section 2.3). The measures
of maximal effort were used to evaluate the effort of the participant instantly and were
noted in the participant’s medical chart. However, the end criteria were not recorded in
the main study database.
3.3 Data management
Data sources
Health screening data of all eligible participants who met the inclusion and exclusion
criteria (table 3.1) were recorded in a computerised database called “PF Studie”. All
data were pseudonymised using a unique identification number. A key file to link the
personal data and the unique identification number was stored at the Prevention First®
centre in Rüdesheim. For this cross-sectional analysis, only the baseline data was exported
to the main dataset. If there was more than one contact of a subject and Prevention
18
3.3. DATA MANAGEMENT 3. Material & Methods
First®, only the first contact was included in the dataset. The variable “study centre”
and some CPET modalities were not recorded in the “PF Studie” database. CPET
modalities were documented in medical records and the study centre was recorded in a
second database of Prevention First® (“PF Patient”). This additional information was
added retrospectively. The variable study centre could be added using probabilistic record
linkage as it was stored in a database, but CPET modalities had to be acquired manually
from medical records. Due to a large number of observations, the additional CPET test
results could only be provided for a random subset of the main dataset with an a priori
calculated sample size of n = 252 participants (section 3.3). An overview of the data
sources is displayed in fig. 3.1.
Random sample
Exercise test modalities were not recorded in the main study dataset; rather, these were
included in medical records that were stored separately. This information had to be ac-
quired manually. As the acquisition of the information for the entire main study dataset
would have been excessively time-consuming, a random sample was drawn from the main
study dataset. The variables were added manually and a second dataset (“random sam-
ple”) was created. Sample size calculation was used to estimate the size of the random
sample. The minimum sample size was calculated for a proportion and 95% CI of sub-
jects who achieved exertion (≥ 90% of age-predicted maximal heart rate or RER ≥ 1.10
or blood lactate levels ≥ 8 mmol/L). The margin of error (ME) for a single proportion
with the assumption of normal approximation was used [72]:
ME = z1−α2 ∗
p̂ ∗ (1 − p̂)
n
(3.1)
Where ME denotes the margin of error, z1-α2 is the critical value of the standard normal
distribution that corresponds to the level of confidence, p̂ is the point estimator for the
expected sample proportion and n is the a priori sample size of the random sample. Using
ME of 0.05 and 95% CI (α=0.05), the sample size is calculated as:
n =
1.962 ∗ p̂ ∗ (1 − p̂)
0.052
(3.2)
For a proportion of 80% of all individuals reaching exertion, n = 246 and for 90% of all
individuals reaching VO2peak, n = 139. At the start of data analysis, the main outcome
variable (relative VO2peak) included 218/10189 (2.1%) missing values. A subsequent data
acquisition yielded the described numbers of non-missing cases (fig. 3.2). Therefore, the
sample size was adjusted for the amount of missing values. Hence, the final sample size
was calculated as:
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In order to test the representativity of the random sample for the full dataset, a set of
characteristics (A.1) were compared between the random sample and the full dataset.
However, none of the compared characteristics were significantly different between the
entire main study dataset and the random sample.
Record linkage
In contrast to the CPET modalities, information on the study centre was acquired from
the second database using record linkage. The information on the study centre was stored
in the database “PF Patient” and had to be linked with the main dataset, which was
based on the database “PF Studie”. However, as there was no key identifier to link both
databases, record linkage was necessary to merge “PF Studie” and “PF Patient”. As the
data were typed into the databases separately by hand, it was also necessary to consider
typing errors. Probabilistic record linkage was selected to address these conditions.
The participant’s name and sex were present in both databases and could be used for
record linkage. Birthdate was recorded in “PF Patient” but not in “PF Studie”, which
only included the year of the first contact with Prevention First® as well as the age in years
at the time of this contact. Based on this, the participant’s birth year could be determined
with an inaccuracy of one year. The calculated birth year was correct if the contact with
Prevention First® was later than the subjects birthday and it was one year too low if the
contact was before the subjects birthday. This inaccuracy was also necessary to consider
in probabilistic record linkage. In light of the above-mentioned requirements for record
linkage, two software programmes were considered: i) the R package recordlinkage [8]
and ii) “Fine-grained record linkage (FRIL)” software [29]. FRIL software performed
better using the specifications outlined in 3.2.
Table 3.2: Specifications of record linkage.
Variable Linkage algorithm Weight
First name Edit distance 40%
Last name Edit distance 40%
Year of birth Numeric distance 10%
Sex Equal fields 10%
Note: Acceptance level was set at 90; FRIL
software was used for record linkage [29].
Additional data acquisition
After drawing the random sample (section 3.3), additional data acquisition was conducted
for the full dataset aiming to reduce the number of missing values in the variables age
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as well as absolute and relative V̇O2peak. This yielded the final main study dataset as
described in fig. 3.2.

















The representativity of the present study population was analysed by comparing eligible
characteristics to data from DEGS1∗ [19]. DEGS1 is a study based on a representative
sample of the German population and was performed by the German governmental organ-
isation which is responsible for disease control and prevention (RKI†). The information
needed for the comparison with the present study was based on a cross-sectional study
sample with an enquiry period from 2008 to 2011. The study acquired a sample of 8,152
adult subjects using a multistage-sampling process. The participants of the study were
more than 18 years of age, and the sample was representative of the German population
from 2011.
Variables from the present study were eligible for comparison with DEGS1 if i) the in-
formation was recorded in “PF Studie” as well as in DEGS1, ii) the variable was binary,
coded with yes/no, iii) the unit of measurement of this characteristic was identical or
could be transformed to be identical, iv) 95% confidence intervals were provided for the
proportions in DEGS1, and v) the results were reported separately for men and women
in DEGS1. Eligible variables according to these criteria are displayed in table 3.3.
∗“Studie zur Gesundheit Erwachsener in Deutschland”
†“Robert Koch-Institut”
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Table 3.3: Eligible variables of the present study for comparison with DEGS1.
Characteristic DEGS1 source
Smoking status Lampert et al. (2013) [38]
Ex-smoker Lampert et al. (2013) [38]
Overweight Mensink et al. (2013)[43]
Obesity Mensink et al. (2013) [43]
High blood pressure Neuhauser et al. (2013) [48]
Note: Overweight: BMI ≥ 25 kg/m2
Obesity: BMI ≥ 30 kg/m2
Hypertension: systolic blood pressure ≥ 140
mmHg or diastolic blood pressure ≥ 90 mmHg
The variables of the present study were transformed to directly age-standardised propor-
tions using the R package epitools [2] to compare the results of DEGS1 to the present
population. The German population as reported in the census 2011 [62] was selected as
the standard population for age standardisation. This was done because the results of
DEGS1 were age-standardised for this population [38, 43, 48]. Consequently, only the
proportions of the present population had to be transformed to achieve comparability.
3.5 Sample description
To analyse differences in the study centres and to perform external validation, the full
dataset was separated into two datasets using i) data recorded in Rüdesheim or Frankfurt
and ii) data recorded in Munich. The separation was conducted in this form as there
were participants who could be assigned to either Rüdesheim or Frankfurt but not def-
initely to one of both locations. This was because some participants appeared in both
locations because they might have visited both study centres due to the spatial proximity
of Rüdesheim and Frankfurt. Participants who could not be assigned definitely to either
Rüdesheim/Frankfurt or Munich, on the other hand, were excluded from reference values.
Furthermore, participants with missing values in the variables age or absolute as well as
relative V̇O2peak were excluded.
In their systematic literature review, Paap & Takken (2014) [50] recommended to exclude
smokers, and earlier studies [34, 26] also excluded obese subjects in order to produce
reference values that are representative for a healthy population. Other reference values
did not exclude smokers or obese subjects [30, 17, 30, 53]. For purpose of this study,
smokers and obese subjects were not excluded in the main analysis, but subgroup analyses
were performed. A flow chart of excluded cases is displayed in fig. 3.2.
Participants aged 25 to 69 years were included in the present analysis. Participants
aged ≥70 years or < 25 years were excluded. The participants were excluded because
the integer variable “age in years” had to be transformed to a categorical variable with
5-year age classes to perform the apparent and external validation of the present study
(section 3.6). In this analysis, age class as an ordinally scaled variable was modelled as a
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metric predictor. This approach was critically discussed in the literature and required the
assumption of a metrically scaled variable [68]. Comparatively few cases of the present
study were recorded in the age groups of < 25 years and ≥70 years, and therefore the
reduction of the sample size was approved to perform the validation analysis as mentioned
above.
The final study dataset was compared with the cases that were excluded due to missing
values to analyse if there was a selective dropout of participants. Selective dropout could
bias the final results and would be present if participants with specific characteristics were
more likely to be excluded. Selective dropout can be analysed by comparing the excluded
and the included cases (table A.2). In the present study, some statistically significant
differences were present between both groups. However, the extents of the differences
were low, and the significant results were likely due to high numbers of cases. Selective
dropout that severely impacts the results of the present study was therefore unlikely.
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Figure 3.2: Flow chart showing numbers of cases included in reference values.
Baseline:
Overall n = 10,189
Men n = 6,512
Women n = 3,677
No missing values:
Overall n = 9,417
Men n = 6,098
Women n = 3,319
Included in analysis:
Overall n = 9,354
Men n = 6,063





- Apparent validation data
Overall n = 7,516
Men n = 4,710
Women n = 2,806
Study centre
Munich:
- External validation data
Overall n = 1,838
Men n = 1,353
Women n = 485
Excluded due to missing values:
V̇O2peak (absolute/relative) n = 96
Study centre n = 673
Age n = 3
Other exclusion criteria:
Age < 25 OR age ≥ 70 years n = 63
3.6 Statistical methods
General framework
The statistical analyses were performed using R software version 3.3.1 [54]. Analyses
were stratified for sex and adjusted for age if adequate. All 95% confidence intervals were
approximated using ordinary non-parametric bootstrapping with 10,000 pseudo-random
bootstrap samples [14, p. 120-123]. Statistical significance was assumed for P values
of less than 0.05 or when 95% confidence intervals did not overlap using a two-sided
significance level of α = 0.05. There was no correction of P values for multiple testing.
The computational code of statistical analyses should be published to ascertain repro-
ducible research [25, 52]. The code of the present analysis is outlined in chapter 7 and can
be accessed via the online appendix of this study at https://github.com/rappdaniel/vo2peak.
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Descriptive statistics
A subset of all variables in the original dataset was selected for descriptive statistics and
for multivariable quantile regression modelling. Quantitative variables were described as
median [1st quartile; 3rd quartile] and qualitative variables as n (%). Comparisons of
two groups were conducted using Mann-Whitney U test for quantitative variables and
χ2 test for qualitative variables. Fisher’s exact test was not considered as expected cell
counts with n < 5 under the null hypothesis were not present. Two-way descriptive tables
were performed using the R package compareGroups [65]. For quantitative variables, the
assumption of normal distribution was analysed using (supplementary tables, [49]):
1. box plots and histograms
2. skewness
3. quantile based skewness [22, p. 14]
Kolmogorov-Smirnov and Shapiro-Wilk tests were not applied as the sample size was
large and particularly Shapiro-Wilk tests cannot be computed for samples with n > 5000
using the described version of the R software [54].
Quantile regression modelling and conducting nomograms
Several approaches were used to arrange age-adjusted reference values as nomograms.
Kaminsky et al. [30, 31] categorised age in 10-year classes and calculated quantiles within
each class. The quantiles were also visualised using box plots for each age class. Well-
known and widely used nomograms are the WHO’s Child Growth Standards for paedi-
atrics [75]. For those nomograms, age was modelled as a continuous predictor, and cubic
spline smoothing was used to fit the regression models to the data [73]. Koch et al. (2009)
[34] published quantile reference values and nomograms for maximal oxygen uptake and
used polynomial quantile regression. Accordingly, the present study used quantile regres-
sions (R package quantreg [36]) to model conditional quantiles and to estimate predicted
quantile values of maximal oxygen uptake depending on age as a continuous predictor.
Age as a linear and polynomial predictor as well as b-spline smoothing (R package splines
[54]) were compared using Akaike Information Criterion (AIC) and also in apparent (sec-
tion 3.6). For nomograms, the quantiles 0.05, 0.1, 0.2, 0.25, 0.3, 0.4, 0.5, 0.6, 0.7, 0.75,
0.8, 0.9, and 0.95 were selected.
Validation of regression models
After fitting quantile regression, the models’ performance was tested and compared with
empirical data. Validation of the statistical models was also a quality criterion in the
systematic review of Paap & Takken (2014) [50]. Two major approaches were applied in
the underlying data analyses: i) in apparent validation, the regression fits were compared
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with the original data to which the regressions were fitted [64, p. 300]. This usually
leads to results that are too optimistic. Therefore, ii) in external validation the regression
fits were compared with new subjects who were not used to fit the regression models.
A graphical technique of model validation is the calibration plot [56] where predicted
and observed values are plotted. Additionally, linear ordinary least square regression
was performed in the calibration data using observed and predicted values of V̇O2peak as
dependent and independent variables, respectively.
To perform external validation in the present analysis, the dataset was split by study
centre prior to regression modelling. Data from Rüdesheim and Frankfurt were used
as training data to fit quantile regressions and data from Munich as validation data for
external validation. Compared to other predictive models, there were some challenges
in the validation of the present regression models. i) There were 13 regression models
(for the quantiles 0.05, 0.1,..., 0.95) for men and women each, ii) the goal of the present
analysis was not to get the best prediction of maximal oxygen uptake for a given age but to
predict quantiles for a given age. Due to these challenges, regular calibration plots could
not be performed. To address these problems, age was recoded into 5-year age classes
for model validation and empirical quantiles of V̇O2peak were calculated within each age
class. Subsequently, quantile regression models were fitted using the recoded age classes
as a metrically scaled predictor (section 3.5). That way, the predicted quantile could be
compared with the empirical quantile for each age class, and it was also possible to derive
observed and predicted values for all age classes and quantiles (figs. 4.7 to 4.10). It was
also possible to acquire one single calibration plot for all age classes and quantiles. For
model validation, the quantiles 0.25, 0.5, and 0.75 were selected and were coded in graphs
as ● 0.25, ▴ 0.5 and ◾ 0.75 (figs. 4.7 to 4.10). For the calibration plot, predictions from
all three quantile regressions (quantiles 0.25, 0.5, and 0.75) were compared to observed
data and plotted within a single calibration plot. Linear regression was performed using
the same calibration data to get one overall regression result for all quantiles.
Further nomograms and subgroup analyses
In addition to the described reference values, additional nomograms were conducted.
On the one hand, this was done to ascertain comparability with past studies that ex-
cluded smokers and obese participants [50]. On the other hand, subgroup analyses
were conducted using only participants from either Frankfurt and Rüdesheim or par-
ticipants from Munich. All nomograms can be accessed via the online appendix at
https://github.com/rappdaniel/vo2peak.
Measures of exertion in random sample
As described in sections 3.2 and 3.3, the measures of exertion were acquired for a random
sample of 252 subjects in the present study. It was not possible to exclude cases with poor
effort as the measures of exertion were not recorded in the entire main study dataset. This
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is a critical issue because participants who did not exert maximal effort are not valid and
should be excluded from the analysis. If, for example, a participant terminated CPET
immediately after the start because of anxiety caused by wearing the gas exchange mask,
the measured maximal oxygen uptake would be close to the resting oxygen consumption.
Such cases would distort the reference values. Therefore, this study aimed to estimate the
proportion of participants who did not continue CPET until the maximal volitional effort.
On the other hand, the goal was to estimate how the reference values were affected by
keeping such participants in the analysis. These analyses were performed in the random
sample in which the measures of maximal effort were gathered retrospectively. First, the
proportion and 95% confidence intervals of participants who did not reach the end criteria
(section 3.2) was calculated. Secondly, a visual approach was used: Median regression
lines were plotted using i) all cases of the random sample and ii) only cases which reached
exertion in CPET. Peak oxygen uptake was used as the dependent and age in years as the
independent variable, respectively. Additionally, an analysis of covariance was applied
using i) age in years, ii) exertion (yes/no) as well as iii) an interaction term of both
as independent variables in median regressions. This was done to derive P values for
the variable “exertion” and to see if the regression was significantly altered by keeping
subjects with poor effort in the data.
Multivariable regression modelling
The sample characteristics of the present dataset were considered for multivariable quan-
tile regression modelling. In contrast to the calculation of nomograms, the quantiles
0.25, 0.50, and 0.75 were used. A correlation matrix of all quantitative variables using
Spearman’s correlation coefficient was calculated before the variables were included in the
regression model to avoid collinearity. If there was a high correlation between two vari-
ables, one was considered to be eliminated heuristically. Histograms, as well as measures
of skewness, were used to check for normality of the distribution of quantitative variables.
If a quantitative variable appeared to follow a non-normal distribution, the variable was
recoded into a binary variable using dummy coding (0 = no, 1 = yes). All variables were
added to an AIC-based stepwise variable selection using backward and forward selection.
Furthermore, a pseudo R squared according to Hao et al. (2007) [22, p. 52] was calculated
for all quantile regression models.
Quantile calculator
The goal of the present analysis was to present reference values for peak oxygen uptake
that can be interpreted by physicians and CPET participants. An interactive web appli-
cation was created (section 7.1) to facilitate doctor-patient communication and increase
the value of the presented reference values in clinical practice (www.uks.eu/vo2peak). This
web application followed four goals:
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1. Plotting the individual results of a CPET participant that are obtained in the course
of a preventive health screening on a nomogram produced by the present study.
2. Calculating a sex-specific and age-specific percentile for the individual’s result. It
was aimed to present a percentile which is exact within one percent.
3. Optional plotting of 95% confidence intervals to visualise the uncertainty of the
estimation.
4. Interactive subgroup analyses by excluding smokers and obese participants from the
reference values.
The methods that were used for this web application were slightly different from the rest
of present analysis (chapter 3.3). The overall sample size in this analysis was 10,090
instead of 9,354 because participants who provided no information on the study centre
(n=673) and participants who were not 25 to 70 years old (n=63) were not excluded.
The material and methods for this analysis are also described in Rapp et al. (2018) [55].
The web application was created using the R software package shiny [10]. A screenshot
is displayed in fig. 4.12.
Parallelisation
Some of the statistical procedures of the present study were computationally intensive.
Especially the calculation of 95% confidence intervals using 10,000 bootstrap samples was
time-consuming. Therefore, parallel computing was applied to decrease the computation
time using the R software package parallel [54], and mostly 4 CPUs. The calculation
of 95% confidence intervals in the online web application required the greatest amount of
time. The hardware used for these calculations was a DELL-Server (DELL PowerEdge
R720) with two 8-core-processors (CPUs) and 256GB RAM memory using a Debian-
based Linux operating system. Despite using 12 of the 16 CPUs in this case, the overall
computation process lasted more than 150 hours.
Missing data
Participants with missing values in one of the primary variables of interest (peak oxy-
gen uptake, age and sex) were excluded from the data (fig. 3.2). In multiple quantile
regression, casewise deletion was used. Casewise deletion means that cases with a missing
value in the dependent variable or one of the independent variables are excluded from the
regression model in which they appear. In the R-code, casewise deletion is specified by
the term na.action = “na.omit”.
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3.7 Reporting
The results of the present study were reported according to the RECORD∗ guidelines
[69], which are an extension of the STROBE† reporting guidelines. A complete RECORD
checklist can be accessed via the online appendix [49].
∗Reporting of studies conducted using observational routinely-collected data




The time period of data collection ranged from 18 July 2001 to 20 November 2015.
Rüdesheim was the first study centre to record the data in 2001, followed by Frankfurt in
2006 and Munich in 2008. The cumulative number of participants by examination date
is plotted in fig. 4.1.
Overall, 9,354 participants (6,063 men, 3,291 women) were included in the analysis. 7,516
subjects (4,710 men, 2,806 women) were recorded in Rüdesheim or Frankfurt and 1,838
(1,353 men, 485 women) subjects were recorded in Munich (table 4.1).
The overall median age was 45 [41; 50] years for men and also for women (supplementary
table 1 [49]). Despite a high number of observations overall, the marginal age groups
were sparse. For example, only one women in the age class [30; 35) years was recorded in
Munich (table 4.1). The distributions of the participants’ ages are displayed in figs. A.1
and A.2.
Median absolute V̇O2peak was 3.0 LO2/min [2.6; 3.4] for men and 1.9 LO2/min [1.7; 2.2]
for women (supplementary table 1 [49]). Relative V̇O2peak was 35.3 mLO2/min/kg [30.3;
40.5] for men and 28.7 mLO2/min/kg [24.4; 33.2] for women. The differences between
men and women in both, absolute and relative V̇O2peak were statistically significant.
However, there was no statistically significant difference of peak oxygen uptake between
study centres except for absolute V̇O2peak in men (table 4.1).
Peak oxygen uptake was lower in older participants. In men, median relative V̇O2peak
was 37.2 mLO2/min/kg in the age group [25; 30) and 29.3 mLO2/min/kg in the age
group [65; 70). A similar decrease was observed in women. Quantiles of relative and
absolute V̇O2peak by sex and age group are displayed in tables 4.2 and 4.3, respectively.
The distribution of absolute and relative V̇O2peak is visualised in figure 4.2. Furthermore,
all quantitative characteristics were plotted as histograms and scatter plot matrices in
figs. A.1 to A.4.
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Figure 4.1: Cumulative number of participants from Rüdesheim, Frankfurt and Munich by date
































N=4710 N=1353 N=2806 N=485
V̇O2peak
Relative [mLO2/min/kg] 35.2 [30.3;40.5] 35.5 [30.3;40.6] 0.846 28.6 [24.3;33.1] 28.9 [24.7;33.8] 0.168
Absolute [LO2/min] 3.02 [2.64;3.41] 2.95 [2.57;3.36] <0.001 1.95 [1.68;2.20] 1.90 [1.66;2.19] 0.186
Anthropometric
Age [years] 45.0 [40.0;50.0] 46.0 [41.0;51.0] <0.001 45.0 [41.0;50.0] 45.0 [41.0;49.0] 0.863
Age class [years]
[25,30) 22 (0.47%) 3 (0.22%) 9 (0.32%) 4 (0.82%)
[30,35) 103 (2.19%) 21 (1.55%) 51 (1.82%) 1 (0.21%)
[35,40) 412 (8.75%) 132 (9.76%) 106 (3.78%) 25 (5.15%)
[40,45) 1816 (38.6%) 413 (30.5%) 1208 (43.1%) 197 (40.6%)
[45,50) 1056 (22.4%) 374 (27.6%) 655 (23.3%) 137 (28.2%)
[50,55) 721 (15.3%) 247 (18.3%) 439 (15.6%) 80 (16.5%)
[55,60) 401 (8.51%) 117 (8.65%) 232 (8.27%) 31 (6.39%)
[60,65) 143 (3.04%) 38 (2.81%) 81 (2.89%) 8 (1.65%)
[65,69] 36 (0.76%) 8 (0.59%) 25 (0.89%) 2 (0.41%)
Weight [kg] 85.0 [78.0;94.0] 83.0 [76.0;91.0] <0.001 67.0 [60.0;76.0] 64.0 [59.0;73.0] 0.001
Heigh [cm] 181 [177;186] 181 [177;185] 0.414 167 [163;172] 167 [163;172] 0.806
BMI [kg/m2] 25.7 [23.8;28.2] 25.2 [23.5;27.4] <0.001 23.8 [21.4;26.9] 23.1 [21.1;25.8] 0.001
Body fat Caliper [%] 23.0 [19.0;27.0] 22.6 [19.0;26.7] 0.173 31.0 [26.0;36.5] 28.5 [24.6;33.7] <0.001
Overweight <0.001 0.001
no 1865 (39.6%) 625 (46.2%) 1729 (61.7%) 337 (69.5%)
yes 2842 (60.4%) 728 (53.8%) 1075 (38.3%) 148 (30.5%)
Obesity <0.001 0.014
no 4078 (86.6%) 1228 (90.8%) 2474 (88.2%) 447 (92.2%)
yes 629 (13.4%) 125 (9.24%) 330 (11.8%) 38 (7.84%)
































N=4710 N=1353 N=2806 N=485
Blood pressure
Systolic [mmHg] 128 [120;138] 124 [118;134] <0.001 120 [110;130] 116 [106;128] 0.006
Diastolic [mmHg] 82.0 [80.0;90.0] 80.0 [78.0;88.0] <0.001 80.0 [70.0;82.0] 78.0 [70.0;82.0] 0.051
Hypertension 0.007 0.014
no 3193 (67.9%) 971 (71.8%) 2303 (82.1%) 421 (86.8%)
yes 1508 (32.1%) 381 (28.2%) 501 (17.9%) 64 (13.2%)
Glucose metabolism
Blood glucose [mg/dL] 96.0 [90.0;102] 93.0 [88.2;99.0] <0.001 91.0 [86.0;98.0] 89.5 [83.0;94.0] <0.001
HbA1c [%] 5.40 [5.10;5.60] 5.40 [5.20;5.60] <0.001 5.30 [5.10;5.60] 5.40 [5.20;5.50] 0.054
Diabetes mellitus 0.061 0.636
no 4524 (96.9%) 1305 (97.9%) 2738 (98.3%) 478 (98.8%)
yes 146 (3.13%) 28 (2.10%) 46 (1.65%) 6 (1.24%)
Lipid metabolism
Total cholesterol [mg/dL] 216 [191;242] 208 [185;232] <0.001 209 [186;235] 200 [180;222] <0.001
HDL cholesterol [mg/dL] 52.0 [45.0;60.0] 54.0 [47.0;63.0] <0.001 66.0 [56.0;75.0] 72.0 [61.0;84.0] <0.001
LDL cholesterol [mg/dL] 135 [114;158] 128 [107;151] <0.001 122 [102;145] 110 [94.0;131] <0.001
Triglycerides [mg/dL] 117 [85.0;164] 104 [75.0;149] <0.001 87.0 [68.0;119] 75.0 [58.0;100] <0.001
































N=4710 N=1353 N=2806 N=485
Smoking status
Smoker <0.001 <0.001
no 3990 (85.1%) 1226 (91.4%) 2352 (84.3%) 434 (90.8%)
yes 696 (14.9%) 116 (8.64%) 439 (15.7%) 44 (9.21%)
Ex-smoker <0.001 <0.001
no 3391 (72.4%) 1102 (82.1%) 2045 (73.3%) 395 (82.6%)
yes 1295 (27.6%) 240 (17.9%) 746 (26.7%) 83 (17.4%)
Note: Overweight: BMI ≥ 25kg/m2, obesity: BMI ≥ 30kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg or diastolic
blood pressure ≥ 90 mmHg
Quantitative characteristics are displayed as median [1st quartile; 3rd quartile], qualitative characteristics as n (%).
No P values were calculated for the characteristic “age class” because this resulted in 2-by-9 contingency tables with expected
cell counts with n < 5 under the null hypothesis were present.
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Figure 4.2: Box plots of absolute and relative V̇O2peak by age group.
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0.05 0.1 0.2 0.25 0.3 0.4 0.5 0.6 0.7 0.75 0.8 0.9 0.95 n
Female
[25,30) 23.1 23.5 25.1 26.1 27.9 32.5 34.2 35.2 37.4 39.1 39.8 40.6 40.9 13
[30,35) 20.3 24.2 25.9 26.4 27.2 30.0 30.8 32.5 34.0 34.8 36.4 40.1 43.5 52
[35,40) 22.9 25.1 26.7 27.4 28.6 30.1 31.8 33.8 35.0 36.5 37.8 40.5 44.1 131
[40,45) 20.4 22.4 24.9 26.0 27.0 28.6 30.0 31.7 33.3 34.5 35.4 38.4 40.4 1405
[45,50) 19.4 21.6 23.7 24.8 25.6 27.1 28.8 30.6 32.5 33.4 34.6 37.3 39.7 792
[50,55) 17.2 19.0 21.5 22.5 23.5 25.1 26.3 28.0 30.3 31.2 32.2 34.7 36.9 519
[55,60) 16.0 18.9 21.7 22.2 22.8 23.6 25.2 26.8 28.2 28.9 29.4 32.0 33.8 263
[60,65) 15.4 16.9 18.8 19.7 19.9 21.6 22.7 24.2 25.1 26.4 27.3 30.1 32.3 89
[65,69] 15.6 18.8 19.7 20.2 20.6 21.2 22.8 23.6 24.9 25.4 26.2 27.0 29.7 27
Male
[25,30) 29.7 30.9 33.1 33.5 33.7 35.9 37.2 37.8 39.3 39.9 40.3 42.1 44.0 25
[30,35) 26.8 28.5 31.7 33.6 34.1 36.5 38.7 40.4 42.8 43.9 45.3 48.0 50.9 124
[35,40) 26.2 29.5 31.8 32.9 34.2 36.1 38.5 40.3 42.5 43.4 44.8 47.8 50.7 544
[40,45) 25.4 28.0 30.9 32.0 33.1 34.9 36.8 38.7 40.7 41.9 43.2 46.5 49.5 2229
[45,50) 25.1 27.1 30.0 31.0 32.1 33.9 35.6 37.5 39.3 40.3 41.6 44.6 47.5 1430
[50,55) 21.7 24.0 27.3 28.2 29.2 30.9 32.8 34.9 36.7 37.6 39.2 42.7 46.2 968
[55,60) 20.8 23.2 25.4 26.6 27.3 29.1 30.7 32.7 34.7 35.7 36.7 39.7 42.8 518
[60,65) 19.5 21.7 24.1 24.8 25.7 27.7 28.6 29.8 31.7 32.1 33.3 37.7 40.7 181
[65,69] 19.7 22.0 23.7 24.5 26.1 27.9 29.3 30.1 30.6 32.8 34.8 36.4 38.0 44
Note: Relative V̇O2peak was measured in mLO2/min/kg, age in years, participants from Frankfurt,
Rüdesheim and Munich included.




0.05 0.1 0.2 0.25 0.3 0.4 0.5 0.6 0.7 0.75 0.8 0.9 0.95 n
Female
[25,30) 1.47 1.66 1.91 1.95 1.97 1.99 2.17 2.32 2.41 2.50 2.64 2.86 2.97 13
[30,35) 1.49 1.61 1.73 1.78 1.91 2.08 2.17 2.25 2.29 2.41 2.45 2.62 2.70 52
[35,40) 1.55 1.64 1.80 1.86 1.90 1.99 2.08 2.13 2.23 2.29 2.37 2.60 2.84 131
[40,45) 1.43 1.55 1.71 1.77 1.83 1.93 2.02 2.11 2.20 2.26 2.32 2.50 2.70 1405
[45,50) 1.37 1.50 1.66 1.72 1.78 1.88 1.97 2.06 2.17 2.23 2.29 2.47 2.65 792
[50,55) 1.25 1.36 1.54 1.59 1.63 1.72 1.81 1.90 2.00 2.05 2.12 2.30 2.43 519
[55,60) 1.16 1.34 1.46 1.51 1.55 1.63 1.71 1.80 1.86 1.92 2.02 2.10 2.25 263
[60,65) 1.10 1.19 1.29 1.33 1.38 1.47 1.55 1.65 1.74 1.79 1.86 2.00 2.07 89
[65,69] 1.37 1.43 1.48 1.50 1.52 1.57 1.62 1.68 1.73 1.75 1.77 2.03 2.11 27
Male
[25,30) 2.62 2.75 2.80 2.95 3.09 3.14 3.15 3.27 3.37 3.57 3.65 3.89 4.06 25
[30,35) 2.31 2.49 2.72 2.89 3.00 3.12 3.27 3.41 3.60 3.72 3.80 4.15 4.25 124
[35,40) 2.32 2.54 2.77 2.84 2.90 3.05 3.18 3.35 3.50 3.60 3.69 3.93 4.16 544
[40,45) 2.22 2.41 2.66 2.77 2.85 2.99 3.14 3.27 3.43 3.51 3.60 3.87 4.09 2229
[45,50) 2.17 2.37 2.59 2.66 2.74 2.89 3.02 3.17 3.31 3.40 3.49 3.75 3.95 1430
[50,55) 1.96 2.13 2.38 2.47 2.55 2.70 2.84 3.00 3.11 3.21 3.31 3.53 3.73 968
[55,60) 1.80 2.05 2.22 2.35 2.40 2.54 2.66 2.80 2.90 3.00 3.13 3.37 3.53 518
[60,65) 1.77 1.95 2.11 2.23 2.28 2.42 2.52 2.64 2.76 2.81 2.86 3.05 3.30 181
[65,69] 1.61 1.81 2.00 2.06 2.12 2.23 2.35 2.49 2.64 2.75 2.87 2.93 3.06 44
Note: Absolute V̇O2peak was measured in LO2/min, age in years, participants from Frankfurt,
Rüdesheim and Munich included.
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4.2 Representativity
To get information on the representativity for the German population, some characteris-
tics were compared between the underlying dataset and results from ’Studie zur Gesund-
heit Erwachsener in Deutschland’ (DEGS1) [32]. Five binary characteristics (smoker,
ex-smoker, overweight, obesity, hypertension) were measured equally in both sources and
were therefore eligible for comparison (table 4.4). Direct age standardisation was applied
to achieve comparable results (chapter 3.4).
Especially in women, the proportions of the underlying data differed from DEGS1 results.
The only non-significant difference was in ex-smoking. The differences between the present
study and DEGS1 were smaller in men. The proportions of smokers, overweight and obese
men were significantly lower in the present study. Almost all of these compared risk factors
were more prevalent in DEGS1 compared to the present study. Only hypertension in men
and ex-smoking in women were less prevalent in DEGS1 (table 4.4). Large differences
were observed for obesity in women as well as for smoking status in men. 23.9% of the
women in DEGS1 and only 12.1% in the present study were obese. In DEGS1, 26.1% of























Table 4.4: Comparison of study population to results of DEGS1.
Male Female
PF Studie DEGS1 PF Studie DEGS1
Smoker 14.7 (12.7 to 16.9) 26.1 (24.0 to 28.2) 14.7 (12.1 to 17.6) 21.4 (19.7 to 23.1)
Ex-smoker 29.9 (27.3 to 32.5) 33.7 (31.9 to 35.5) 26.9 (23.6 to 30.4) 22.8 (21.4 to 24.2)
Overweight 61.0 (58.3 to 63.6) 67.1 (65 to 69.2) 38.4 (35.0 to 42.1) 53.0 (50.8 to 55.1)
Obesity 13.9 (12.1 to 15.9) 23.3 (21.2 to 25.4) 12.1 (10.0 to 14.3) 23.9 (22.0 to 25.9)
Hypertension 36.4 (33.8 to 39.2) 33.3 (31.1 to 35.6) 20.7 (18.2 to 23.5) 29.9 (28.1 to 31.9)
Note: Frequencies are displayed as % [95% confidence interval]. For this analysis, participants from all study
centres (Frankfurt/Rüdesheim and Munich) were included (N = 9,354).
Overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥ 30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg
or diastolic blood pressure ≥ 90 mmHg.
DEGS1 data extraction for smoking and ex-smoking [38], overweight and obesity [43] and hypertension [48].
Direct age standardisation was performed for results from the present study with the R package epitools [2]
using the German age structure of 2011 as standard population [63]. Proportions in which 95% confidence
intervals do not overlap are printed bold.
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4.3 Nomograms and regression model validation
Quantile regressions were fitted using peak oxygen uptake as the dependent variable
and age in years of the participant as the independent variable to plot age-dependent
nomograms of peak oxygen uptake. Three different approaches of how to model age as
the independent variable were described in section 3.6. Age could be modelled as i) a
linear predictor, ii) a polynomial predictor or iii) using b-spline smoothing. All approaches
were compared using Akaike Information Criterion (AIC) as well as in apparent validation
of the models (figs. A.5 and A.6 and tables A.4 and A.5). Calibration data included three
quantile regressions for the quantiles 0.25, 0.5, and 0.75. Box plots of observed data
and predicted quantiles per age class were plotted (fig. A.5) and in calibration plots, the
results of all three regressions were compared with observed quantiles in each age group
(fig. A.6). The results from linear regressions that were fitted to calibration data are
displayed in table A.4.
Quantile regressions with b-spline smoothing showed the most accurate results in apparent
validation. Age as a linear predictor yielded the worst results. Age as a second-degree
polynomial predictor fell in between these approaches. As an example, the results from
linear regressions of calibration data should be outlined for men and relative V̇O2peak: In
apparent validation, intercept, slope and R squared were 6.21, 0.80 and 0.89 for linear
regression, 5.94, 0.83 and 0.92 for polynomial regression as well as 1.16, 0.97 and 0.98 for
regression with b-splines, respectively (table A.4). AICs in relative V̇O2peak of men for
median regressions were 8,175, 8,152, and 8,145 for linear regression, polynomial regression
and regressions with b-splines, respectively (A.5). Overall, spline regressions performed
best. Nevertheless, spline regression models often yield complex regression equations and
cannot be formulated like univariable, multivariable or polynomial regression models [42].
As the final models should be outlined in a table, the more feasible approach was selected
over the most accurate and final nomograms were conducted using age as a predictor with
a second-degree polynomial. The final models were defined as:
V̇O2peak i,τ = β̂0(τ) + β̂1(τ) ∗ agei + β̂2(τ) ∗ age
2
i + ei,τ (4.1)
where τ denotes the τ-quantile, i = 1,..., n the i-th participant, age indicates the age in
years of the participant β̂0, β̂1, β̂2 the regression coefficients to be estimated and e the
error term.
The validation of polynomial quantile regressions is displayed in figs. 4.7 to 4.8. Figure
4.7 shows predicted quantiles based on Frankfurt/Rüdesheim in comparison to observed
quantiles from Frankfurt/Rüdesheim. The 95% confidence intervals of the predicted values
(red shades) include a substantial proportion of the observed quantiles. This means that
there was no statistically significant difference between observed and predicted values.
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The predicted values were particularly accurate in central age classes and less accurate
in marginal age classes. Significant differences between predicted and observed quantiles
appeared especially in the age classes 25 to 29 years and 65 to 69 years. These results
were also observed in the calibration plot (fig. 4.8) with results of R squared close to
1, intercept close to 0 and slope close to 1. As to be expected, the results of external
validation showed less accurate results. However, especially the predictions in the central
age classes ranging from 30 to 59 years were still accurate. In the marginal age classes, it
has to be noted that the numbers of participants were low, leading to distorted empirical
quantiles (fig. 4.9). This could also be observed in the calibration plots where the linear
regressions showed some deviation from the angle bisector (fig. 4.10).
Regression coefficients of the final polynomial quantile regression models are displayed in
tables 4.5 and 4.6 and plotted in figs. 4.5 and 4.6.
In addition to the presented results, subgroup analyses were performed. Reference values
and nomograms were conducted using the entire dataset from Rüdesheim, Frankfurt and
Munich but also using only non-smokers and non-obese participants (supplementary tables
and figures, [49]).
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Figure 4.3: Nomogram of absolute V̇O2peak (Rüdesheim/Frankfurt)
Note: Participants from Rüdesheim and Frankfurt were included (2,806 women , 4,710 men).
Shades are 95% confidence intervals.
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Figure 4.4: Nomogram of relative V̇O2peak (Rüdesheim/Frankfurt)
Note: Participants from Rüdesheim and Frankfurt were included (2,806 women , 4,710 men).















































95% CI 95% CI 95% CI
Coefficient Lower bound Upper bound Coefficient Lower bound Upper bound Coefficient Lower bound Upper bound
Women
fit0.05 1.49913043 0.57906056 2.55129982 0.00916667 -0.03576120 0.04884738 -0.00025362 -0.00068089 0.00022411
fit0.1 2.10653061 0.87801975 2.70606696 -0.01180272 -0.03565934 0.04133534 -0.00003401 -0.00060396 0.00020259
fit0.2 2.06037037 0.99757677 2.58000000 -0.00018519 -0.02199574 0.04324667 -0.00018519 -0.00061728 0.00004548
fit0.25 2.06284600 1.41904762 2.92625754 0.00168129 -0.03425926 0.02863636 -0.00019981 -0.00047890 0.00017037
fit0.3 2.24454545 1.73953912 3.10143878 -0.00380808 -0.03949346 0.01845158 -0.00014478 -0.00039112 0.00022059
fit0.4 2.49637500 1.58473106 3.09074986 -0.00950000 -0.03444444 0.02871359 -0.00009375 -0.00048486 0.00015670
fit0.5 2.27391994 1.80357829 2.81044196 0.00387164 -0.01857143 0.02294894 -0.00023464 -0.00042357 -0.00000700
fit0.6 2.34365265 1.72597017 2.78857293 0.00549134 -0.01330923 0.03057967 -0.00026099 -0.00051054 -0.00006443
fit0.7 2.17450000 1.61368034 3.04000000 0.01662500 -0.01879120 0.03977625 -0.00037500 -0.00061006 -0.00001852
fit0.75 2.45054545 1.58603838 2.96052881 0.00778961 -0.01390476 0.04346154 -0.00028831 -0.00064935 -0.00006250
fit0.8 2.14655462 1.52331800 2.91912279 0.02270308 -0.00892053 0.04914586 -0.00043417 -0.00070996 -0.00011311
fit0.9 2.76728938 1.59563467 3.61307576 0.00614286 -0.02926714 0.05407547 -0.00028938 -0.00076925 0.00007775
fit0.95 2.70967546 1.46509311 4.05118261 0.01959770 -0.03775323 0.06983979 -0.00046991 -0.00096202 0.00013889
Men
fit0.05 2.01681818 0.69031328 3.04755405 0.03117045 -0.01423629 0.08840770 -0.00060227 -0.00121296 -0.00011252
fit0.1 2.12961538 1.22997586 3.24016740 0.03401282 -0.01423148 0.07290991 -0.00062821 -0.00104848 -0.00011396
fit0.2 2.38682051 1.88285642 3.51403260 0.03267873 -0.01388917 0.05393145 -0.00061237 -0.00083575 -0.00013689
fit0.25 2.88086957 1.89875652 3.55889773 0.01565217 -0.01273666 0.05764334 -0.00043478 -0.00087558 -0.00013974
fit0.3 2.91333333 2.16329239 3.39361014 0.01857143 -0.00232158 0.05000046 -0.00047619 -0.00080000 -0.00025000
fit0.4 2.76311037 2.29830183 3.34193204 0.03023226 0.00621205 0.05076022 -0.00058900 -0.00080953 -0.00034446
fit0.5 2.79016667 2.19178512 3.41613125 0.03676786 0.01027467 0.06064167 -0.00067560 -0.00091471 -0.00040070
fit0.6 2.93021008 2.27226144 3.74169030 0.03679622 0.00338730 0.06380689 -0.00068277 -0.00095586 -0.00034259
fit0.7 3.31865801 2.39498904 4.13723057 0.02893939 -0.00540859 0.06700078 -0.00062771 -0.00101121 -0.00027174
fit0.75 3.44690821 2.52533731 4.33076923 0.02795743 -0.00880982 0.06764484 -0.00062651 -0.00103451 -0.00025132
fit0.8 3.66909091 2.65130000 4.39115654 0.02250000 -0.00773616 0.06597359 -0.00056818 -0.00102779 -0.00025298
fit0.9 3.77000000 2.82190745 4.69615087 0.02984848 -0.00780413 0.07077050 -0.00064738 -0.00107629 -0.00026695
fit0.95 3.47483516 2.59020000 4.36079514 0.05066904 0.01467532 0.08978920 -0.00086296 -0.00127605 -0.00051435















































95% CI 95% CI 95% CI
Coefficient Lower bound Upper bound Coefficient Lower bound Upper bound Coefficient Lower bound Upper bound
Women
fit0.05 23.84835165 5.59087363 50.10395565 0.05785714 -1.05766005 0.80808081 -0.00335165 -0.01087569 0.00828160
fit0.1 33.97500000 18.19006800 43.70057692 -0.27500000 -0.69098656 0.39722149 -0.00000000 -0.00702743 0.00443350
fit0.2 40.43443223 24.81967857 51.45452772 -0.44472527 -0.88907457 0.20955888 0.00172161 -0.00500019 0.00608467
fit0.25 36.92186235 27.44654913 52.76745790 -0.25205321 -0.87316774 0.14559597 -0.00028918 -0.00439815 0.00571448
fit0.3 40.60000000 28.60000000 51.31336184 -0.34722222 -0.79009010 0.14013260 0.00046296 -0.00434783 0.00493336
fit0.4 38.79090909 29.83139244 49.74464580 -0.18954545 -0.64419192 0.17418103 -0.00136364 -0.00492071 0.00328683
fit0.5 39.08561208 29.59427572 47.29127948 -0.13156598 -0.48431904 0.24256936 -0.00204293 -0.00571978 0.00172630
fit0.6 36.30400000 26.91236870 46.57357367 0.05600000 -0.36562469 0.44546489 -0.00400000 -0.00796333 0.00023389
fit0.7 35.43421053 24.80867857 49.55557875 0.16206140 -0.42500000 0.61746128 -0.00504386 -0.00991429 0.00092639
fit0.75 37.06990553 23.17532322 51.68217906 0.14028340 -0.44874416 0.71469368 -0.00492578 -0.01077501 0.00087933
fit0.8 42.74829932 27.61014348 52.20000000 -0.03265306 -0.41126892 0.59666723 -0.00340136 -0.00980392 0.00036332
fit0.9 37.39480519 28.70107143 55.42313862 0.30930736 -0.42363415 0.65714547 -0.00692641 -0.01031061 0.00047619
fit0.95 36.22440000 23.26127906 60.39901657 0.50340000 -0.54513889 0.99632070 -0.00940000 -0.01404791 0.00176304
Men
fit0.05 28.48571429 13.51236584 37.21760006 0.09285714 -0.27608749 0.74345431 -0.00396825 -0.01093750 -0.00000000
fit0.1 27.88750000 19.37541893 41.02363248 0.25555556 -0.31394850 0.60809598 -0.00601852 -0.00960426 0.00000000
fit0.2 31.39411765 20.99703725 39.25569048 0.22835294 -0.10408144 0.67366977 -0.00576471 -0.01041098 -0.00236799
fit0.25 29.13552632 23.26838235 37.53445760 0.37580409 0.01533095 0.63142962 -0.00738304 -0.01012987 -0.00365365
fit0.3 29.32000000 22.28888889 38.71196815 0.42400000 0.03333180 0.73387758 -0.00800000 -0.01134086 -0.00400942
fit0.4 31.32521008 20.88379840 40.66076087 0.42710084 0.03901366 0.84573873 -0.00819328 -0.01233775 -0.00414456
fit0.5 35.04000000 25.28893872 43.13656566 0.35500000 0.01778344 0.77170597 -0.00750000 -0.01192318 -0.00406143
fit0.6 35.34126984 29.02319610 44.60513183 0.42412698 0.04187771 0.70001282 -0.00825397 -0.01118308 -0.00443175
fit0.7 35.49010989 26.26422054 46.28282552 0.52516484 0.06362250 0.90667045 -0.00956044 -0.01335110 -0.00467829
fit0.75 36.55503247 27.04126082 46.66736161 0.52857143 0.11196168 0.93800238 -0.00957792 -0.01388286 -0.00540391
fit0.8 37.67414530 26.01267857 50.32868654 0.55384615 0.00917467 1.03611742 -0.01004274 -0.01497867 -0.00428571
fit0.9 48.66599327 33.83227273 66.70263062 0.23686869 -0.50892308 0.86269943 -0.00690236 -0.01339288 0.00070355
fit0.95 47.24897959 33.48281704 61.63508967 0.38350340 -0.21507143 0.96266353 -0.00799320 -0.01387266 -0.00182853
Note: Relative V̇O2peak was measured in mLO2/min/kg.
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Figure 4.5: Coefficient plots of all quantile regressions coefficients plotted in nomograms (abso-
lute V̇O2peak, table 4.5).
Figure 4.6: Coefficient plots of all quantile regressions coefficients plotted in nomograms (relative
V̇O2peak, table 4.6).
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Figure 4.7: Apparent validation of quantile regression models.
Note: Quantiles are displayed as ● = 0.25, ▴ = 0.5, ◾ = 0.75.
For apparent validation, the box plots as well as the regression predictions were based on partic-
ipants from Frankfurt/Rüdesheim. The 95% confidence intervals for predicted values are plotted
in red; age was modelled in classes.
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Figure 4.8: Apparent validation calibration plots.
Note: Quantiles are displayed as ● = 0.25, ▴ = 0.5, ◾ = 0.75.
For apparent validation, the observed values as well as the regression predictions were based on
participants from Frankfurt/Rüdesheim.
47
4.3. NOMOGRAMS AND REGRESSION MODEL VALIDATION 4. Results
Figure 4.9: Apparent validation of quantile regression models.
Note: Quantiles are displayed as ● = 0.25, ▴ = 0.5, ◾ = 0.75. For external validation, participants
from Munich were used for the box plots and participants from Frankfurt/Rüdesheim were used
to to obtain predicted values. The 95% confidence intervals for predicted values are plotted in
red; age was modelled in classes.
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Figure 4.10: External validation calibration plots.
Note: Quantiles are displayed as ● = 0.25, ▴ = 0.5, ◾ = 0.75.
For external validation, the observed values were based on participants from Munich and the
predicted values were based on participants from Frankfurt/Rüdesheim.
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Table 4.7: Regression coefficients and R squared for linear regression in calibration data for
apparent validation.
Absolute V̇O2peak Relative V̇O2peak
Women
Intercept 0.11 [-0.12 to 0.33] 1.06 [-1.29 to 3.35]
Slope 0.94 [0.83 to 1.05] 0.97 [0.88 to 1.05]
R squared 0.95 [0.92 to 0.99] 0.95 [0.9 to 0.98]
Men
Intercept 0.26 [0.07 to 0.45] 5.94 [1.35 to 9.91]
Slope 0.91 [0.84 to 0.97] 0.83 [0.71 to 0.96]
R squared 0.97 [0.95 to 0.99] 0.92 [0.85 to 0.97]
95% confidence intervals in square brackets.
Table 4.8: Regression coefficients and R squared for linear regression in calibration data for
external validation.
Absolute V̇O2peak Relative V̇O2peak
Women
Intercept 0.64 [0.26 to 0.96] 8.54 [2.48 to 14.63]
Slope 0.63 [0.46 to 0.83] 0.67 [0.45 to 0.91]
R squared 0.64 [0.4 to 0.85] 0.65 [0.4 to 0.87]
Men
Intercept 0.01 [-0.18 to 0.22] 1.47 [-2.73 to 4.61]
Slope 0.97 [0.9 to 1.04] 0.99 [0.9 to 1.12]
R squared 0.98 [0.96 to 0.99] 0.94 [0.9 to 0.97]
95% confidence intervals in square brackets.
4.4 Exercise test modalities and random sample
Some characteristics of CPET test modalities were not recorded in the full dataset. There-
fore, 252 participants were randomly selected from the entire main study dataset, and
CPET modalities were manually added from medical records for this random sample
(chapter 3.3). Some characteristics were compared between full dataset and the random
sample (table A.1), to evaluate wheather the random sample was representative for the
whole dataset. However, none of the characteristics were significantly different in the two
datasets. Therefore, the representativity of the random sample was assumed.
Three measures of the participants’ effort were analysed in the random sample. Adequate
effort was defined when either RER ≥ 1.1 or lactate ≥ 8 mmol/L or the heart rate was ≥
90% of the age-predicted maximal heart rate [66, 45]. Overall, 239/247 (96.8% 95% CI
94.4% to 98.8%) of the observations achieved exertion as defined above. This proportion
was 150/155 (96.8% 95% CI 93.6% to 99.4%) in men and 89/92 (96.7% 95% CI 92.5% to
100%) in women. In five participants who were selected for the random sample, none of
these three variables was recorded.
Multistage protocols were used in 130/243 (54%, 95% CI 47% to 60%) exercise tests of the
random sample, and ramp protocols in 113/243 (47%, 95% CI 40% to 53%) exercise tests
of the random sample. The overall median maximal heart rate was 174/min [164;182]
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(men: 174/min [165;182], women: 175/min [163;182]).
To depict how reference values were affected when subjects with poor effort were excluded,
median regressions were fitted for i) the entire random sample and ii) individuals with no
adequate effort excluded (fig. 4.11). The regression lines were approximately congruent.
In addition to the graphical approach, median regressions were also calculated for the
sample data, including an interaction term of age and exertion as the independent variable
(4.9). None of the regression coefficients were statistically significant.
Figure 4.11: Median regressions for inclusion versus exclusion of participants with no maximal
effort.
Note: Median regressions were calculated using i) all subjects without missing values in the
random sample (n = 247) and ii) only subjects that showed maximal effort (n = 239, dashed line,
table 2.1). Participants with no adequate effort are printed red.
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Table 4.9: Median regression using exertion and age as interaction terms.
95% CI
Coefficients Lower bound Upper bound P value
Men, absolute V̇O2peak
Intercept 12.61 -27.95 25.08 0.262
Age -0.20 -0.45 0.61 0.352
Exertion(yes) -3.99 -10.18 16.18 0.477
Age * Exertion(yes) 0.08 -0.32 0.21 0.447
Men, relative V̇O2peak
Intercept 165.81 -402.94 345.16 0.232
Age -2.73 -6.24 8.72 0.309
Exertion(yes) -57.26 -144.86 225.74 0.408
Age * Exertion(yes) 1.18 -4.52 2.89 0.380
Women, absolute V̇O2peak
Intercept 1.29 -0.39 3.95 0.322
Age -0.00 -0.04 0.04 1.000
Exertion(yes) 0.47 -1.07 1.54 0.519
Age * Exertion(yes) -0.00 -0.03 0.02 0.817
Women, relative V̇O2peak
Intercept 18.27 -1.48 31.99 0.108
Age 0.11 -0.24 0.57 0.633
Exertion(yes) 5.85 -4.54 20.94 0.414
Age * Exertion(yes) -0.07 -0.38 0.18 0.636
Note: Exertion was coded as “yes” =2 and “no” = 1. Only 5 men and 3
women were recorded in the group exertion = “no”. Therefore, the results
have to be interpreted with caution.
4.5 Web application
An interactive web application was created to facilitate the interpretation of the present
study’s results. This application can be accessed at www.uks.eu/vo2peak. A screenshot
is displayed in fig. 4.12.
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Figure 4.12: Screenshot of the V̇O2peak calculator web application which was deployed as part
of the present study (www.uks.eu/vo2peak, section 3.6, [55])
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4.6 Multivariable analyses
An explorative multivariable regression modelling was performed to find associations of
peak oxygen uptake and characteristics of the present study sample. Quantile regressions
were calculated using the quantiles 0.25, 0.5, and 0.75. The regression coefficients are
displayed in tables 4.10 to 4.13. Figs. 4.13, 4.14, 4.15, and 4.16 are coefficient plots of
the regression coefficients.
Correlation matrices were calculated for all eligible quantitative variables that were con-
sidered for multivariable regression (figs. A.3 and A.4) to avoid collinearity. Some variables
were excluded because they were shown to be highly correlated. A high correlation was
observed between BMI, body weight, waist circumference and body fat. Therefore, only
BMI was considered for multivariable analyses and body weight, waist circumference and
body fat were excluded. Another high correlation was present between total cholesterol
and LDL cholesterol. As total cholesterol includes HDL and LDL cholesterol, and HDL
cholesterol was also considered for the analysis, total cholesterol was excluded. LDL and
HDL were recoded into binary variables (section 3.2) because some skewed distributions
were observed.
The regressions’ goodness of fit showed to be quite high in absolute V̇O2peak and lower
in relative V̇O2peak. In absolute V̇O2peak, all R squared were above 90%. In relative
V̇O2peak, R squared were observed to be around 20% (figs. 4.13 to 4.16).
Some characteristics were associated with peak oxygen uptake in the multivariable anal-
yses. Age showed statistically significant associations in both sexes and in all regressions.
Peak oxygen uptake was lower in older ages. In both men and women, cigarette smoking
was found to be strongly associated with absolute and relative V̇O2peak. This was also
observed across all regression quantiles. In men, for example, the estimated 0.75 quantile
of relative V̇O2peak was 2.2 mLO2/min/kg (95% CI 2.9 to 1.3) lower compared to non-
smokers. Furthermore, triglycerides were shown to be negatively associated with peak
oxygen uptake in all regressions. In women with elevated triglycerides, the estimated
0.75 quantile of relative V̇O2peak was 2.2 mLO2/min/kg (95% CI 2.9 to 1.1) lower com-
pared to women with triglyceride levels below 150 mg/dL. Low HDL cholesterol levels
were also strongly associated with lower peak oxygen uptake across all regressions of men
but in none of the models of women. The estimated 0.75 quantile of relative V̇O2peak
was 2.1 mLO2/min/kg (95% CI 2.9 to 1.4) lower compared to men with HDL cholesterol
levels above 40 mg/dL. The body composition, represented by overweight and obesity,
was also associated with decreased relative and increased absolute V̇O2peak. On the other
hand, body height was shown to be positively associated with absolute peak oxygen up-
take. Diabetes mellitus and hypertension were associated with lower peak oxygen uptake
especially in men.
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Figure 4.13: Coefficient plots of multivariable quantile regression models for absolute V̇O2peak
in men.
Note: Dependent variable = absolute V̇O2peak [LO2/min].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Independent variables were
selected using stepwise regression. AIC was used as criterion statistic for model comparison.
Backward and forward variable elimination were selected as direction. Pseudo R2 was calculated
according to [22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥
30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90
mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL, high LDL: LDL cholesterol ≥ 115 mg/dL, high
TG: triglycerides ≥ 150 mg/dL, diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5%
(section 3.2). 55
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Figure 4.14: Coefficient plots of multivariable quantile regression models for absolute V̇O2peak
in women.
Note: Dependent variable = absolute V̇O2peak [LO2/min].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Independent variables were
selected using stepwise regression. AIC was used as criterion statistic for model comparison.
Backward variable elimination was selected as direction. Pseudo R2 was calculated according to
[22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥
30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90
mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL, high LDL: LDL cholesterol ≥ 115 mg/dL, high
TG: triglycerides ≥ 150 mg/dL, diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5%
(section 3.2). 56
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Figure 4.15: Coefficient plots of multivariable quantile regression models for relative V̇O2peak in
men.
Note: Dependent variable = relative V̇O2peak [mLO2/min/kg].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Independent variables were
selected using stepwise regression. AIC was used as criterion statistic for model comparison.
Backward variable elimination was selected as direction. Pseudo R2 was calculated according to
[22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥
30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90
mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL, high LDL: LDL cholesterol ≥ 115 mg/dL, high
TG: triglycerides ≥ 150 mg/dL, diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5%
(section 3.2). 57
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Figure 4.16: Coefficient plots of multivariable quantile regression models for relative V̇O2peak in
women.
Note: Dependent variable = relative V̇O2peak [mLO2/min/kg].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Independent variables were
selected using stepwise regression. AIC was used as criterion statistic for model comparison.
Backward variable elimination was selected as direction. Pseudo R2 was calculated according to
[22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥
30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90
mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL, high LDL: LDL cholesterol ≥ 115 mg/dL, high
TG: triglycerides ≥ 150 mg/dL, diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5%
(section 3.2). 58
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Table 4.10: Regression coefficients of multivariable quantile regressions for relative V̇O2peak in
men.
95% CI
Coefficient Lower bound Upper bound P value
Quantile 0.25
Intercept 46.80 45.38 48.10 <0.001
Age -0.24 -0.27 -0.21 <0.001
Overweight -3.41 -3.80 -2.94 <0.001
Obese -4.89 -5.40 -4.32 <0.001
Hypertension -1.03 -1.43 -0.59 <0.001
Low HDL -1.80 -2.31 -1.08 <0.001
High LDL -0.52 -1.00 -0.10 0.025
High TG -1.40 -1.81 -1.02 <0.001
Diabetes mellitus -2.16 -3.22 -0.71 0.001
Smoker -1.76 -2.39 -1.17 <0.001
Ex-smoker -0.28 -0.73 0.18 0.219
Quantile 0.50
Intercept 59.61 52.47 65.60 <0.001
Age -0.28 -0.31 -0.25 <0.001
Height -0.04 -0.07 <-0.01 0.029
Overweight -3.82 -4.27 -3.33 <0.001
Obese -5.39 -5.94 -4.76 <0.001
Hypertension -0.52 -1.00 -0.11 0.023
Low HDL -1.53 -2.39 -0.98 <0.001
High LDL -0.65 -1.13 -0.19 0.006
High TG -1.80 -2.24 -1.29 <0.001
Diabetes mellitus -2.00 -3.10 -0.92 <0.001
Smoker -1.95 -2.54 -1.48 <0.001
Quantile 0.75
Intercept 68.18 62.22 73.78 <0.001
Age -0.30 -0.34 -0.26 <0.001
Height -0.05 -0.08 -0.02 <0.001
Overweight -3.95 -4.51 -3.49 <0.001
Obese -5.75 -6.37 -5.17 <0.001
Hypertension -0.94 -1.32 -0.40 <0.001
Low HDL -2.11 -2.91 -1.35 <0.001
High LDL -0.67 -1.23 -0.18 0.013
High TG -2.03 -2.47 -1.51 <0.001
Diabetes mellitus -1.61 -3.13 -0.30 0.031
Smoker -2.16 -2.89 -1.33 <0.001
Exsmoker -0.34 -0.78 0.20 0.178
Note: Dependent variable = relative V̇O2peak [mLO2/min/kg].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Inde-
pendent variables were selected using stepwise regression. AIC was used as
criterion statistic for model comparison. Backward variable elimination was
selected as direction. Pseudo R2 was calculated according to [22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2,
obesity: BMI ≥ 30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg
or diastolic blood pressure ≥ 90 mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL,
high LDL: LDL cholesterol ≥ 115 mg/dL, high TG: triglycerides ≥ 150 mg/dL,
diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5% (section 3.2).
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Table 4.11: Regression coefficients of multivariable quantile regressions for relative V̇O2peak in
women.
95% CI
Coefficient Lower bound Upper bound P value
Quantile 0.25
Intercept 32.26 25.74 38.11 <0.001
Age -0.20 -0.23 -0.17 <0.001
Height 0.03 <-0.01 0.07 0.077
Overweight -3.70 -4.21 -3.21 <0.001
Obese -3.96 -4.70 -3.34 <0.001
Hypertension -1.32 -1.80 -0.63 <0.001
High LDL -0.40 -0.77 0.07 0.064
High TG -1.29 -1.94 -0.58 <0.001
Smoker -1.27 -1.88 -0.60 <0.001
Ex-smoker 0.40 -0.10 0.87 0.099
Quantile 0.50
Intercept 42.03 40.48 43.50 <0.001
Age -0.23 -0.26 -0.20 <0.001
Overweight -4.23 -4.65 -3.80 <0.001
Obese -4.10 -4.78 -3.47 <0.001
Hypertension -1.27 -1.97 -0.60 <0.001
High TG -1.73 -2.59 -1.09 <0.001
Diabetes mellitus -1.23 -2.20 0.34 0.065
Smoker -1.30 -1.85 -0.77 <0.001
Ex-smoker 0.40 -0.13 0.85 0.115
Quantile 0.75
Intercept 47.36 45.34 49.11 <0.001
Age -0.27 -0.31 -0.23 <0.001
Overweight -4.86 -5.51 -4.25 <0.001
Obese -4.59 -5.38 -3.65 <0.001
Hypertension -0.37 -1.29 0.20 0.344
High TG -2.20 -2.94 -1.05 <0.001
Smoker -1.10 -1.98 -0.15 0.016
Ex-smoker 0.39 -0.18 0.95 0.177
Note: Dependent variable = relative V̇O2peak [mLO2/min/kg].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Inde-
pendent variables were selected using stepwise regression. AIC was used as
criterion statistic for model comparison. Backward variable elimination was
selected as direction. Pseudo R2 was calculated according to [22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2,
obesity: BMI ≥ 30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg
or diastolic blood pressure ≥ 90 mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL,
high LDL: LDL cholesterol ≥ 115 mg/dL, high TG: triglycerides ≥ 150 mg/dL,
diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5% (section 3.2).
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Table 4.12: Regression coefficients of multivariable quantile regressions for absolute V̇O2peak in
men.
95% CI
Coefficient Lower bound Upper bound P value
Quantile 0.25
Intercept -1.70 -2.25 -1.20 <0.001
Age -0.02 -0.02 -0.02 <0.001
Height 0.03 0.03 0.03 <0.001
Overweight 0.15 0.11 0.18 <0.001
Obese 0.05 -0.01 0.10 0.072
Hypertension -0.04 -0.08 0.01 0.098
Low HDL -0.12 -0.17 -0.06 <0.001
High LDL -0.02 -0.07 0.01 0.251
High TG -0.08 -0.12 -0.05 <0.001
Diabetes mellitus -0.16 -0.29 -0.05 0.006
Smoker -0.14 -0.17 -0.09 <0.001
Quantile 0.50
Intercept -1.31 -1.73 -0.79 <0.001
Age -0.02 -0.02 -0.02 <0.001
Height 0.03 0.03 0.03 <0.001
Overweight 0.13 0.10 0.16 <0.001
Low HDL -0.12 -0.17 -0.06 <0.001
High LDL -0.03 -0.07 0.01 0.104
High TG -0.11 -0.15 -0.07 <0.001
Diabetes mellitus -0.15 -0.22 -0.04 0.002
Smoker -0.17 -0.20 -0.12 <0.001
Quantile 0.75
Intercept -1.02 -1.54 -0.50 <0.001
Age -0.02 -0.03 -0.02 <0.001
Height 0.03 0.03 0.03 <0.001
Overweight 0.15 0.11 0.19 <0.001
Hypertension -0.03 -0.07 0.01 0.154
Low HDL -0.14 -0.19 -0.09 <0.001
High LDL -0.04 -0.09 -0.01 0.021
High TG -0.12 -0.16 -0.08 <0.001
Diabetes mellitus -0.13 -0.26 0.00 0.053
Smoker -0.18 -0.23 -0.14 <0.001
Ex-smoker -0.02 -0.06 0.02 0.211
Note: Dependent variable = absolute V̇O2peak [LO2/min].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Inde-
pendent variables were selected using stepwise regression. AIC was used as
criterion statistic for model comparison. Backward variable elimination was
selected as direction. Pseudo R2 was calculated according to [22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2,
obesity: BMI ≥ 30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg
or diastolic blood pressure ≥ 90 mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL,
high LDL: LDL cholesterol ≥ 115 mg/dL, high TG: triglycerides ≥ 150 mg/dL,
diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5% (section 3.2).
61
4.6. MULTIVARIABLE ANALYSES 4. Results
Table 4.13: Regression coefficients of multivariable quantile regressions for absolute V̇O2peak in
women.
95% CI
Coefficient Lower bound Upper bound P value
Quantile 0.25
Intercept -1.32 -1.77 -0.89 <0.001
Age -0.01 -0.02 -0.01 <0.001
Height 0.02 0.02 0.02 <0.001
Overweight 0.12 0.08 0.16 <0.001
Obese 0.07 0.02 0.13 0.013
Hypertension -0.03 -0.06 0.01 0.173
Low HDL 0.08 -0.02 0.15 0.068
High TG -0.09 -0.15 -0.04 0.001
Smoker -0.10 -0.14 -0.03 <0.001
Ex-smoker 0.04 <0.01 0.08 0.046
Quantile 0.50
Intercept -0.92 -1.37 -0.54 <0.001
Age -0.01 -0.02 -0.01 <0.001
Height 0.02 0.02 0.02 <0.001
Overweight 0.10 0.08 0.14 <0.001
Obese 0.13 0.07 0.18 <0.001
Hypertension -0.05 -0.09 -0.01 0.023
High TG -0.09 -0.15 -0.05 <0.001
Smoker -0.11 -0.15 -0.07 <0.001
Ex-smoker 0.03 -0.01 0.05 0.097
Quantile 0.75
Intercept -1.10 -1.58 -0.62 <0.001
Age -0.02 -0.02 -0.01 <0.001
Height 0.02 0.02 0.03 <0.001
Overweight 0.11 0.08 0.15 <0.001
Obese 0.15 0.09 0.20 <0.001
High TG -0.13 -0.17 -0.05 <0.001
Diabetes mellitus -0.12 -0.19 0.18 0.218
Smoker -0.12 -0.16 -0.07 <0.001
Note: Dependent variable = absolute V̇O2peak [LO2/min].
Quantile regressions for the quantiles 0.25, 0.5, and 0.75 were fitted. Inde-
pendent variables were selected using stepwise regression. AIC was used as
criterion statistic for model comparison. Backward variable elimination was
selected as direction. Pseudo R2 was calculated according to [22, p. 52].
Units of measurement: age [years], height [cm], overweight: BMI ≥ 25 kg/m2,
obesity: BMI ≥ 30 kg/m2, hypertension: systolic blood pressure ≥ 140 mmHg
or diastolic blood pressure ≥ 90 mmHg, low HDL: HDL cholesterol ≤ 40 mg/dL,
high LDL: LDL cholesterol ≥ 115 mg/dL, high TG: triglycerides ≥ 150 mg/dL,
diabetes mellitus: fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5% (section 3.2).
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5 Discussion
Low CRF is a crucial predictor for a plethora of health threats as well as for premature all-
cause mortality. The measurement of CRF in the course of preventive health screenings is
valuable because regular exercise can increase CRF. CRF is accepted as one of the most
important modifiable risk factors due to strong associations with cardiovascular disease
and premature all-cause mortality (section 2.1). Therefore, incremental cardiopulmonary
exercise testing is a frequently applied procedure in clinical practice to estimate cardiores-
piratory fitness by determining peak oxygen uptake. However, as V̇O2peak is associated
with sex and age [23], it is only conclusive to interpret the V̇O2peak of an individual in the
light of sex-specific and age-specific reference values. The presented study provides sex-
specific and age-specific reference values for peak oxygen uptake that are based on 25- to
69-year-old participants who underwent primary preventive health screenings and CPET
using cycle ergometry in one of three German cities. By acquiring 9,354 participants, this
study is one of the largest that has been published so far in this field [50] [53, p. 88].
This chapter discusses the results of the present study. First, the presented reference
values are compared with the literature in section 5.1. The representativity of this study
population and the generalisability of the results is described in section 5.2. The sections
5.3, 5.4, and 5.5 discuss the quality of V̇O2peak measurement, the statistical methods
as well as the results of the multivariable quantile regressions, respectively. Finally the
strengths and limitations of this study are outlined in section 5.6.
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5.1 Reference values
The presented values for V̇O2peak showed a strong association with sex and age. Women
had lower peak oxygen uptake compared to men and participants with higher ages had
a lower peak oxygen uptake than younger participants. Furthermore, there was a wide
range of V̇O2peak for a given sex and age, which was likely to be - at least partially -
the result of physical activity and endurance exercise. The decline over age was present
in both sexes and at all levels of fitness. Hawkins & Wiswell (2003) [23] described that
the age-dependent decline of V̇O2peak was approximately 10% per decade regardless of
the individual level of fitness. In the present study, this decline seems to be lower in
both sexes. Median relative V̇O2peak in men at the ages of 30, 40, 50 and 60 years were
38.9, 37.2, 34.0 and 29.3 mLO2/min/kg, respectively. In women, it was 33.3, 30.6, 27.4
and 23.8 mLO2/min/kg, respectively (table 4.6
∗). Some reasons for the decline might be
difficulties maintaining training in higher ages, a decline of maximal heart rate and lean
body mass. According to ACSM guidelines [53], physical activity and exercise should be
performed to maintain CRF and lean body mass. Maximal heart rate, on the other hand,
seems not to be strongly associated with physical activity [23].
Although CRF was lower in women and older individuals, the results also demonstrated
that women with high fitness were fitter than men with poor fitness and also that elders
with good fitness were fitter than young with low fitness. When relative V̇O2peak in men
was compared, a 60-year-old at the 95% quantile showed a higher fitness level than the
median at 30-years. Also, women at the 95% quantile were fitter than the median in men
for the entire age-span.
The present reference values compared with past studies are plotted in fig. 5.1. For
this comparison, the SHIP study by Koch et al. (2009) [34] was selected because the
study was conducted in Germany. The FRIEND study by Kaminsky (2017) [31] was
also chosen due to its recency and large sample size. The reference values of the present
study and the SHIP study were comparable. The median of 40-year-old men was 37.2
∗
men:
RelativeV̇O2peak = (0.355 ∗ 30) + (−0.0075 ∗ 30 ∗ 30) + 35.04 = 38.9mLO2/min/kg
RelativeV̇O2peak = (0.355 ∗ 40) + (−0.0075 ∗ 40 ∗ 40) + 35.04 = 37.2mLO2/min/kg
RelativeV̇O2peak = (0.355 ∗ 50) + (−0.0075 ∗ 50 ∗ 50) + 35.04 = 34.0mLO2/min/kg
RelativeV̇O2peak = (0.355 ∗ 60) + (−0.0075 ∗ 60 ∗ 60) + 35.04 = 29.3mLO2/min/kg
women:
RelativeV̇O2peak = (−0.131566 ∗ 30) + (−0.002043 ∗ 30 ∗ 30) + 39.085612 = 33.3mLO2/min/kg
RelativeV̇O2peak = (−0.131566 ∗ 40) + (−0.002043 ∗ 40 ∗ 40) + 39.085612 = 30.6mLO2/min/kg
RelativeV̇O2peak = (−0.131566 ∗ 50) + (−0.002043 ∗ 50 ∗ 50) + 39.085612 = 27.4mLO2/min/kg
RelativeV̇O2peak = (−0.131566 ∗ 60) + (−0.002043 ∗ 60 ∗ 60) + 39.085612 = 23.8mLO2/min/kg
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mLO2/min/kg (table 4.6
∗) in the present study and 36.5 mLO2/min/kg [34]
† in the SHIP
study. Reference values from FRIEND study showed higher values in the youngest age
group but also a rapid decline and lower values in all other age groups. The median for
40-year-old men was only 27.1 mLO2/min/kg. Some reasons for the differences between
the reference values are discussed below.
A number of past reference values excluded smokers and obese subjects from reference
values [34, 26]. The exclusion of smokers was also recommended in the systematic review
by Paap & Takken (2014) [50]. Therefore, the present study included subgroup analyses
by excluding smokers and obese subjects from the analyses (supplementary tables and
figures [49]). The reference values were considerably higher when smokers were excluded
from the sample. Median relative V̇O2peak in 45-year-old men was 37.3 mLO2/min/kg
when smokers and obese subjects were excluded and 35.8 mLO2/min/kg when smokers
and obese subjects remained in the reference data (supplementary tables and figures [49]
‡).
Aside from the exclusion of smokers and obese subjects, subgroup analyses were also
performed for the inclusion of all subjects from Rüdesheim, Frankfurt and Munich. In
that case, the reference values were consistent with the primary results (supplementary
tables and figures [49]).
Past studies have shown that V̇O2peak can be increased by physical activity and exercise.
The average effect was estimated at 5.4 mLO2/min/kg in men and 3.2 mLO2/min/kg in
women by Lin et al. (2015) [39]. When those estimations are compared to the present
nomograms, the mean effect of structured exercise on V̇O2peak of 40-year old men and
women may be equal to the difference of median and 0.7 quantile. This can be interpreted
as a 20% increase relative to the reference population.
∗RelativeV̇O2peak = (0.355 ∗ 40) + (−0.0075 ∗ 40 ∗ 40) + 35.04 = 37.2mLO2/min/kg
†RelativeV̇O2peak = 47.7565 + (−0.9880 ∗ 2) + (−0.2356 ∗ 2 ∗ 2) + (−8.8697 ∗ 1) + (2.3597 ∗ 0) + (−2.0308 ∗
2 ∗ 0) + (−3.7405 ∗ 1 ∗ 0) + (0.2512 ∗ 2 ∗ 1) + (1.3797 ∗ 2 ∗ 1 ∗ 0) = 36.5, where male sex was denoted by 1,
the age class of 35 to 44 years as 2 and BMI < 25 kg/m2 as 0.
‡men:
RelativeV̇O2peak = (0.37 ∗ 45) + (−0.0075 ∗ 45 ∗ 45) + 35.8375 = 37.3mLO2/min/kg
RelativeV̇O2peak = (0.355 ∗ 45) + (−0.0075 ∗ 45 ∗ 45) + 35.04 = 35.8mLO2/min/kg
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Figure 5.1: Comparison of reference values for relative V̇O2peak.
Note: SHIP (cycle ergometry-based): 95%, 50% and 5% percentiles plotted; [34]; FRIEND (cycle
ergometry-based) 50% percentile plotted (the study did not provide 5% and 95% percentiles) [31]);
Prevention First (cycle ergometry-based) 95%, 50% and 5% percentiles plotted.
5.2 Study population and representativity
Study population and data acquisition
Several reference values for peak oxygen uptake have been published using different study
designs and populations [50, 30, 31, 53]. In the rating system of the systematic review
by Paap & Takken (2014) [50], four items dealt with study design and sampling. The
authors assigned one point each for i) community-based sampling (27/35 of the reviewed
studies, 77%), ii) including a randomization process (1/35 of the reviewed studies, 3%),
iii) a large sample size with uniform distribution of age and sex (2/35 of the reviewed
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studies, 6%), as well as iv) a prospective study design (23/35 of the reviewed studies,
66%). The present study was based on register data, and no population-based sampling
process was conducted to select the participants of the study. The numbers of women
(n = 3,291) were lower compared to men (n = 6,063) and the distribution of age showed
low numbers of cases in marginal age groups (figs. A.1 and A.2). This effect of sparse
age groups was less prevalent in population-based studies. In the underlying training
dataset (Frankfurt/Rüdesheim), only nine women were observed in the age class 25 to 29
years. In the study of Koch et al. (2009) [34] the age class with the least number of cases
was the class of women above 75 years. 23 participants were recorded in this class. In
other well-designed population-based studies, the observations were also rather uniformly
distributed over the age groups [17, 26]. Furthermore, the problem of sparsity in marginal
age groups is smaller in recent register-based studies [30, 31]. Due to the relatively low
number of cases in marginal age groups, estimations for these groups were less precise
in the present study. This was represented by wide confidence intervals at both ends of
the regression curves (figs. 4.3 and 4.4). However, age groups from 30 to 64 years showed
higher numbers of observations compared to most other studies leading to more precise
estimations and narrow confidence intervals. The reference values for these age groups
are particularly precise compared to other studies.
Reference population
When the data collection in studies was not based on a population-based sampling, it is
important to know the general setup of the data acquisition. For this reason, an outline
is provided to explain why CPET was performed in the first place. The reference values
are not appropriate for an individual when the reference population is distinctly differ-
ent from the individual’s population. This becomes particularly obvious when reference
values of the present study are compared with data from Kaminski et al. (2015, 2017)
[30, 31] or long-established reference values from Wasserman (cited by [70]). The par-
ticipants of Kaminski et al. conducted CPET prior to exercise programmes or research
studies, and Wasserman et al. acquired former shipyard workers. Both populations were
different from the sample of the underlying study which was primarily composed of Ger-
man workers with a predominantly sedentary working environment. Men at the age of
45 years had a median relative V̇O2peak of 35.8 mLO2/min/kg in the present study (ta-
ble 4.6∗), 27.1 mLO2/min/kg in the study of Kaminski et al. (2015) [30] and a mean of
34.0 mLO2/min/kg
† for a male at 180 cm and ideal weight using Wasserman’s equation
[70]. Reference values from Wasserman were higher compared to Kaminski et al. The rea-
son for this might be that shipyard workers had a physically active working environment.
∗RelativeV̇O2peak = (0.355 ∗ 45years) + (−0.0075 ∗ 45years ∗ 45years) + 35.04 = 35.8mLO2/min/kg
†Ideal weight = 0.79 ∗ 180cm − 60.7 = 81.5kg




= 34.0mLO2/min/kg, see [70, p. 158]
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In Kaminski et al., the participants conducted CPET prior to exercise programmes. This
may suggest that there was an indication for exercise prescriptions to counteract sedentary
lifestyles or other risk factors such as smoking or obesity. Furthermore, there were more
than 20 years between the data collection of both reference values, and both Kaminski’s
and Wasserman’s reference values were based on a US-American sample, which might
impact the results. As the present study was based on German workers with a primarily
sedentary working environment, distinct differences from the reference values mentioned
above were observed. Hence, reference values based on US-American samples should be
applied with caution to German participants.
Representativity
The sample of the present study was compared to ’Studie zur Gesundheit Erwachsener in
Deutschland (DEGS1)’ [19], which was based on a population-based sampling process and
was representative for the German population. Five binary characteristics were selected
that were published in DEGS1 and were measured equally in the underlying data. All five
characteristics can be characterised as cardiovascular risk factors. DEGS1 results were
age-standardised using the German population of 2011 as standard [38, 43, 48] and the
presented results were standardised according to DEGS1 (section 3.4). Men and women
showed significant differences from DEGS1 results (table 4.4). In men, 3/5 characteristics
were significantly different in the present study compared to DEGS1. Smoking, over-
weight and obese participants were less prevalent in the present study. In women, 4/5
characteristics were significantly different, and only ex-smokers did not differ significantly.
The differences were particularly large in regard to obesity, where 23.9% of the women
in DEGS1 but only 12.1% in the underlying data met the criterion. A large difference
was also present in the smoking status of men. 26.1% of men in DEGS1 were smok-
ers but only 14.7% of the underlying data. The risk factors were less prevalent in the
present study compared to DEGS1. This might indicate selection bias. It is likely that
the present study sample consisted of persons with a particularly healthy lifestyle. The
reason for this could be that the participation in the workplace health promotion pro-
grammes was voluntary and persons who participated were more prone to live a healthy
lifestyle. The presented reference values might be assumed to be higher compared to the
German population and also probably higher than in the population of German workers
with a sedentary working environment because it is likely that there was a selection of
particularly healthy participants.
Koch et al. (2009) [34] published reference values using a population-based sampling but
assumed that selection bias was present in their study, nevertheless. This would also have
led to higher reference values compared to the whole population. 45-year-old women had
a median relative V̇O2peak of 29.0 mLO2/min/kg in the present study (table 4.6
∗) and
∗RelativeV̇O2peak = (−0.131566 ∗ 45years) + (−0.002043 ∗ 45years ∗ 45years) + 39.085612 =
29.0mLO2/min/kg
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26.4 mLO2/min/kg
∗ in the SHIP study by Koch et al. However, it has to be noted that
age was modelled in 10-year age classes by Koch et al. Another reason for the differences
was that smokers and obese subjects were excluded by Koch et al. As peak oxygen
uptake is associated with smoking status and obesity, the exclusion of such participants
was likely to increase the reference values. However, reference values by Koch et al. were
slightly lower, overall. This might be due to a more severe selection of study subjects in
the present study or also regional differences. Koch et al. collected the data in north-
eastern Germany, the present study in regions of southern Germany. The time between
publication by Koch et al. (2009) and the present study was not assumed to have a strong
impact as data collection at Prevention First® started in 2001.
Itoh et al. (2013) [26] produced reference values based on a Japanese population. Com-
pared to the present study, 45-year-old women showed an even higher V̇O2peak of 31.3
mLO2/min/kg
†. However, this study performed even more rigorous exclusion than Koch
et al. [34]. In summary, the results of the present study were more comparable to the
results based on the German population [34], rather than the US-American or Japanese
reference values [31, 70]. Reference values from different nations and settings showed
large differences. This has to be considered when reference values are used to interpret
the V̇O2peak of a CPET participant.
Exclusion criteria
The exclusion criteria were different in past studies, and there is no clear guideline regard-
ing which participants should be excluded or not. Paap & Takken (2014) suggested to
exclude smokers and obese participants as these cases do not represent a healthy popula-
tion. However, if this rationale is used, participants with other conditions such as arterial
hypertension or dyslipoproteinemia should also be excluded. This leads to an artificial
study population and is likely to increase the reference values because healthy persons
probably have a higher V̇O2peak. Some of the past studies performed rigorous exclusion of
smokers, obese individuals and such with other risk factors [34, 50]. Itoh et al. (2013) [26]
also excluded individuals with abnormal blood pressure at rest and those who exercised
more than twice a week or were not 145 to 190 cm tall. Other studies [30, 31] did not
provide information on how they treated smokers and obese subjects.
The present study did not exclude individuals with risk factors from the sample for the
primary results. However, subgroup analyses were performed with exclusion of smokers
and obese subjects (supplementary tables and figures, [49]). As expected, reference val-
ues were slightly higher when smokers were excluded (section 5.1). However, by keeping
participants with risk factors in the sample, this study aimed to represent the entire Ger-
∗RelativeV̇O2peak = 47.7565 + (−0.9880 ∗ 3) + (−0.2356 ∗ 3 ∗ 3) + (−8.8697 ∗ 2) + (2.3597 ∗ 0) + (−2.0308 ∗
3 ∗ 0) + (−3.7405 ∗ 2 ∗ 0) + (0.2512 ∗ 3 ∗ 2) + (1.3797 ∗ 3 ∗ 2 ∗ 0) = 26.4mLO2/min/kg, where women were
coded as 2, age group of 45 to 54 as 3 and BMI ≥ as 0 [34].
†RelativeV̇O2peak = 61.06+ (−0.510 ∗ 45years) + (−20.4 ∗ 1) + (0.301 ∗ 1 ∗ 45years) = 31.3mLO2/min/kg
(29 mLO2/min/kg in the present study), where female was coded as 1 [26].
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man population. This might increase the generalisability of the present reference values
for the German population. Furthermore, interactive subgroup analyses are possible at
www.uks.eu/vo2peak.
Further population information
As mentioned above, differences in peak oxygen uptake between countries were observed.
Furthermore, it is valuable to report the level of physical activity of the study population.
In the systematic review by Paap & Takken (2014) [50], physical activity was reported by
20/35 (57%) of the reviewed studies. Itoh (2013) [26], for example, excluded participants
who stated that they exercised more than twice a week. Edvardsen et al. (2013) [17]
recorded physical activity using activity accelerometers and questionnaires. In the present
study, no information on physical activity level was recorded, which is why the level of
physical activity of the present sample remained unknown.
Paap & Takken (2014) [50] emphasised that the ethnicity of the sample should be de-
scribed. Few past studies have provided information on the ethnic composition of their
sample or have taken this information into account by stratification or exclusion of sub-
jects. Caucasian, Japanese and Scandinavian populations were mostly used as reference
population. According to Paap & Takken, Asian, Middle-Eastern, African and South-
American populations have been underrepresented so far. The underlying data for the
present study did not provide information on ethnicity but it can be assumed that largely
Caucasian subjects were recorded.
To sum up, the present registry-based study provided one of the largest study samples in
its field. Most of the participants were white-collar workers with a primarily sedentary
working environment. As in other registry-based studies and also in population-based
studies, it can be assumed that a selection of particularly healthy participants was present.
Compared to other studies, the present reference values were relatively high. Furthermore,
there was no exclusion of participants with cardiovascular risk factors, but an exclusion
can be performed interactively by using the online web application (www.uks.eu/vo2peak)
or by using the appropriate nomograms from the subgroup analyses (supplementary tables
and figures, [49]).
5.3 Exercise test modalities
Some CPET test modalities such as the choice of ergometer (cycle or treadmill) and the
time of termination of CPET have a substantial impact on the V̇O2peak. The CPET
modalities of the present study and the impact on the test results are summarised below.
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Type of ergometer
Most exercise test protocols are based on an incremental work rate (section 2.3). The most
common devices for conducting test protocols are cycle ergometers or treadmills. However,
the choice of ergometer type has a strong impact on the V̇O2peak, which is measured in the
exercise test. The differences between cycle ergometry-based and treadmill-based V̇O2peak
can be observed by comparing the studies of Kaminski et al. (2015 and 2017) [30, 31].
Both studies were based on the same registry (Fitness Registry and the Importance of
Exercise National Database, “FRIEND”) but used either cycle ergometers or treadmills to
assess V̇O2peak. 35-year-old men showed a median relative V̇O2peak of 42.4 mLO2/min/kg
using treadmill ergometer [30] and 30.1 mLO2/min/kg using cycle ergometer [31]. This
difference is even stronger than the difference between sexes and also considerably higher
than the 5 to 10% increase stated by ATA/ACCP guidelines [1, p. 218]. Medians in 35-
year-old women were 30.2 mLO2/min/kg using treadmill and 21.6 mLO2/min/kg using
cycle ergometer. A similar effect was observed by Itoh et al. (2013) [26]. The relative
V̇O2peak for a 35-year old man using treadmill and cycle ergometer was expected to be
43.2 mLO2/min/kg
∗ and 32.7 mLO2/min/kg
†, respectively. In 35-year-old women, the
expected values for treadmill and cycle ergometers were 33.4 mLO2/min/kg
‡ and 28.3
mLO2/min/kg
§. In the present study, the type of ergometer was not recorded in the
entire dataset. Prevention First® provided both options - cycle or treadmill ergometer -
but it was assumed that all tests that were recorded for the present study were performed
using cycle ergometer. To validate this assumption, the type of ergometer was recorded
retrospectively in the random sample of 252 observations. 249/249 tests were recorded
using cycle ergometer, and in three tests, no information on the type of ergometer has
been recorded. This provided further evidence that exclusively cycle ergometers were
used in this study. However, this information is based on a random sample and was not
recorded for the entire dataset. If tests using treadmill ergometers were present, it would
be likely that the presented reference values were falsely high.
Measures of maximal effort
Another CPET test modality that impacts the measured V̇O2peak is the time of termi-
nation of the exercise test. Ideally, the participant has to perform until the true peak
volitional work rate is achieved to capture a V̇O2peak that is close to the true peak vo-
litional oxygen uptake. However, this is dependent on the participant’s motivation and
effort. To assess the participants’ effort, several techniques were suggested: i) the rela-
tionship between increasing work rate and increasing oxygen uptake could be considered
∗RelativeV̇O2peak = 61.07 + (−0.510 ∗ 35) + (−20.4 ∗ 0) + (0.301 ∗ 0 ∗ 35) = 43.2mLO2/min/kg
†RelativeV̇O2peak = 42.05 + (−0.268 ∗ 35) + (−7.22 ∗ 0) + (0.0811 ∗ 0 ∗ 35) = 32.7mLO2/min/kg
‡RelativeV̇O2peak = 61.07 + (−0.510 ∗ 35) + (−20.4 ∗ 1) + (0.301 ∗ 1 ∗ 35) = 33.4mLO2/min/kg
§RelativeV̇O2peak = 42.05 + (−0.268 ∗ 35) + (−7.22 ∗ 1) + (0.0811 ∗ 1 ∗ 35) = 28.3mLO2/min/kg [26]
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(section 2.3). If a levelling-off (that is, smaller increases of oxygen uptake per increase
of work) appears, the recorded V̇O2 can be assumed to be close to the true physiological
peak oxygen uptake. This relationship was not used extensively in past studies as a V̇O2
increase of ≤ 150 mLO2/min is rarely observed [59]. Other measures of the participant’s
effort were used more frequently including ii) respiratory exchange ratio (RER = V̇CO2
V̇O2
),
iii) capillary lactate levels and iv) maximal heart rate. An RER of ≥ 1.1, capillary lactate
levels of ≥ 8 mmol/L or heart rate of ≥ 90% of the age-predicted maximal heart (APMHR)
rate should be achieved [59, 45] to ascertain adequate effort. The criteria for maximal
effort were different in past studies. For example, Kaminsky et al. used an RER of ≥
1.1 for CPET using cycle ergometers [31] and RER of ≥ 1.0 for CPET using treadmill
ergometers. Itoh et al. (2013) [26] defined RER of < 1.0 as poor effort.
In most prospectively-designed studies, participants with poor effort were excluded from
the sample and were not used for calculation of reference values. In the present study, the
measures of maximal effort were not recorded in the entire database but were acquired
manually for the random sample (section 4.4). Measures of good exertion were defined
as mentioned above (RER ≥ 1.1 or capillary lactate levels ≥ 8 mmol/L or maximal heart
rate ≥ 90% of APMHR). 97% (95% CI 94% to 99%) of the participants in the random
sample showed adequate effort. However, as measures of effort were not recorded in
the database, participants with poor effort could not be excluded from the analysis.
Therefore an estimated 3% of the exercise tests were not valid. Assuming that patients
with poor effort showed lower V̇O2 at the time of termination, the here presented reference
values were reduced by keeping these participants in the sample. To see if this effect
was present in the random sample, median regressions were calculated in the random
sample for i) inclusion and ii) exclusion of subjects with poor effort. Furthermore, a
multivariable median regression including a binary predictor variable for exertion (yes/no)
and an interaction term (age∗exertion) was calculated to see if the effect was significant.
However, regression lines did not show a large deviation in the sample (fig. 4.11) and
exertion, as well as interaction terms in men, were not significant (table 4.9). In women,
only three observations with poor effort were available leading to imprecise regression
estimates. To conclude, it can be stated that the numbers of invalid exercise test results
were low in the present study. Based on the random sample, it is likely that the effect on
the presented reference values of those tests was low.
Exercise test protocol
In incremental exercise tests, the work rate is low at the beginning and increases over time.
There are plenty of protocols for incremental exercise tests including ramp protocols or
multistage protocols (section 2.3). In past studies, mostly one single protocol was used
throughout the data acquisition. Itoh et al. (2013) [26] used ramp protocols and different
increments of work per time. They described that work rate at peak exercise was higher
if the increments were higher. However, there was no impact of the different increments
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on the assessed V̇O2peak. This finding is similar to earlier studies which did not find an
association between protocol and peak oxygen uptake [6, 47]. In the present study, the
type of exercise test protocol was not recorded in the entire database but was assessed
retrospectively in the random sample. Multistage protocols (130/243 times) were used
more often compared to ramp protocols (113/243 times). However, based on the litera-
ture, it can be assumed that there is no substantial effect of the exercise test protocol on
the measured value of V̇O2peak.
To conclude, it can be stated that the test modalities were not recorded in the entire study
dataset and had to be estimated based on a random sample. The choice of ergometer has
a substantial impact on reference values. In the random sample, all exercise tests were
performed using cycle ergometer. Participants with poor effort remained in the dataset
and contributed to the reference values. However, as there was an estimated proportion
of 97% participants with adequate effort, the impact of this shortcoming was low.
Table 5.1: Quality assessment of the measurement of V̇O2peak.
Characteristic Value
Study design
- Prospective design 0
- Proper randomization 0
- Community-based sampling of the study population 0
- The number of study subjects is at least as high as calculated in sample size estimation 1
Characteristics of the exercise tests
- Measurement of gas exchange data and VO2peak is averaged over time to avoid noise
(preferably ≥ 30 seconds intervals)
0
- CPET was performed using breath-by-breath or mixing chamber analysis according to
ATS/ACCP guidelines
1
- Quality control was performed according to ATS/ACCP guidelines 1
Important background reported
- Level of physical activity reported 0
- Exercise testing protocol described 1
Data analysis and reporting
- External validation of the statistical model 1
- Adequate fitting of the regression model was performed 1
- Analysis was done stratified by racial group 0
- Smokers were excluded 1
- Confidence limits were given for descriptive statistics 1
Sum 8/14
Note: This rating score was modified according to Paap & Takken (2014) [50]. The overall quality
score of the present study’s measurement was 8/14. The quality of measurement can therefore be
rated as “medium quality” (section 2.4).
5.4 Statistical methods
Modelling maximal oxygen uptake
Past studies of reference values for V̇O2peak used different statistical approaches. The
most common choices were i) to use age as categorical variable and to calculate empirical
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quantiles within each age class [53, 30, 31] or ii) to perform linear regression with age as
predictor variable [26, 17]. iii) Koch et al. [34] used second-degree polynomial quantile
regression. Further well-accepted reference values which are, however, not related with
V̇O2peak are the WHO’s nomograms for child growth. The authors of these reference
values used spline smoothing [75].
Those four approaches were also considered for the present analysis. However, it was
decided that some approaches were less adequate for reference values. First, linear re-
gression would not be sufficient to represent the distribution of V̇O2peak for a given age
because only the conditional mean would be estimated and the large variation of CRF
due to physical activity and interpersonal factors would not be represented. Secondly,
in order to calculate quantiles, age had to be measured in age classes and could not be
treated as a continuous variable. Past studies often treated age as a categorical variable
using ten-year age classes [30, 31, 34, 53]. In the present study, substantial differences
were observed within a 10-year age class. For women, median relative V̇O2peak was 27.4
mLO2/min/kg
∗ and 24.2 mLO2/min/kg
† for 50 and 59 years, respectively. This leads
to a difference of 3.2 mLO2/min/kg, which is approximately equivalent to the difference
between median and 0.7 quantile in women of that age group the present study.
As the approaches mentioned above would have yielded a large imprecision, this study
estimated quantiles based on age as a continuous predictor. To achieve this, quantile
regression was selected. The decision of how to treat age as a predictor (linear, polynomial
or using spline smoothing) was based on AIC as well as apparent and external validation.
Linear quantile regression performed worst and was hence excluded. The most accurate
regression fits were observed for spline regression. However, this study used polynomial
quantile regression instead of spline models because polynomial quantile regression models
are less complex than spline models. The number of regression coefficients was equal in
all quantile regressions of this study. Therefore, it was possible to display the regression
coefficients in tables (section 4.3).
Validation of reference values
Paap & Takken (2014) [50] suggested to do external validation of reference values for
V̇O2peak. However, none of the reviewed studies since 2010 conducted validation of the
reference values in an external population.
The present study aimed to perform external validation by splitting the dataset by study
centre. Data from Rüdesheim and Frankfurt were used as training data and data from
Munich were used as external validation data. Validation was performed as i) apparent
validation using the training data to fit regression models and also for validation and ii)
external validation using the training data to fit regression models and external validation
data for validation.
∗RelativeV̇O2peak = (−0.131566 ∗ 50) + (−0.002043 ∗ 50 ∗ 50) + 39.085612 = 27.4mLO2/min/kg
†RelativeV̇O2peak = (−0.131566 ∗ 59) + (−0.002043 ∗ 59 ∗ 59) + 39.085612 = 24.2mLO2/min/kg, table 4.6
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Validation according to established approaches was not possible for several reasons. This
should be outlined based on the example of validation of a linear regression model. In
linear regression, the conditional mean of the continuous dependent variable y is estimated
as the expected value (e.g. the best prediction) for an individual i conditional to the values
in a set of predictor variables of that individual i. Validation can easily be performed
using the predicted value ŷi and the observed value yi to plot a scatter plot. In this
calibration data of ŷi and yi, a linear regression can be performed and coefficients for
the intercept close to 0 and for the slope close to 1 are desirable. This technique applies
to apparent as well as external validation using the training data or external validation
data to obtain yi, respectively. In the present study, however, it was not desired to
get the best prediction of V̇O2peak for an individual but to derive quantiles based on
age as a continuous predictor. As quantiles could not be calculated for an individual,
aggregated empirical data had to be used. Therefore, the observed age was aggregated
into age classes. To be able to compare the predicted quantiles with aggregated empirical
quantiles, age has also been aggregated as the predictor in quantile regression models to
obtain estimated quantiles. This aggregarion was only done for model validation but not
for the calculation of nomograms and reference values. Therefore, there was a limitation
of not using the same models in nomograms and for model validation. The true validity,
hence, could only be estimated based on this approach.
This validation process showed that the regression models fitted the empirical data well.
As expected, better validity was observed in apparent validation compared to external
validation. In men aged 25 to 29 years, the predicted V̇O2peak was higher than the
observed V̇O2peak. This was observed in apparent and external validation. However,
this age group was sparse, including only 22 observations (figs. 4.7 and 4.8). Regression
coefficients also showed adequate validity with most intercepts close to zero and slope as
well as R squared close to one. A larger deviation from ideal values was observed for
V̇O2peak of men. Here, intercept was 5.9 (95% CI 1.4 to 9.9), slope 0.8 (95% CI 0.7 to
1.0) and R squared 0.9 (95% CI 0.9 to 1.0). Significant differences from intercept = 0 and
slope = 1 were especially observed in men. All coefficients of men in apparent validation
showed significant differences from the ideal coefficients. Apparent validation of women,
on the other hand, showed accurate results. In external validation, the results were more
accurate in men but less accurate in women.
Nevertheless, although there were significant differences in calibration plots, the regres-
sion fits seemed quite accurate, especially in the age classes from 30 to 64 years (figs. 4.7
to 4.10). The approach for model validation of the present study can assumed to be
particularly rigorous and might be accountable for some of the deviation from optimal
values. As mentioned above, observed quantiles were based on V̇O2peak which was cal-
culated within age classes. However, the numbers of observations in age classes were
different across the age classes. The age classes 25 to 29 years and 65 to 69 years were
relatively sparse. The estimation of quantiles was less precise in these age classes. There-
fore, the differences between predicted and observed values were relatively large. As each
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age class weighted the same in the calibration plot, regardless of the number of cases
within the age class, the presented validation underestimated the validity of the present
quantile regressions.
To sum up, apparent as well as external validation were rarely performed in past stud-
ies in this field. Still, validation adds some valuable information on how adequate and
valid reference values are when they are compared to other individuals besides the study
population. The reference values presented by this study showed adequate regression fits
but also significant differences from optimal values in some cases. As different approaches
were used for the calculation of reference values and model validation, it was only possible
to get an estimation of how valid the presented quantile curves were.
Number of observations
For the development of reference values, high numbers of cases and a uniform distribution
over all age classes are desirable to achieve precise estimations and narrow confidence
intervals [50]. Overall, the present study was based on one of the largest datasets that
were reported in this field, so far. Using the search term from Paap & Takken et al.
(2014) [50] in the search engine Pubmed (https://www.ncbi.nlm.nih.gov/pubmed/) did
not yield any study with higher numbers at the time of preparation of this manuscript.
Only the sample of reference values by the Cooper Institute (cited by [53, p. 88]) was
larger. However, it has to be noted that the total number of cases in the present study
were large, but the cases were not uniformly distributed across the age classes. This led to
more precise estimations in age classes 30 to 64 years, but also to less precise estimations
in marginal classes (< 25 years and ≥ 65 years). The overlapping confidence intervals
visualised the less precise estimations in the nomograms (figs. 4.3 and 4.4).
5.5 Multivariable analyses
In addition to reference values, exploratory analyses were performed using multivariable
quantile regression for the quantiles 0.25, 0.5, and 0.75. AIC-based forward and backward
variable selection was used to select predictors for V̇O2peak. The goodness of fit, which was
assessed using pseudo R squared (section 3.6), showed high values of ≈90% for absolute
and lower values of ≈20% for relative V̇O2peak. This large deviation of R squared in
absolute or relative V̇O2peak was likely to be explained by the presence of the variable
“overweight” as an independent variable. Being overweight showed a strong positive
association in each regression where absolute V̇O2peak was used and a strong negative
association in each regression where relative V̇O2peak was used. This was likely due to the
fact that relative V̇O2peak was defined as absolute V̇O2peak relative to body weight
∗. The
findings in the present study showed that V̇O2peak increases with body weight, that is, a
∗Absolute V̇O2peak measured in LO2/min
Relative V̇O2peak measured in mLO2/min/kg.
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heavier person is able to consume more oxygen. On the other hand, obese subjects seem
to have lower CRF relative to their body weight compared to non-obese subjects. This
effect has already been described by Edvardsen et al. (2013) [17]. It was the largest effect
over all predictors and was even stronger than the effect of tobacco smoking. In addition
to body weight, triglycerides and in some cases higher blood glucose levels or diabetes
mellitus were associated with lower peak oxygen uptake. HDL on the other hand, was
higher in men with a good CRF. However, this association was not present in women.
A comprehensive meta-analysis by Lin et al. (2015) [39] found associations between
physical activity, CRF and lipids as well as lipoprotein markers. The authors suggested
that physical activity increased CRF and HDL cholesterol and decreased triglycerides. In
this meta-analysis, physical activity led to decreased triglycerides by -5.3 mg/dL (95%
CI -10.6 to -0.9). Accordingly, in the present study men with triglycerides ≥ 150 mg/dL
showed a decreased median of relative V̇O2peak by -1.8 mLO2/min/kg (95% CI -2.2 to
-1.3) compared to men with lower triglyceride levels (table 4.10).
Another strong association with V̇O2peak was observed for tobacco smoking. Median
relative V̇O2peak in women was decreased by 1.3 mLO2/min/kg (95% CI 1.9 to 0.8, ta-
ble 4.11). This effect was even stronger in men (-2.0 mLO2/min/kg, 95% CI -2.5 to -1.5,
table 4.10) and was observed across all regression quantiles. Ex-smokers, on the other
hand, did not show significantly decreased CRF. However, there was no measure of how
long non-smoking had been sustained. Tobacco smoking has been widely considered in
past studies. Smokers were excluded from some analyses because they were assumed to
distort the results and because the samples were intended to represent a healthy popula-
tion [34, 26]. Therefore, smoking and obesity were considered in multivariable analyses
and in subgroup analyses of this study (www.uks.eu/vo2peak, supplementary tables and
figures [49]).
Diabetes mellitus was associated with lower V̇O2peak especially in men. This effect was
also well-described in past studies such as the meta-analysis by Zaccardi et al. (2015)
[77]. The hazard ratio to develop diabetes mellitus was 0.93 per 1-MET increase of CRF.
In contrast to this result, diabetes mellitus was used as an independent variable in the
present study. Men with diabetes showed a lower V̇O2peak (-2.0 mLO2/min/kg, 95% CI
-3.1 to -0.9). However, it was interesting to see that this association was not present in
women of the present study. This might be parcially due to the lower numbers of women
in the dataset but future studies might consider sex as effect modifier or report stratified
results.
Furthermore, as mentioned before, an inverse association of V̇O2peak and age was observed.
This association was well-described before [23, 50] and was present in this analysis even
when the effect was adjusted for other predictors.
A positive association was observed between V̇O2peak and body height. However, as body
height cannot be influenced, this result seemed to be of minor interest.
Weaker associations were observed for blood pressure and LDL cholesterol.
To conclude, explorative multivariable results yielded some strong inverse associations
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between V̇O2peak and body composition as well as tobacco smoking. Smaller effects were
observed for other blood lipids, hypertension and diabetes mellitus. Even though those
associations were based on explorative analyses, the results confirmed results from past
studies [39, 50].
5.6 Summary of strengths and limitations
This section summarises the strengths and limitations of the present study compared to
other studies.
One important strength was the large amount of data, which included a sample size of
more than 9,000 individuals. Based on this data, precise reference values could be calcu-
lated, especially for age groups from 30 to 64 years. Secondly, the data analysis was done
using age as a continuous predictor and using quantile regression to plot nomograms for a
number of quantiles. The nomograms were desired to be helpful in clinical practice when
the results of CPET are interpreted. Thirdly, in contrast to past studies, validation of
the reference values was performed in an external population in order to get information
on the external validity of the reference values. The validity was shown to be adequate.
Finally, CPET was performed by experienced exercise test instructors of a quality net-
work for primary preventive health screening institutions. Finally, an interactive web
application was created to facilitate the usage of the reference values in clinical practice
(www.uks.eu/vo2peak).
On the other hand, the present study also showed some limitations. Firstly, the numbers
of observations were low in the age classes of < 30 years and ≥ 64 years. Reference values
for those ages were less precise. Furthermore, the study population was not drawn by a
prospective population-based sampling process including a randomisation process. There
were also large differences from the German population, indicating a selection of healthy
participants. The quality of the data acquisition according to Paap & Takken (2014) [50]
was only “moderate” (table 5.1) and the exercise test modalities were not documented in
the main data file. Therefore, a small proportion of participants who did not continue the
exercise test until exertion remained in the data. Another limitation was the validation
of regression models as it was performed in the present study. The approach of using
quantile regressions necessitated aggregation of the data, and therefore, age was treated
as a continuous predictor for reference values and as a categorical predictor for model
validation.
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The present study provides reference values for peak oxygen uptake. They can be used
for participants of cycle ergometry-based cardiopulmonary exercise tests who are 25 to
69 years old and who are part of a population that is similar to this study.
Reference values are essential for cardiopulmonary exercise testing because they allow the
classification of individual results based on the reference population. It is only possible
to classify the individual cardiorespiratory fitness as “high” or “low” if the result is com-
pared with sex-specific and age-specific reference values from a comparable population.
If the cardiorespiratory fitness of a person is low compared to other persons of the same
sex and age, this person has an increased risk to die prematurely. From a public health
perspective, it is therefore particularly valuable to increase the cardiorespiratory fitness
of the population. Preventive health screenings are an appropriate setting to achieve this
goal. However, it is essential that physicians consider cardiorespiratory fitness as a risk
factor in addition to well-known risk factors such as tobacco smoking or arterial hyper-
tension.
The present study adds important value to this field. The study population yielded one
of the most extensive samples that has been published so far. The participants of this
study were predominantly German workers with a sedentary lifestyle. A large proportion
of the populations of industrialised countries have similar working environments.
This study aimed to facilitate the interpretation and access of the presented reference val-
ues by constructing nomograms and an interactive web application (www.uks.eu/vo2peak).
Depending on which population is desired as the reference population, subgroup analyses
can be performed interactively. Furthermore, this study allows physicians to evaluate the
cardiorespiratory fitness of an exercise test participant precisely. Past studies often have
used 10-year age classes or linear regression, but these approaches yielded substantial
imprecision. This study presents the reference values as percentile values, which is an
accurate representation of the inter-individual variability.
The evaluation of the validity and the generalisability is crucial for the interpretation of
reference values. External validation was suggested by Paap & Takken (2014) [50], but
the validity and the representativity were rarely assessed in previous studies. Although
these two analyses revealed some shortcomings of the present sample, they are valuable
for the interpretation of the presented reference values. It is important to keep in mind
that this sample was probably a selection of healthy participants. This might have led
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to optimistic reference values. Hence, the cardiorespiratory fitness of an exercise test
participant who is compared with the present reference values might be evaluated too
pessimistically. This has to be considered by the exercise test instructor.
It is important that reference values for cardiorespiratory fitness are presented and up-
dated regularly. Further accurate studies are needed to create valid and generalisable








# Define UI for application that draws a histogram
shinyUI(fluidPage(theme = shinytheme("sandstone"),
# Application title
titlePanel(h1("Peak oxygen uptake calculator for cycle ergometry")),
navbarPage(id="selectedTab",
"",
# how to put the title on top and the panels below?
















choices = c("Male", "Female")),
sliderInput("age", "Your age",
min = 25, max = 69, value = 40, step = 1),
uiOutput("slider"),
selectInput("relabs", "Absolute or relative \\(\\dot{\\text{V}}\\text{O}_{\\text{2peak}}\\)",




), # end of well panel
###############################################################




checkboxInput("opts_ci", "Display confidence intervals", F),
checkboxInput("opts_ex", "Exclude smokers and obese participants from reference values", F),
checkboxInput("opts_tab", "Display regression coefficients", F)
)# end of well panel
),
# Show a plot of the generated distribution
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)# End of mainPanel
)# End of this sidebarLayout







sliderInput("wgt", "Your body weight (kilograms)",
min = 50, max = 125, value = 75, step = 1),
sliderInput("wtt", "Your maximal work rate (watts)",
min = 90, max = 350, value = 200, step = 5)








),# End of well panel
wellPanel(
h3("Rationale"),
p("If no gas exchange measurement was conducted during cardiopulmonary exercise testing,
\\(\\dot{\\text{V}}\\text{O}_{\\text{2peak}}\\)
can be estimated based on maximal work rate from incremental exercise tests and body weight.")
)# End of well panel
)# End of mainPanel
)# End of sidebarLayout







h3("Quantile reference values for cycle ergometry"),br(),
p("Quantile reference values have been derived from a sample of 10,090 German white-collar workers who were recorded to the
'Prevention Fitst Registry'. For further information please check [1].")
),# End of well panel
wellPanel(
h3("Estimation of \\(\\dot{\\text{V}}\\text{O}_{\\text{2peak}}\\)"),br(),
p("For estimation we used the ACSM equation [2]:"),br(),
p("\\(\\text{Estimated} \\ \\dot{\\text{V}}\\text{O}_{\\text{2peak}} = (10.8*\\text{W}*\\text{M}ˆ{-1}) + 7\\)"),
helpText("W = maximal work rate in incremental cycle ergometry measured in watts", br(),
"M = body mass in kilograms")
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)# End of well panel
)# End of mainPanel
)# End of tabPanel3
)# End of this navbarPage
)# End of fluidPage
)# End of Ui
7.1.2 server.R
library(shiny)





# Make dynamic slider for absolute/relative VO2max
output$slider <- renderUI({
sliderInput("inSlider", "Your result from exercise test using cycle ergometry",
min = ifelse(input$relabs == "Relative", 11, 0.9),
max = ifelse(input$relabs == "Relative", 61, 5),
value = ifelse(input$relabs == "Relative", 30, 2.7),















if(input$gender == "Male" & input$relabs == "Relative" & input$opts_ex == F) mat <- q_m_rel
if(input$gender == "Female" & input$relabs == "Relative" & input$opts_ex == F) mat <- q_f_rel
if(input$gender == "Male" & input$relabs == "Absolute" & input$opts_ex == F) mat <- q_m_abs
if(input$gender == "Female" & input$relabs == "Absolute" & input$opts_ex == F) mat <- q_f_abs
if(input$gender == "Male" & input$relabs == "Relative" & input$opts_ex == T) mat <- q_m_ex_rel
if(input$gender == "Female" & input$relabs == "Relative" & input$opts_ex == T) mat <- q_f_ex_rel
if(input$gender == "Male" & input$relabs == "Absolute" & input$opts_ex == T) mat <- q_m_ex_abs










if(input$gender == "Male" & input$relabs == "Relative" & input$opts_ex == F) ci <- ci_m_rel
if(input$gender == "Female" & input$relabs == "Relative" & input$opts_ex == F) ci <- ci_f_rel
if(input$gender == "Male" & input$relabs == "Absolute" & input$opts_ex == F) ci <- ci_m_abs
if(input$gender == "Female" & input$relabs == "Absolute" & input$opts_ex == F) ci <- ci_f_abs
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if(input$gender == "Male" & input$relabs == "Relative" & input$opts_ex == T) ci <- ci_m_ex_rel
if(input$gender == "Female" & input$relabs == "Relative" & input$opts_ex == T) ci <- ci_f_ex_rel
if(input$gender == "Male" & input$relabs == "Absolute" & input$opts_ex == T) ci <- ci_m_ex_abs
if(input$gender == "Female" & input$relabs == "Absolute" & input$opts_ex == T) ci <- ci_f_ex_abs
# x and y coordinates of matrices
mat_x <- which(input$age == 25:69) + 1
if(input$relabs == "Relative") mat_y <- which(input$inSlider == 11:61)
if(input$relabs == "Absolute") mat_y <- which(input$inSlider == seq(from = 0.9, to = 5, by = 0.1))
# confidence intervals reactive to checkbox
if(input$opts_ci == F){ci_txt <- ""} else {ci_txt <- paste("(95% CI ", ci[mat_y,mat_x], ")", sep = "")}
t <- paste(mat[mat_y,mat_x]*100, "% ", ci_txt, " of the reference population had a lower peak oxygen uptake than you.", sep = "")
})
###############################################################














col <- c("dodgerblue","dodgerblue1","tomato3","dodgerblue2","dodgerblue3", "dodgerblue4",
"tomato3",
"dodgerblue4", "dodgerblue3", "tomato3", "dodgerblue2", "dodgerblue1", "dodgerblue")
# function for fitting of ggplots
library(ggplot2)
library(directlabels)
# function for fitting of ggplots





# y breaks by 1
ybr <- 1
# digits 0





# y breaks by 0.1
ybr <- 0.1
# digits 2
ymin <- round(ymin, digits = 1)
}
lmt <- c(ymin, ymax)
brk <- seq(from = ymin, to = ymax, by = ybr)
ggp <- ggplot(data = dat, aes(x = ALTER, y = fit)) +
# defining background of ggplot
theme(panel.grid.major = element_line(colour = "grey30", linetype = "dotted"),
panel.background = element_rect(fill = "white"),
axis.text.x = element_text(angle = 90, vjust=0.5, size=14),
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axis.text.y = element_text(size=14),
plot.title = element_text(hjust = 0.5, size = 14, face = "bold"),
axis.title = element_text(size=14,face="bold")) +
scale_x_continuous(limits = c(25,69),
breaks = seq(from = 25, to = 69, by = 1))+
scale_y_continuous(limits = lmt,
breaks = brk) +
labs(x = "Age",
y = ylb,
title = sex) +
geom_vline(xintercept = c(30, 40, 50, 60),
colour = "gray25",
size = 0.6)
# adding confidence bands
if(ci == T){
ggp <- ggp +
geom_ribbon(aes(x = ALTER, ymin = lower, ymax = higher, fill = percentile),
alpha = 0.3, inherit.aes = F, show.legend = F, na.rm = T) +
scale_fill_manual(values = col)
}
# adding quantile curves
ggp <- ggp +
geom_line(aes(x = ALTER, y = fit, colour = percentile),
show.legend = F, size = 1, na.rm = T) +
scale_color_manual(values = col)
ggp <- direct.label(ggp, list("last.polygons", colour = "white"))
return(ggp)
}# End of plt-function
# if else etatements to select adjacent plot
# strategy to avoid error "argument is of length zero":
# decisions...
# 1st: are there additional opts? --> no? --> data set "all"
# 2nd: additional opts but no exclusion? --> data set "all"
# 3rd: additional opts and exclusion? --> data set "ex"
if(input$opts_ex == F){
if(input$gender == "Male" & input$relabs == "Relative") ds <- m_rel_all
if(input$gender == "Female" & input$relabs == "Relative") ds <- f_rel_all
if(input$gender == "Male" & input$relabs == "Absolute") ds <- m_abs_all
if(input$gender == "Female" & input$relabs == "Absolute") ds <- f_abs_all
}
if(input$opts_ex == T){
if(input$gender == "Male" & input$relabs == "Relative") ds <- m_rel_ex
if(input$gender == "Female" & input$relabs == "Relative") ds <- f_rel_ex
if(input$gender == "Male" & input$relabs == "Absolute") ds <- m_abs_ex
if(input$gender == "Female" & input$relabs == "Absolute") ds <- f_abs_ex
}
# relative or absolute
if(input$relabs == "Relative") rel.true <- T
if(input$relabs == "Absolute") rel.true <- F
yc <- input$inSlider
ggplt <- plt(ds, input$gender, min(ds[,"lower"]), max(ds[,"higher"]), rel = rel.true, ci = input$opts_ci)







if(input$opts_ex == F & input$gender == "Female" & input$relabs == "Absolute") ds1 <- read.csv("./www/tables/adff.csv")
if(input$opts_ex == F & input$gender == "Male" & input$relabs == "Absolute") ds1 <- read.csv("./www/tables/adfm.csv")
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if(input$opts_ex == F & input$gender == "Female" & input$relabs == "Relative") ds1 <- read.csv("./www/tables/rdff.csv")
if(input$opts_ex == F & input$gender == "Male" & input$relabs == "Relative") ds1 <- read.csv("./www/tables/rdfm.csv")
# Exclusion of smokers and obese
if(input$opts_ex == T & input$gender == "Female" & input$relabs == "Absolute") ds1 <- read.csv("./www/tables/exadff.csv")
if(input$opts_ex == T & input$gender == "Male" & input$relabs == "Absolute") ds1 <- read.csv("./www/tables/exadfm.csv")
if(input$opts_ex == T & input$gender == "Female" & input$relabs == "Relative") ds1 <- read.csv("./www/tables/exrdff.csv")




#if(input$opts_tab == F) data.frame()




# Estimation of VO2max
###############################################################
output$vo2.tab <- renderTable({
# based on ACSM guidelines (Franklin, 2000)
in.thousend <- 10.8 * input$wtt + 7 * input$wgt
abs.vo2.est <- in.thousend / 1000
rel.vo2.est <- in.thousend / input$wgt








ref <- c("Rapp D, Scharhag J, Wagenpfeil S, Scholl J. Reference values for peak oxygen uptake: cross-sectional analysis of cycle ergometry-
based cardiopulmonary exercise tests of 10,090 adult German volunteers from the Prevention First Registry. BMJ Open. 2018 Mar 5;8(3):e018697.
doi: 10.1136/bmjopen-2017-018697",
"Franklin BA, Balady GJ, American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 6. ed.
Philadelphia: Lippincott Williams & Wilkins 2000, ISBN: 978-0-7817-2735-8, p. 303.")
)
}, include.colnames = F)
})
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7.2 Calculations for web application
############################################################




# data sets overall and exclusion af obese and smokers
df <- readRDS("./170525_n10090_bmj")
df <- df[,c("Geschlecht","ALTER", "REL_VO2_MAX", "VO2_MAX", "obese", "ZIGARETTEN")]
dfm <- subset(df, Geschlecht == "Male")
dff <- subset(df, Geschlecht == "Female")
dfm_ex <- subset(dfm, obese == "no" & ZIGARETTEN == "no")
dff_ex <- subset(dff, obese == "no" & ZIGARETTEN == "no")
# quantiles
taus <- seq(from = 0.01, to = 0.99, by = 0.01)
# range of REL vo2max (0.1 to 99.9 percentiles of data)
rvo <- seq(from = 11, to = 61, by = 1)
avo <- seq(from = 0.9, to = 5, by = 0.1)
# range of age
ag <- 25:69
rfrm <- as.formula("REL_VO2_MAX ˜ ALTER + I(ALTERˆ2)")
afrm <- as.formula("VO2_MAX ˜ ALTER + I(ALTERˆ2)")
nboot <- 10000
############################################################
# FUNCTIONS FOR MATRIX "QUANTILE"
############################################################
# equivalent to predict.rq
# predict.rq cannot be applied
# as 10,000*100 quantile regressions (coeficients, residuals etc) are stored in RAM (too large)





newdata = matrix(rep(25:69, 99),nrow = 45)
colnames(newdata) <- as.character(taus)
prd <- function(i) Intercept[i] + Slope1[i] * newdata[,i] + Slope2[i] * newdata[,i] * newdata[,i]
for(i in 1:99) newdata[,i] <- prd(i)
newdata <- as.data.frame(newdata)
newdata$ALTER <- 25:69 # adding ALTER
return(newdata)
}
# which predicted value from which tau is the closest for given age and vo2max?
# CAVE: data set has to be called pred!
q.check.fun <- function(age, vo2){
sset <- subset(pred, ALTER == age)
sset <- sset[,!(names(sset)) == "ALTER"] # drop ALTER




# for a given age: taus are calculated for each vo2max
q.inner <- function(x) {
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col <- lapply(vo, function(y) q.check.fun(age = x, vo2 = y))






q.outer <- function() {
matrix <- lapply(ag, q.inner)

















































fit <- rq(frm, data = dff, tau = taus)$coefficients
pred <- predict_rq(fit)
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q_f_abs <- q.outer()
write.csv(q_f_abs, "q_f_abs.csv")









# function to calculate 10,000 bootstrap samples
# output are 10,000 rq coefficients!
boot_all <- function(dat){
cl <- makeCluster(mc <- getOption("cl.cores", parallel::detectCores()-1))
clusterEvalQ(cl,library(quantreg))
clusterExport(cl,varlist = c("taus", "dfm","dff","dfm_ex", "dff_ex", "frm"))
# creating bootstrap sample (replace = T)
gen_sample <- function() dat[sample(nrow(dat), replace = T),]




# predicted values for all quantile regressions and all ages
# input must be called l
pred_all <- function() {






# function for checking out nearest tau of quantile regression
# list must be called l1
check.fun <- function(age, vo2){
l2 <- lapply(l1, function(x) subset(as.data.frame(x), ALTER == age)[,as.character(taus)])
qtl <- lapply(l2, function(x) {
col <- which.min(abs(x - vo2))
qtl <- as.numeric(names(col))
return(qtl)
})# End of lapply
qtl1 <- t(do.call(data.frame,qtl))
lo <- round(quantile(qtl1, probs = c(0.025))*100, digits = 0)
hi <- round(quantile(qtl1, probs = c(0.975))*100, digits = 0)
ci <- paste0(lo, "% to ", hi, "%")
return(ci)
}
# apply check.fun to all achieved vo2_max (inner function) and all ages (outer function)
# INNER FUNCTION
inner <- function(x) {
col <- lapply(vo, function(y) check.fun(age = x, vo2 = y))
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}
# OUTER FUNCTION
outer <- function() {
cl <- makeCluster(mc <- getOption("cl.cores", parallel::detectCores()-1))
clusterExport(cl=cl, varlist=c("vo", "ag", "l1", "inner", "check.fun", "taus"))
clusterCall(cl, function() library("quantreg"))
ci_matrix <- parLapply(cl, ag, inner)
stopCluster(cl)















































































# defining numer of bootstrap samples
NBOOT <- 10000
# labels for plots
REL_LAB <- expression("Relative"˜dot("V")*O["2peak"]˜"[mL"*O["2"]*"/min/kg"*"]")
ABS_LAB <- expression("Absolute"˜dot("V")*O["2peak"]˜"[L"*O["2"]*"/min"*"]")
# function for saving plots
SAVE.PLOT <- function(PLOT, FILE.NAME, HEIGHT, WIDTH){
# path














# reading full data
df <- read.table(
"./data/160301_Originaldaten.csv",
header = T, sep = ";", dec = ",")
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# adding missing data
df2 <- read.table(
"./data/missings161020.csv",
header = T, dec = ",", sep = ";")
##################################################
# Calculating new variables
##################################################
# renaming id
names(df)[which(names(df) == "Ã¯..ID")] <- "id"
names(df2)[which(names(df2) == "Ã¯..ID")] <- "id"
# adding missing data
df_miss <- subset(df, id %in% df2$id)
df_miss <- df_miss[order(df_miss$id),]
df2 <- df2[order(df2$id),]
df_miss$ALTER <- df2$ALTER # adding age from df2
df_miss$REL_VO2_MAX <- df2$REL_VO2_MAX # adding rel VO2 from df2
df_miss$VO2_MAX <- df2$VO2_MAX # adding abs VO2 from df2
df_nomiss <- subset(df, !(df$id %in% df2$id))
df <- rbind(df_miss, df_nomiss)
# define date variable
df$datum <- as.Date(df$DATUM, "%d.%m.%Y")
df <- df[order(df$datum),]
df$DATUM <- NULL
# recode binary variables with -1 / 0
# defining relevant variables
vars <- c("ZIGARETTEN","EXRAUCHER")
# function for changing -1 to 1
f <- function(x){
ifelse(x == -1, 1 , x)}
# apply function to all relevant variables
df[, vars] <- sapply(df[, vars], f)
# computing vars
# diabetes, hypertension, overweight, obesity
df$MANIFEST_DM <- ifelse(df$BLUTZUCKER >= 126 | df$HBA1C >= 6.5, 1, 0)
df$BLUTHOCHDRUCK_WHO <- ifelse(df$SYST >= 140 | df$DIAST >= 90, 1, 0)
df$BMI_GE_25 <- ifelse(df$BMI >= 25, 1, 0)
df$obese <- ifelse(df$BMI >= 30, 1, 0)
##################################################
# adding study center
##################################################
sto <- read.csv("./data/160810_standort.csv")
df <- merge(df, sto, by = "id", all.x = T)
df$standort <- factor(df$standort,
levels = c("F", "M"),




# Function for assinging NA to implausible cases
f <- function(var, mi = min(df[var]), ma = max(df[var])){




df$ALTER <- f("ALTER", 15, 100)
df$KOERPERFETT_TANITA <- f("KOERPERFETT_TANITA", 0, 100)
df$KOERPERFETT_CALIPER <- f("KOERPERFETT_CALIPER", 0, 100)
df$SYST <- f("SYST", 50, 400)
df$DIAST <- f("DIAST", 30, 200)
df$VO2_MAX <- f("VO2_MAX", 0, 7)
df$REL_VO2_MAX <- f("REL_VO2_MAX", 0, 100)
df$GESAMTCHOLESTERIN <- f("GESAMTCHOLESTERIN", 0, 600)
df$HDL_CHOLESTERIN <- f("HDL_CHOLESTERIN", 10, 150)
df$TRIGLYCERIDE <- f("TRIGLYCERIDE", 0, 2000)
df$HBA1C <- f("HBA1C", 0, 100)
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# implausible dates
df <- df[order(df$datum), ]
df$datum[df$datum < as.Date("2000-01-01")] <- NA
# defining factor variables in df
f <- function(var){











# create variable ex smoker
df$EXRAUCHER[which(df$ZIGARETTEN == "yes")] <- "no"
df$EXRAUCHER[which(df$ZIGARETTEN == "no" & is.na(df$EXRAUCHER))] <- "no"
# add variable age group
df$ageclass <-cut(df$ALTER,
breaks = c(25,30,35,40,45,50,55,60,65,69),
include.lowest = TRUE, include.highest = F, right = F)





keeps <- c("id", "Geschlecht", "ALTER",
"GEWICHT", "GROESSE",





"MANIFEST_DM", "BLUTHOCHDRUCK_WHO", "BMI_GE_25", "obese",
"ageclass", "ageclass_double",
"BLUTZUCKER", "HBA1C", "datum", "standort")
df <- df[,which(names(df) %in% keeps)]
##################################################
# Adding Hmisc variable labels
##################################################
label(df$Geschlecht) <- "Sex"
label(df$ALTER) <- "Age [years]"
label(df$ageclass) <- "Age class"
label(df$REL_VO2_MAX) <- "Relative $\\dot{V}O_{2peak}$ [$\\unitfrac{mL}{min*kg}$]"
label(df$VO2_MAX) <- "Absolute $\\dot{V}O_{2peak}$ [$\\unitfrac{L}{min}$]"
label(df$GEWICHT) <- "Weight [kg]"
label(df$GROESSE) <- "Height [cm]"
label(df$BMI) <- "BMI [$\\unitfrac{kg}{mˆ2}$]"
label(df$KOERPERFETT_CALIPER) <- "Body fat Caliper [\\%]"
label(df$BMI_GE_25) <- "Overweight"
label(df$obese) <- "Obese"
label(df$SYST) <- "Systolic [mmHg]"
label(df$DIAST) <- "Diastolic [mmHg]"
label(df$BLUTHOCHDRUCK_WHO) <- "Hypertension"
label(df$BLUTZUCKER) <- "Blood glucose [$\\unitfrac{mg}{dl}$]"
label(df$HBA1C) <- "$HbA1_c$ [\\%]"
label(df$MANIFEST_DM) <- "Diabetes mellitus"
label(df$GESAMTCHOLESTERIN) <- "Total cholesterol [$\\unitfrac{mg}{dl}$]"
label(df$HDL_CHOLESTERIN) <- "HDL Cholesterol [$\\unitfrac{mg}{dl}$]"
label(df$LDL_CHOLESTERIN) <- "LDL Cholesterol [$\\unitfrac{mg}{dl}$]"
label(df$TRIGLYCERIDE) <- "Triglycerides [$\\unitfrac{mg}{dl}$]"
label(df$ZIGARETTEN) <- "Smoker"
label(df$EXRAUCHER) <- "Ex smoker"
label(df$standort) <- "Study center"
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7.3.3 Random sample
##################################################





# compare full data vs. sample
##################################################
# df for comparison of df and spl
spl$spl <- 1
df_no_spl <- subset(df, !(df$id %in% spl$id))
df_no_spl$spl <- 0
test_spl <- rbind(df_no_spl, spl)
test_spl$spl <- factor(test_spl$spl,
levels = c(0,1),
labels = c("Full data", "Random sample"))




frm <- as.formula(paste0("spl ˜", paste(c(qvars, cvars), collapse = " + ")))
# creating bivariate table for sample vs. full data




# reading file with manually added information
##################################################
# read sample Ruedesheim and create two data sets
# sr: only sample characteristics
# sf: merged with original data
# (without excluded cases as random IDs were drawn prior to exclusion)
sr <- read.csv("./data/sample_Rued_ergaenzt_160622.csv",
sep=";", dec=",", header=T)
sr <- merge(sr, df, by.x = "ID", by.y = "id", all.x = T)
##################################################
# measures of exertion
##################################################
# calculating age-predicted maximal heart rate (APMHR, pmid: 11153730)
# the criterion for maximal effort is 90% of APMHR (pmid: 18027991)
sr$th_hr_max <- (208 - 0.7 * sr$ALTER) * 0.9
# measure of exertion: lac>8 OR RER >1.1 OR HR >90% of APMHR
sr$lac_ge8 <- ifelse(sr$Laktat >= 8,1,0)
sr$rer_ge1 <- ifelse(sr$RER >= 1.1,1,0)
sr$hr_ge <- ifelse(sr$HF.max >= sr$th_hr_max,1,0)
# specifying rows where lac, rer and hr are all NA
sr$na <- rowSums(is.na(cbind(sr$rer_ge1,sr$lac_ge8,sr$hr_ge)))
sr$Ex <- rowSums(cbind(sr$lac_ge8,sr$rer_ge1,sr$hr_ge),na.rm=T)
sr$Ex <- ifelse(sr$na == 3, NA, sr$Ex)
sr$Exertion <- ifelse(sr$Ex >=1,1,sr$Ex)
# Bootstrapped 95% confidence intervals for proportions
SAMPLE.PROPORTION <- function(x, d) {
z = sum(x[d]==1, na.rm = T)




# function to list N(%) [95% CI] of exertion
EXERTION <- function(SUBGROUP = ""){
x <- sr[SUBGROUP, "Exertion"]
YES <- sum(x == 1, na.rm = T)
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NO <- sum(x == 0, na.rm = T)
N <- paste0(YES, "/", YES + NO)
PERCENT <- round((YES / (YES + NO))*100, digits = 0)
set.seed(1)
b <- boot(x, SAMPLE.PROPORTION, R = NBOOT)
CI <- paste(round(quantile(b$t, probs = c(0.025, 0.975))*100, digits = 0))
return(paste0(N, " (", PERCENT, "%)", " [", CI[1], "% to ", CI[2], "%]"))
}
# overall, males, females




# does inclusion of cases with exertion == "no" change results?
##################################################
sr$Exertion <- factor(sr$Exertion, levels = c(0, 1), labels = c("no", "yes"))
# checking visually using scatter plots
# producing scatter plot with two regression lines:
# 1) all cases of the sample 2) only cases with Exertion == "yes"
# for males and females / absolute and relative vo2max (fig 4.13)
SC.PLOT <- function(SEX = "m", OUTCOME, XLAB, YLAB, TITLE = ""){
DAT <- subset(sr, sex == SEX)
DAT.NOEX <- subset(DAT, Exertion == "yes")
FRM <- as.formula(paste(OUTCOME, "˜ ALTER"))
FIT <- rq(FRM, data = DAT, tau = 0.5)$coefficients
FIT.NOEX <- rq(FRM, data = DAT.NOEX, tau = 0.5)$coefficients
gp <- ggplot(data = DAT, aes_string(x = "ALTER", y = OUTCOME, colour = "Exertion")) +
geom_point(na.rm = T) +
geom_abline(intercept = FIT[1], slope = FIT[2]) +
geom_abline(intercept = FIT.NOEX[1], slope = FIT.NOEX[2], lty = 2) +
scale_x_continuous(limits = c(25,69), breaks = seq(from = 25, to = 69, by = 5)) +
scale_y_continuous(limits = c(min(DAT[,OUTCOME]), max(DAT[,OUTCOME]))) +
labs(x = XLAB, y = YLAB, title = TITLE) +





SC.PLOT("m", "REL_VO2_MAX", "", REL_LAB, "Men"),
SC.PLOT("w", "REL_VO2_MAX", "", "", "Women"),
SC.PLOT("m", "VO2_MAX", "Age [years]", ABS_LAB, ""),




# function to create an xtable with ANCOVA- results
# Question: does Exertion significantly alter Results?
# Median regression:
# DV = VO2peak
# IV = ALTER + Exertion (yes/no) + interaction term ALTER * Exertion
ANCOVA <- function(dat = srf, outcome = "REL_VO2_MAX"){
# 1) data without missings (avoid error by boot.rq)
dat <- dat[!is.na(dat[,outcome ]),]
dat <- dat[!is.na(dat[,"ALTER" ]),]
dat <- dat[!is.na(dat[,"Exertion"]),]
# 2) how many cases with "exertion = no"?
print(table(dat[,"Exertion"]))
# 2) extract variables
A <- dat[,"ALTER"]
E <- as.numeric(dat[, "Exertion"])
DV <- dat[, outcome]
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# 3) create formula
frm <- paste(outcome, "˜ A + E + I(A * E)")
frm <- as.formula(frm)
# 4) estimate for coefficient and bootstrapped P values
fit <- rq(frm, tau = 0.5, data = dat)
estpv <- summary(fit, se = "boot")$coefficients
est <- estpv[,1]
pval <- estpv[,4]
# 5) bootstrapped confidence intervals
set.seed(1)
fit.b <- boot.rq(cbind(1, A, E, I(A * E)), DV, tau = 0.5, R = NBOOT)
ci <- t(apply(fit.b$B, 2, quantile, c(0.025,0.975)))
# 6) cbind to create a table
tab <- cbind(est, ci, pval)
tab <- as.data.frame(tab)
row.names(tab) <- c("Intercept", "Age", "Exertion(yes)", "Age * Exertion(yes)")
print(xtable(tab,digits=c(2,2,2,2,3)), include.rownames = T)
}
ANCOVA(dat = subset(sr, sex == "m"), outcome = "REL_VO2_MAX")
ANCOVA(dat = subset(sr, sex == "m"), outcome = "VO2_MAX")
ANCOVA(dat = subset(sr, sex == "w"), outcome = "REL_VO2_MAX")
ANCOVA(dat = subset(sr, sex == "w"), outcome = "VO2_MAX")
## PLAUSIBILITY CHECK:
## visualise the regression lines for exertion = yes/no seperately
#pdat <- data.frame(age = seq(from = 20, to = 80))
#pdat$pred_exertion <- 18.27 + (0.11*pdat$age) + (5.85*2) + (-0.07*2*pdat$age)
#pdat$pred_no_exertion <- 18.27 + (0.11*pdat$age) + (5.85*1) + (-0.07*1*pdat$age)
#ggplot() +
# geom_point(aes(x = ALTER, y = REL_VO2_MAX), data = srf, na.rm = T) +
# geom_line(aes(x = age, y = pred_exertion), data = pdat, colour = "red") +
# geom_line(aes(x = age, y = pred_no_exertion), data = pdat, colour = "blue")
7.3.4 Descriptive statistics
##################################################
# Numbers of cases for flow chart
##################################################
# function for counting non-missings
n <- function(x) sum(!is.na(x))



















# exclusion of age>=70 or <25
ex(df[!is.na(df$REL_VO2_MAX) &
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frm <- as.formula(paste0("dropout ˜", paste(c(qvars, cvars), collapse = " + ")))
# creating bivariate table for sample vs. full data




df <- df[df$dropout == 0,]
tapply(df$VO2_MAX,df$Geschlecht,n)
# split data by location
df_FR <- subset(df, standort == "Frankfurt/Ruedesheim")
df_M <- subset(df, standort == "Munich")
# split data by sex
dfm <- subset(df, Geschlecht == "Men")
dff <- subset(df, Geschlecht == "Women")
# split data by sex and location
dfm_FR <- subset(df_FR, Geschlecht == "Men")
dff_FR <- subset(df_FR, Geschlecht == "Women")
dfm_M <- subset(df_M, Geschlecht == "Men")
dff_M <- subset(df_M, Geschlecht == "Women")
##################################################
# Date and location
##################################################
SAVE.PLOT(
# density function of date of examination
ggplot(df, aes(x = datum, colour = Geschlecht)) +
stat_bin(data=subset(df,Geschlecht=="Men"),aes(y=cumsum(..count..)),geom="step", na.rm = T)+
stat_bin(data=subset(df,Geschlecht=="Women"),aes(y=cumsum(..count..)),geom="step", na.rm = T)+
scale_x_date(breaks = seq(as.Date("2001-01-01"), as.Date("2015-12-31"), by="2 years"), date_labels = "%Y") +
scale_y_continuous(breaks = seq(from = 0, to = 6000, by = 1000)) +
scale_colour_discrete(name ="Sex",
breaks=c("Women", "Men")) +
geom_vline(xintercept = as.Date("2001-01-01", "%Y-%m-%d"), colour = "grey60", size = 0.3 ) +
geom_vline(xintercept = as.Date("2015-12-31", "%Y-%m-%d"), colour = "grey60", size = 0.3 ) +
labs(y = "Cumulative number of participants", x = "Date")
, "time.png", 5, 5
)
##################################################
# Bivariate descriptive Table
##################################################
# bivariate desctiptive table
# exclude missing values from
# age, relative and absolute VO2peak
# use only subset of variables
vars <- c(
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# id, independent and dependent variables
"Geschlecht", "REL_VO2_MAX", "VO2_MAX", "ALTER", "ageclass",
# descriptive statistics and multivariable regression
"GEWICHT", "GROESSE", "BMI", "KOERPERFETT_CALIPER", "BMI_GE_25", "obese",
"SYST", "DIAST", "BLUTHOCHDRUCK_WHO", "BLUTZUCKER", "HBA1C", "MANIFEST_DM",
"GESAMTCHOLESTERIN", "HDL_CHOLESTERIN", "LDL_CHOLESTERIN", "TRIGLYCERIDE",
"ZIGARETTEN", "EXRAUCHER", "standort")
df1 <- df[, vars]







caption = "Descriptive statistics by sex.")
# description of data for reference values
df1m <- subset(df1, Geschlecht == "Men")
df1f <- subset(df1, Geschlecht == "Women")
males <- compareGroups(









export2latex(cbind(Males = males, Females = females),
header=c(p.overall='P value'),
caption = "Descriptive statistics by sex and study center.")
##################################################
# Description of all variables in data set
##################################################





# other quantitative variables
"GEWICHT", "GROESSE", "BMI", "KOERPERFETT_CALIPER", "KOERPERFETT_TANITA", "BAUCHUMFANG",
"SYST", "DIAST", "BLUTZUCKER", "HBA1C",
"GESAMTCHOLESTERIN", "HDL_CHOLESTERIN", "LDL_CHOLESTERIN", "TRIGLYCERIDE")
qvars_labels <- c(
# target variables
"Age" , "Relative \n VO2peak", "Absolute \n VO2peak" ,
# other quantitative variables
"Weight", "Height", "BMI", "Body fat \n (Caliper)", "Body fat \n (Tanita)", "Waist \n circumference",
"Systolic", "Diastolic", "Blood \n glucose", "HbA1c",
"Total \n cholesterol", "HDL \n cholesterol", "LDL \n cholesterol", "Tri- \n glycerides")





# histograms for all qvars using labels
hst <- function(dat){
# empty list to save in
lst <- list()
for(i in qvars){
# calculate means, sd and the index of label
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m <- mean(dat[, i], na.rm = T)
s <- sd(dat[, i], na.rm = T)
num <- qvars_labels2[which(qvars %in% i)]
# plot
g <- ggplot(data = dat, aes_string(x = i)) +
geom_histogram(aes(y=..density..), color="black", bins = 15, na.rm= T) +
scale_x_continuous(limits = c(m - 3*s, m + 3*s)) +
stat_function(fun = dnorm, args = list(mean = m, sd = s), color = "red", na.rm = TRUE) +
labs(x="", y="") +
ggtitle(num)
# save plot in list
lst[[i]] <- g }
return(lst)
}
# Arranging all plots to one
# males
lst_m <- hst(dfm)
lst_m[[18]] <- blankPanel<-grid.rect(gp=gpar(col="white")) # adding white space




lst_f[[18]] <- blankPanel<-grid.rect(gp=gpar(col="white")) # adding white space
gf <- do.call(grid.arrange, c(lst_f, list(ncol = 6, top = "Women")))
SAVE.PLOT(gf, "histograms_female.png", 10,15)
# correlation matrices (SPLOM)






















# defining quantile-based skewness (Hao, 2007: 14)
qsk <- function(x){
qsk_numerator <-
quantile(x, probs = 0.90, na.rm = T) -
quantile(x, probs = 0.5, na.rm = T)
qsk_denominator <-
quantile(x, probs = 0.5, na.rm = T) -
quantile(x, probs = 0.1, na.rm = T)
qsk <- (qsk_numerator / qsk_denominator) - 1
return(qsk)}
# Skewness and qsk for all quantitative variables
melted <- melt(df[, c(qvars, "Geschlecht")], id.vars = "Geschlecht")
grouped <- group_by(melted, Geschlecht, variable)
tab <- summarise(grouped, skewness = skewness(value, na.rm = T), qsk=qsk(value))
tab <- cbind(tab[tab$Geschlecht == "Men", 2:ncol(tab)],
tab[tab$Geschlecht == "Women", 3:ncol(tab)])
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print(xtable(tab), include.rownames = F)
##################################################
# Box plots Vo2 by age class
##################################################
# Function because BPLs are also needed for validation
PLT.BPL <- function(DAT, REL = T, LAB = REL_LAB){
# ageclass is needed as "factor"
DF1 <- ddply(DAT, c("ageclass", "Geschlecht"), transform, N = length(ageclass))
DF1$label <- paste0(DF1$ageclass, "\n" , "(n=",DF1$N,")")








BRK = seq(from = 0,to = 6,by = 0.5)
}
# absolute VO2peak
BPL <- ggplot(DF1, aes_string(x = "label", y = OUTCOME)) +
geom_boxplot(na.rm = T) +
scale_y_continuous(limits = LMT, breaks = BRK) +





SAVE.PLOT(grid.arrange(PLT.BPL(df, REL = F, LAB = ABS_LAB),




# read standard population
sb <- read.table("./data/Altersverteilung_Zensus_2011.csv",
header = T, sep = ";", dec = ",")
sb$Men <- sb$Male
sb$Women <- sb$Female
sb$Male <- sb$Female <- NULL
# same age groups for standard population and PF sample
df$a.standard <- cut(df$ALTER,
breaks = c(25,30,35,40,45,50,55,60,65,69),
include.lowest = TRUE, include.highest = F, right = F)
sb$a.standard <- cut(sb$Alter,
breaks = c(25,30,35,40,45,50,55,60,65,69),
include.lowest = TRUE, include.highest = F, right = F)
# restricting census age groups to the margins of the present sample
sb <- subset(sb, !is.na(a.standard))
# aggregating standard population by age group
sb <- aggregate(cbind(Men, Women) ˜ a.standard, data = sb, sum)
# bootstrap function











# aggregating PF sample by age group
events <- aggregate(
x = bt[,repvars],
by = bt[,c("a.standard", "Geschlecht")],





e <- subset(events, Geschlecht == sex)
n <- subset(n_per_AG, Geschlecht == sex)
# event rate
er <- epitools::ageadjust.direct(
e[,var], n[,var], stdpop = standard[,sex])
return(er*100)
}
# function to execute bootstrap for sexes and variables
bt <- function(sx, vr){
b = boot::boot(
data = df,









# Creating overall table
PF_MALE <- data.frame(
Smoker = bt("Men", "ZIGARETTEN"),
Former_Smoker = bt("Men", "EXRAUCHER"),
Overweight = bt("Men", "BMI_GE_25"),
Obesity = bt("Men", "obese"),
Hypertension = bt("Men", "BLUTHOCHDRUCK_WHO")
)
PF_FEMALE <- data.frame(
Smoker = bt("Women", "ZIGARETTEN"),
Former_Smoker = bt("Women", "EXRAUCHER"),
Overweight = bt("Women", "BMI_GE_25"),
Obesity = bt("Women", "obese"),
Hypertension = bt("Women", "BLUTHOCHDRUCK_WHO")
)
DEGS_MALE <- data.frame(
Smoker = c(26.1, 24.0, 28.2),
Former_Smoker = c(33.7, 31.9, 35.5),
Overweight = c(67.1, 65.0, 69.2),
Obesity = c(23.3, 21.2, 25.4),
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Smoker = c(21.4, 19.7, 23.1),
Former_Smoker = c(22.8, 21.4, 24.2),
Overweight = c(53.0, 50.8, 55.1),
Obesity = c(23.9, 22.0, 25.9),







)), digits = 1)
LTAB <- cbind(
paste0(TAB[,1], " (", TAB[,2]," to ", TAB[,3], ")"),
paste0(TAB[,4], " (", TAB[,5]," to ", TAB[,6], ")"),
paste0(TAB[,7], " (", TAB[,8]," to ", TAB[,9], ")"),
paste0(TAB[,10], " (", TAB[,11]," to ", TAB[,12], ")")
)
LTAB <- as.data.frame(LTAB)
names(LTAB) <- c("PF_M", "DEGS_M", "PF_F", "DEGS_F")
row.names(LTAB) <- row.names(TAB)













# aggregating by TAUS and age class
tab1 <- aggregate(REL_VO2_MAX ˜ ageclass + Geschlecht,
data = df,
FUN = function(x) quantile(x, probs = TAUS))
tab2 <- aggregate(REL_VO2_MAX ˜ ageclass + Geschlecht,
data = df,
FUN = function(x) length(x))
tab <- do.call(data.frame, merge(tab1, tab2, by = c("Geschlecht", "ageclass")))
names(tab) <- c("Sex", "Age class", TAUS, "N")
print(xtable(tab,
digits = c(0, 0, rep(1, 15))),
include.rownames = F)
## PLAUSIBILITY CHECK:
# sum(df_FR$Geschlecht == "Female" & df_FR$ageclass == "[25,30)")
# quantile(subset(dfm_FR, ageclass == "[65,69]")$REL_VO2_MAX, probs = TAUS)
# correct!
# absolute VO2peak
tab1 <- aggregate(VO2_MAX ˜ ageclass + Geschlecht,
data = df,
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FUN = function(x) quantile(x, probs = TAUS))
tab2 <- aggregate(VO2_MAX ˜ ageclass + Geschlecht,
data = df,
FUN = function(x) length(x))
tab <- do.call(data.frame, merge(tab1, tab2, by = c("Geschlecht", "ageclass")))
names(tab) <- c("Sex", "Age class", TAUS, "N")
print(xtable(tab,





# Geschlecht == "Male" &
# ALTER >= 25 &
# ALTER < 30)$REL_VO2_MAX,




# Nomograms: calculation data
##################################################
PLT.DAT <- function(dat, var){
# empty list to save results
lst <- list()
# loop over all taus and calculate predicted values
for(i in TAUS){
# fit quantile regression
fit <- rq(dat[,var] ˜ ALTER + I(ALTERˆ2), data = dat, tau = i)
# create empty prediction data set
pdat <- data.frame(ALTER = seq(from = 25, to = 70, length.out = 1000))
# calculate predicted values and confidence intervals, and adding tau
set.seed(1)
pdat <-
cbind(pdat, tau = i,
predict.rq(fit, newdata = pdat, interval = "confidence", level = .95,
se = "boot", type = "percentile", R = NBOOT)
)
# creating list with all results






# ALTER tau fit lower higher
#1 25.00000 0.95 52.41516 49.79706 54.98178
#2 25.04505 0.95 52.40571 49.79676 54.96343
#3 25.09009 0.95 52.39624 49.79642 54.94508
## --> all entries (taus) should be row-binded
############################################
# row-binding for all prediction data frames (pdat)
ds_overall <- do.call(rbind, lst)
# express tau as perventile
ds_overall$tau <- ds_overall$tau*100
ds_overall$percentile <- paste(ds_overall$tau, "%", sep = "")
return(ds_overall)
}# plt.dat function end
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# Apply PLT.DAT to desired data sets
# list of all desired data sets
# --> 8 data sets --> perfect for parallelisation with 4 cpus
DSETS <- list(
# males and females with all observations
dfm = dfm,
dff = dff,
# males and female, smokers and obese excluded
# exm = exclusion of smokers&obese, male
exm = subset(dfm, ZIGARETTEN == "no" & obese == "no"),
exf = subset(dff, ZIGARETTEN == "no" & obese == "no"),
# including only participants from Frankfurt/Ruedesheim
# dfrm = df Ruedesheim, male
dfm_FR = dfm_FR,
dff_FR = dff_FR,
# including only participants from F/R and no smokers/obese
# exrm = exclusion of smoker&obese, Ruedesheim, male
exm_FR = subset(dfm_FR, ZIGARETTEN == "no" & obese == "no"),
exf_FR = subset(dff_FR, ZIGARETTEN == "no" & obese == "no")
)
# initiate clusters for parallel computing
cl <- makeCluster(mc <- getOption("cl.cores", 4))
clusterExport(cl=cl, varlist=ls())
clusterCall(cl, function() library("quantreg"))
ABS <- parLapply(cl, DSETS, function(x) PLT.DAT(x, "VO2_MAX"))
REL <- parLapply(cl, DSETS, function(x) PLT.DAT(x, "REL_VO2_MAX"))
stopCluster(cl)









COL <- c("dodgerblue","dodgerblue1","tomato3","dodgerblue2","dodgerblue3", "dodgerblue4",
"tomato3",
"dodgerblue4", "dodgerblue3", "tomato3", "dodgerblue2", "dodgerblue1", "dodgerblue")
# function for fitting of ggplots











# breaks are not dependent on a "from =" and "to =" argument
brk_fun <- function(k) {
step <- k






d <- rbind(dm, df)
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ggp <- ggplot(data = d, aes(x = ALTER, y = fit)) +
# defining background of ggplot
theme(panel.grid.major = element_line(colour = "grey60", size = 0.3),
panel.background = element_rect(fill = "white"),
axis.text.x = element_text(angle = 90, vjust=0.5),
plot.title = element_text(hjust = 0.5)) +
scale_x_continuous(limits = c(25,69),
breaks = seq(from = 25, to = 69, by = 1))+
scale_y_continuous(breaks = brk_fun(yby)) +
labs(x = "Age [years]",
y = ylb) +
geom_vline(xintercept = c(30, 40, 50, 60),
colour = "gray25",
size = 0.6) +
facet_wrap(˜sex, scales = "free_y", ncol = 1)
# adding confidence bands
ggp <- ggp +
geom_ribbon(aes(x = ALTER, ymin = lower, ymax = higher, fill = percentile),
alpha = 0.3, inherit.aes = F, show.legend = F, na.rm = T) +
scale_fill_manual(values = COL)
# adding quantile curves
ggp <- ggp +
geom_line(aes(x = ALTER, y = fit, colour = percentile),
show.legend = F, size = 1, na.rm = T) +
scale_color_manual(values = COL)
# adding percentile labels to curves




# Only Frankfurt and Ruedesheim (Munich is for external validation)
SAVE.PLOT(PLT(REL$dfm_FR, REL$dff_FR, rel = T, ex = F), "nomo_rel_include_FR.png", 10.5, 7)
SAVE.PLOT(PLT(ABS$dfm_FR, ABS$dff_FR, rel = F, ex = F), "nomo_abs_include_FR.png", 10.5, 7)
SAVE.PLOT(PLT(REL$exm_FR, REL$exf_FR, rel = T, ex = T), "nomo_rel_exclude_FR.png", 10.5, 7)
SAVE.PLOT(PLT(ABS$exm_FR, ABS$exf_FR, rel = F, ex = T), "nomo_abs_exclude_FR.png", 10.5, 7)
# Frankfurt, Ruedesheim and Munich included
SAVE.PLOT(PLT(REL$dfm, REL$dff, rel = T, ex = F), "nomo_rel_include_OVERALL.png", 10.5, 7)
SAVE.PLOT(PLT(ABS$dfm, ABS$dff, rel = F, ex = F), "nomo_abs_include_OVERALL.png", 10.5, 7)
SAVE.PLOT(PLT(REL$exm, REL$exf, rel = T, ex = T), "nomo_rel_exclude_OVERALL.png", 10.5, 7)
SAVE.PLOT(PLT(ABS$exm, ABS$exf, rel = F, ex = T), "nomo_abs_exclude_OVERALL.png", 10.5, 7)
dev.off()
##################################################
# Nomograms: Coefficient tables
##################################################
# calculating all coefficients and all 95% CIs for coefficients
COEF <- function(DAT, OUTCOME){




# loop over all taus and calculate predicted values
for(i in TAUS){
# name
NAM <- paste0("fit", i)
# fit quantile regression
FIT <- rq(DAT[,OUTCOME] ˜ ALTER + I(ALTERˆ2), data = DAT, tau = i)
# bootstrapped confidence intervals for coefficients
BT <- boot.rq(cbind(1, DAT[,"ALTER"], I(DAT[,"ALTER"]ˆ2)),
DAT[, OUTCOME],
tau = i, R = NBOOT)
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COEF[[NAM]] <- FIT$coefficients
CIL[[NAM]] <- apply(BT$B, 2, quantile, c(0.025))
CIH[[NAM]] <- apply(BT$B, 2, quantile, c(0.975))
}# End of loop
return(list(COEF = COEF, CIL = CIL, CIH = CIH))
}
# calculating coefficients for all data sets
# initiate clusters for parallel computing
cl <- makeCluster(mc <- getOption("cl.cores", 4))
clusterExport(cl=cl, varlist=ls())
clusterCall(cl, function() library("quantreg"))
COEF.ABS <- parLapply(cl, DSETS, function(x) COEF(x, "VO2_MAX"))
COEF.REL <- parLapply(cl, DSETS, function(x) COEF(x, "REL_VO2_MAX"))
stopCluster(cl)




# creating tables for all data sets
COEF.TAB <- function(DAT){
C <- round(t(do.call(data.frame, DAT$COEF)), digits = 8)
L <- round(t(do.call(data.frame, DAT$CIL)), digits = 8)
H <- round(t(do.call(data.frame, DAT$CIH)), digits = 8)
# for coefficient plots




# Coefficients + CI, I = Intercept, a = age, a2 = ageˆ2
# names are needed in this format for reshape using varying (coef plots)
names(TAB) <- c(
"c.1", "cil.1", "cih.1", "c.2", "cil.2", "cih.2", "c.3", "cil.3", "cih.3")
TAB$FIT <- row.names(C)
row.names(TAB) <- NULL
# for Latex, FIT is first col






LTAB <- xtable(LTAB, digits = c(0,0,rep(8,9)))





print(COEF.TAB(COEF.ABS$dfm)$LTAB, include.rownames = FALSE)
print(COEF.TAB(COEF.ABS$dff)$LTAB, include.rownames = FALSE)
# exclusion of smokers and obese
print(COEF.TAB(COEF.ABS$exm)$LTAB, include.rownames = FALSE)
print(COEF.TAB(COEF.ABS$exf)$LTAB, include.rownames = FALSE)
# Frankfurt/Ruedesheim (FR)
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print(COEF.TAB(COEF.ABS$dfm_FR)$LTAB, include.rownames = FALSE)
print(COEF.TAB(COEF.ABS$dff_FR)$LTAB, include.rownames = FALSE)
# Frankfurt/Ruedesheim (FR)
print(COEF.TAB(COEF.ABS$exm_FR)$LTAB, include.rownames = FALSE)
print(COEF.TAB(COEF.ABS$exf_FR)$LTAB, include.rownames = FALSE)
# Relative VO2max
# All cases
print(COEF.TAB(COEF.REL$dfm)$LTAB, include.rownames = FALSE)
print(COEF.TAB(COEF.REL$dff)$LTAB, include.rownames = FALSE)
# exclusion of smokers and obese
print(COEF.TAB(COEF.REL$exm)$LTAB, include.rownames = FALSE)
print(COEF.TAB(COEF.REL$exf)$LTAB, include.rownames = FALSE)
# Frankfurt/Ruedesheim (FR)
print(COEF.TAB(COEF.REL$dfm_FR)$LTAB, include.rownames = FALSE)
print(COEF.TAB(COEF.REL$dff_FR)$LTAB, include.rownames = FALSE)
# Frankfurt/Ruedesheim (FR)
print(COEF.TAB(COEF.REL$exm_FR)$LTAB, include.rownames = FALSE)










# Rbindung both sexes
COEF.DATA <- rbind(DM, DF)
# >COEF.DATA
# colnames are: c1 = Intercept, c2 = age, c3 = ageˆ2
#
# c.1 cil.1 cih.1 c.2 cil.2
# fit0.05 2.148064 1.2871575 2.833846 0.0220968 -0.0071967 ...
# fit0.1 2.283736 1.3166107 2.540710 0.0250659 0.0004518 ...
# fit0.2 2.407500 1.2070498 2.863562 0.0309868 -0.0089181 ...
# ...
LONG <- reshape(COEF.DATA, dir="long", varying = 1:9, idvar = c("FIT", "Sex"))
LONG$time <- factor(LONG$time, levels = c(1,2,3),
labels = c("Intercept", "Age",expression(Ageˆ"2")))
# >LONG
# FIT Sex time c cil cih
# fit0.05 Male Age 2.1480645 1.1823432 3.1150844
# fit0.1 Male Age 2.2837363 1.4854133 2.9921140
# fit0.2 Male Age 2.4075000 1.9149587 2.6529048
# ...
PLT <- ggplot(LONG) +
geom_point( aes(x = FIT, y = c)) +
geom_linerange(aes(x = FIT, ymin = cil, ymax = cih)) +
theme(axis.text.x = element_text(angle = 45, hjust = 1),
plot.title = element_text(hjust = 0.5)) +
facet_wrap(Sex ˜ time, scales = "free", labeller = label_parsed) +
geom_hline(yintercept = 0, lty = 2) +
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# All cases
SAVE.PLOT(PLT.COEF(COEF.ABS$dfm,COEF.ABS$dff), "coefplot_abs_OVERALL.png", 4, 8)
# exclusion of smokers and obese
SAVE.PLOT(PLT.COEF(COEF.ABS$exm,COEF.ABS$exf), "coefplot_abs_EX.png", 4, 8)
# Frankfurt/Ruedesheim (FR)
SAVE.PLOT(PLT.COEF(COEF.ABS$dfm_FR,COEF.ABS$dff_FR), "coefplot_abs_FR.png", 4, 8)
# Relative VO2max
# All cases
SAVE.PLOT(PLT.COEF(COEF.REL$dfm,COEF.REL$dff), "coefplot_rel_OVERALL.png", 4, 8)
# exclusion of smokers and obese
SAVE.PLOT(PLT.COEF(COEF.REL$exm,COEF.REL$exf), "coefplot_rel_EX.png", 4, 8)
# Frankfurt/Ruedesheim (FR)
SAVE.PLOT(PLT.COEF(COEF.REL$dfm_FR,COEF.REL$dff_FR), "coefplot_rel_FR.png", 4, 8)
7.3.7 Validation
##################################################
# calculating validation data
##################################################
VALI.DAT <- function(TRN.DAT = dfm_FR, VAL.DAT = dfm_FR, OUTCOME = "REL_VO2_MAX",
FORMULA = "ageclass + I(ageclassˆ2)"){
# GOALS: producing all data for validation
# G1) empirical quantiles (EMP.QTLS) from validation data (VAL.DAT)
# G2) quantile regression in trainaing data (TRN.DAT)
# G3) predicted values from quantile regressions
# G4) 95% CI for predicted values
# G5) AIC table for each TAUS2
# G6) comparing empirical and estimated values in separate function
# quantiles for validation
TAUS2 <- c(0.25,0.5,0.75)
# GOAL 1
# empirical quantiles: tau = {0.25,0.5,0.75}
FRM1 <- as.formula(paste(OUTCOME, "˜ ageclass + Geschlecht"))
EMP.QTLS <- aggregate(FRM1, data = VAL.DAT,
FUN = function(x) quantile(x, probs = TAUS2))
EMP.QTLS <- do.call(data.frame, EMP.QTLS)
names(EMP.QTLS) <- c("ageclass", "Geschlecht", "tau0.25", "tau0.5", "tau0.75")
EMP.QTLS <- melt(EMP.QTLS, id.vars = c("ageclass", "Geschlecht"))
# > EMP.QTLS
# ageclass Geschlecht variable value
# [25,30) Male tau0.25 33.525
# [30,35) Male tau0.25 33.400
# [35,40) Male tau0.25 32.700
# ...
# GOAL 2
# ageclass variable (from trainaing data) for regression
TRN.DAT$ageclass <- as.numeric(TRN.DAT$ageclass)
# formula for quantile regressions
FRM2 <- as.formula(paste(OUTCOME, "˜", FORMULA))
PDAT <- list()
AIC.DAT <- list()
# loop over all taus and calculate predicted values
for(i in TAUS2){
FIT <- rq(FRM2, data = TRN.DAT, tau = i)
# create empty prediction data set
pdat <- data.frame(ageclass = 1:9)
# function to predict value and 95% CI
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se = "boot", type = "percentile",
level = .95, R = NBOOT)
return(PV)
}






# ageclass tau fit lower higher
# 1 tau0.50 39.30000 38.31400 41.09600
# 2 tau0.50 38.83333 38.24494 39.88267
# 3 tau0.50 38.00000 37.70000 38.49750
# ...
# column must be the same name as outcome
# in order to add the dots in the box plot
pdat[,OUTCOME] <- pdat$fit
# saving prediction data
nam1 <- paste0("pdat", i)
PDAT[[nam1]] <- pdat
# saving aic data
nam2 <- paste0("aic", i)
AIC.DAT[[nam2]] <- AIC.rq(FIT)
}
PDAT <- do.call(rbind, PDAT)
row.names(PDAT) <- NULL






return(list(EMP.QTLS = EMP.QTLS, PDAT = PDAT, AIC.DAT = AIC.DAT))
}
# saving all data
# Nomenclature:
# A = a = apparent, e = external
# M = male, F = female
# R = REL_VO2_MAX, A = ABS_VO2_MAX
# __________________________________
# Main models: Quadratic
# __________________________________
# apparent validation
AMR <- VALI.DAT(dfm_FR, dfm_FR, "REL_VO2_MAX", "ageclass + I(ageclassˆ2)")
AFR <- VALI.DAT(dff_FR, dff_FR, "REL_VO2_MAX", "ageclass + I(ageclassˆ2)")
AMA <- VALI.DAT(dfm_FR, dfm_FR, "VO2_MAX", "ageclass + I(ageclassˆ2)")
AFA <- VALI.DAT(dff_FR, dff_FR, "VO2_MAX", "ageclass + I(ageclassˆ2)")
# external validation
EMR <- VALI.DAT(dfm_FR, dfm_M, "REL_VO2_MAX", "ageclass + I(ageclassˆ2)")
EFR <- VALI.DAT(dff_FR, dff_M, "REL_VO2_MAX", "ageclass + I(ageclassˆ2)")
EMA <- VALI.DAT(dfm_FR, dfm_M, "VO2_MAX", "ageclass + I(ageclassˆ2)")
EFA <- VALI.DAT(dff_FR, dff_M, "VO2_MAX", "ageclass + I(ageclassˆ2)")
# __________________________________
# Other models: Linear
# __________________________________
# apparent validation
AMR_lin <- VALI.DAT(dfm_FR, dfm_FR, "REL_VO2_MAX", "ageclass")
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AFR_lin <- VALI.DAT(dff_FR, dff_FR, "REL_VO2_MAX", "ageclass")
AMA_lin <- VALI.DAT(dfm_FR, dfm_FR, "VO2_MAX", "ageclass")
AFA_lin <- VALI.DAT(dff_FR, dff_FR, "VO2_MAX", "ageclass")
# __________________________________
# Other models: spline
# __________________________________
# apparent validation
AMR_spl <- VALI.DAT(dfm_FR, dfm_FR, "REL_VO2_MAX", "bs(ageclass)")
AFR_spl <- VALI.DAT(dff_FR, dff_FR, "REL_VO2_MAX", "bs(ageclass)")
AMA_spl <- VALI.DAT(dfm_FR, dfm_FR, "VO2_MAX", "bs(ageclass)")




# validation box plots
##################################################
# function for adding the estimates or CI to the box plot
ADD.LINES <- function(DAT = DAT, COLOUR = "blue", CI = F, ALPHA = 1){
# adding confidence bands
if(CI == T){
BPL <- BPL +
geom_linerange(data = DAT,
aes(x = ageclass, ymin = lower, ymax = higher, group = tau),
size = 7, colour = "red", alpha = 0.5)
}
BPL <- BPL +
geom_line(data = DAT,
stat = "smooth", method = "loess",
aes(x = ageclass, y = fit, group = tau),
size = 0.5, colour = COLOUR, alpha = ALPHA,
na.rm = T) +
geom_point(data = DAT, aes(x = ageclass, y = fit, shape = factor(tau)),








BPL <- PLT.BPL(dfm_FR, REL = T, LAB = REL_LAB)
BPL1 <- ADD.LINES(DAT = AMR$PDAT, COLOUR = "blue", CI = T)
# rel, females
BPL <- PLT.BPL(dff_FR, REL = T, LAB = "")
BPL2 <- ADD.LINES(DAT = AFR$PDAT, COLOUR = "blue", CI = T)
# abs, males
BPL <- PLT.BPL(dfm_FR, REL = F, LAB = ABS_LAB)
BPL3 <- ADD.LINES(DAT = AMA$PDAT, COLOUR = "blue", CI = T)
# abs, females
BPL <- PLT.BPL(dff_FR, REL = F, LAB = "")
BPL4 <- ADD.LINES(DAT = AFA$PDAT, COLOUR = "blue", CI = T)






BPL <- PLT.BPL(dfm_M, REL = T, LAB = REL_LAB)
BPL1 <- ADD.LINES(DAT = EMR$PDAT, COLOUR = "blue", CI = T)
# rel, females
BPL <- PLT.BPL(dff_M, REL = T, LAB = "")
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BPL2 <- ADD.LINES(DAT = EFR$PDAT, COLOUR = "blue", CI = T)
# abs, males
BPL <- PLT.BPL(dfm_M, REL = F, LAB = ABS_LAB)
BPL3 <- ADD.LINES(DAT = EMA$PDAT, COLOUR = "blue", CI = T)
# abs, females
BPL <- PLT.BPL(dff_M, REL = F, LAB = "")
BPL4 <- ADD.LINES(DAT = EFA$PDAT, COLOUR = "blue", CI = T)
SAVE.PLOT(grid.arrange(BPL1,BPL2,BPL3,BPL4, ncol = 2),
"vali_external.png", 8, 10.5)
# __________________________________
# Apparent validation including linear and spline models
# __________________________________
# rel, males
BPL <- PLT.BPL(dfm_FR, REL = T, LAB = REL_LAB)
BPL <- ADD.LINES(DAT = AMR_lin$PDAT, COLOUR = "red", CI = F, ALPHA = 0.5)
BPL <- ADD.LINES(DAT = AMR$PDAT, COLOUR = "blue", CI = F, ALPHA = 0.5)
BPL1 <- ADD.LINES(DAT = AMR_spl$PDAT, COLOUR = "green", CI = F, ALPHA = 0.5)
# rel, females
BPL <- PLT.BPL(dff_FR, REL = T, LAB = "")
BPL <- ADD.LINES(DAT = AFR_lin$PDAT, COLOUR = "red", CI = F, ALPHA = 0.5)
BPL <- ADD.LINES(DAT = AFR$PDAT, COLOUR = "blue", CI = F, ALPHA = 0.5)
BPL2 <- ADD.LINES(DAT = AFR_spl$PDAT, COLOUR = "green", CI = F, ALPHA = 0.5)
# abs, males
BPL <- PLT.BPL(dfm_FR, REL = F, ABS_LAB)
BPL <- ADD.LINES(DAT = AMA_lin$PDAT, COLOUR = "red", CI = F, ALPHA = 0.5)
BPL <- ADD.LINES(DAT = AMA$PDAT, COLOUR = "blue", CI = F, ALPHA = 0.5)
BPL3 <- ADD.LINES(DAT = AMA_spl$PDAT, COLOUR = "green", CI = F, ALPHA = 0.5)
# abs, females
BPL <- PLT.BPL(dff_FR, REL = F, LAB = "")
BPL <- ADD.LINES(DAT = AFA_lin$PDAT, COLOUR = "red", CI = F, ALPHA = 0.5)
BPL <- ADD.LINES(DAT = AFA$PDAT, COLOUR = "blue", CI = F, ALPHA = 0.5)
BPL4 <- ADD.LINES(DAT = AFA_spl$PDAT, COLOUR = "green", CI = F, ALPHA = 0.5)
SAVE.PLOT(grid.arrange(BPL1,BPL2,BPL3,BPL4, ncol = 2),
"vali_apparent_comparison.png", 8, 10.5)
##################################################
# validation calibration plots
##################################################
# build basic calibration plot without lines
PLT.CALI <- function(REL = T, CITY = "Frankfurt/RÃ¼desheim"){
if(REL == T){ MIN = 20; MAX = 50; BY = 5 }else{
MIN = 1 ; MAX = 4 ; BY = 0.5}
lab <- paste("Observed \n in", CITY)
P <- ggplot(data = D, aes(x = fit, y = value)) +
geom_abline(intercept = 0, slope = 1, lty = 3) +
theme(legend.position = "none") +
scale_x_continuous(limits = c(MIN,MAX), breaks = seq(MIN, MAX, by = BY)) +
scale_y_continuous(limits = c(MIN,MAX), breaks = seq(MIN, MAX, by = BY)) +
labs(x = "Prediction \n based on Frankfurt/RÃ¼desheim", y = lab)
return(P)
}
# add regression lines and dots
LINE.CALI <- function(X = AMR$PDAT, Y = AMR$EMP.QTLS, PLOT = CP, COLOUR = "blue", ALPHA = 1){
Y$ageclass <- as.numeric(Y$ageclass)
D <- merge(X, Y,
by.x = c("ageclass", "tau"),
by.y = c("ageclass", "variable"))
CP <- CP +
geom_line(stat = "smooth", method = "lm", se = F,
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data = D,
aes(x = fit, y = value),
colour = COLOUR, alpha = ALPHA, na.rm = T) +
geom_point(data = D, aes(x = fit, y = value, shape = tau),







CP <- PLT.CALI(REL = T)
CP1 <- LINE.CALI(AMR$PDAT, AMR$EMP.QTLS)
CP2 <- LINE.CALI(AFR$PDAT, AFR$EMP.QTLS)
CP <- PLT.CALI(REL = F)
CP3 <- LINE.CALI(AMA$PDAT, AMA$EMP.QTLS)
CP4 <- LINE.CALI(AFA$PDAT, AFA$EMP.QTLS)
SAVE.PLOT(grid.arrange(
arrangeGrob(CP1,CP2, top = textGrob(REL_LAB)),
arrangeGrob(CP3,CP4, top = textGrob(ABS_LAB)),




CP <- PLT.CALI(REL = T, CITY = "Munich")
CP1 <- LINE.CALI(EMR$PDAT, EMR$EMP.QTLS)
CP2 <- LINE.CALI(EFR$PDAT, EFR$EMP.QTLS)
CP <- PLT.CALI(REL = F, CITY = "Munich")
CP3 <- LINE.CALI(EMA$PDAT, EMA$EMP.QTLS)
CP4 <- LINE.CALI(EFA$PDAT, EFA$EMP.QTLS)
SAVE.PLOT(grid.arrange(
arrangeGrob(CP1,CP2, top = textGrob(REL_LAB)),
arrangeGrob(CP3,CP4, top = textGrob(ABS_LAB)),
ncol = 2), "cali_external.png", 10,8)
# __________________________________
# Apparent validation comparison of regression models
# __________________________________
CP <- PLT.CALI(REL = T) # Males, REL_VO2_MAX
CP <- LINE.CALI(AMR$PDAT, AMR$EMP.QTLS , ALPHA = 0.5, COLOUR = "blue")
CP <- LINE.CALI(AMR_lin$PDAT, AMR_lin$EMP.QTLS, ALPHA = 0.5, COLOUR = "red")
CP1 <- LINE.CALI(AMR_spl$PDAT, AMR_spl$EMP.QTLS, ALPHA = 0.5, COLOUR = "green")
CP <- PLT.CALI(REL = T) # Females REL_VO2_MAX
CP <- LINE.CALI(AFR$PDAT, AFR$EMP.QTLS , ALPHA = 0.5, COLOUR = "blue")
CP <- LINE.CALI(AFR_lin$PDAT, AFR_lin$EMP.QTLS, ALPHA = 0.5, COLOUR = "red")
CP2 <- LINE.CALI(AFR_spl$PDAT, AFR_spl$EMP.QTLS, ALPHA = 0.5, COLOUR = "green")
CP <- PLT.CALI(REL = F) # Males VO2_MAX
CP <- LINE.CALI(AMA$PDAT, AMA$EMP.QTLS , ALPHA = 0.5, COLOUR = "blue")
CP <- LINE.CALI(AMA_lin$PDAT, AMA_lin$EMP.QTLS, ALPHA = 0.5, COLOUR = "red")
CP3 <- LINE.CALI(AMA_spl$PDAT, AMA_spl$EMP.QTLS, ALPHA = 0.5, COLOUR = "green")
CP <- PLT.CALI(REL = F) # Females VO2_MAX
CP <- LINE.CALI(AFA$PDAT, AFA$EMP.QTLS , ALPHA = 0.5, COLOUR = "blue")
CP <- LINE.CALI(AFA_lin$PDAT, AFA_lin$EMP.QTLS, ALPHA = 0.5, COLOUR = "red")
CP4 <- LINE.CALI(AFA_spl$PDAT, AFA_spl$EMP.QTLS, ALPHA = 0.5, COLOUR = "green")
SAVE.PLOT(grid.arrange(
arrangeGrob(CP1,CP2, top = textGrob(REL_LAB)),
arrangeGrob(CP3,CP4, top = textGrob(ABS_LAB)),
ncol = 2), "cali_apparent_comparison.png", 10,8)
##################################################


















# validation coefficient tables
##################################################
COEF.TAB2 <- function(DAT){
X <- DAT["PDAT"]; X <- X$PDAT$fit
Y <- DAT["EMP.QTLS"]; Y <- Y$EMP.QTLS$value
D <- data.frame(X,Y)
COEF.BT <- function(data, INDEX){
set.seed(1)
D1 <- data[INDEX,]
FIT <- lm(Y ˜ X, data = D1)
ROW <- c(FIT$coefficients, summary(FIT)$r.squared)
}
BT <- boot(data = D, statistic = COEF.BT, R = NBOOT)
TAB <- rbind(BT$t0, apply(BT$t, 2, quantile, c(0.025,0.975)))
TAB <- round(t(as.data.frame(TAB)), digits = 2)
COL <- paste0(TAB[,1], " [", TAB[,2], " to ", TAB[,3], "]")
COL <- data.frame(COL = COL)
row.names(COL) <- c("Intercept", "Slope", "Rsquared")
#> COL
#Intercept 5.94 [3.11 to 8.69]
#Slope 0.83 [0.76 to 0.90]




















names(TAB) <- c("Absolute", "Relative")
xtable(TAB)
# __________________________________
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COEF.TAB2(AMR_lin), COEF.TAB2(AMR_spl), COEF.TAB2(AMR))
)
names(TAB) <- c("AL", "AS", "AP", "RL", "RS", "RP")
xtable(TAB)
7.3.8 Multiple quantile regression
# histogram rubust for outliers
h <- function(var){
# set margins of histogram
m <- mean(df[,var], na.rm = T)
s <- sd(df[,var], na.rm = T)
# log transformed variable
d <- df
d$l <- log(df[,var])
ml <- mean(d$l, na.rm = T)
sl <- sd(d$l, na.rm = T)
# histogram with crude variable
c <- ggplot(df, aes_string(x = var)) +
geom_histogram(aes(y = ..density..), bins = 20, na.rm = T) +
scale_x_continuous(limits = c(m - 3*s, m + 3*s)) +
facet_wrap(˜Geschlecht) +
labs(title = "crude")
# histogram with log-transformed variable
l <- ggplot(d, aes(x = l)) +
geom_histogram(aes(y = ..density..), bins = 20, na.rm = T) +






h("BMI") # --> transform --> use overweight/obese
h("GEWICHT") # --> transform --> exclude due to colliearity
h("TRIGLYCERIDE") # --> transform: binary
h("BAUCHUMFANG") # transform -->
h("BLUTZUCKER") # --> transform --> binary as Diabetes_mellitus
h("HBA1C") # --> transform --> binary as Diabetes_mellitus
h("SYST") # --> no transformation
h("DIAST") # --> no transformation
# checking correlation of variables
# remove when r>=0.75 to avoid collinearity
# based on SPLOM
# --> remove:
# GEWICHT, BAUCHUMFANG, KOERPERFETT_CALIPER & TANITA,
# GESAMTCHOLESTERIN






df$High_LDL = ifelse(df$LDL_CHOLESTERIN >=115, 1, 0)
df$High_TG = ifelse(df$TRIGLYCERIDE >=150, 1, 0)
df$Low_HDL = ifelse(df$HDL_CHOLESTERIN <=40, 1, 0)
df$Hypertension = ifelse(df$SYST >= 140 | df$DIAST >= 90, 1, 0)







7.3. STATISTICAL CODE 7. Statistical code
df$LDL_cholesterol <- df$LDL_CHOLESTERIN
# recoding factor variables
# --> necessary for following function
# --> coding as no = 1, yes = 2
BIN <- function(x){
var <- as.numeric(df[,x])












"Hypertension", "Low_HDL", "High_LDL", "High_TG",
"Diabetes_mellitus", "Smoker", "Exsmoker"
)
# removing all cases with NAs in data set
df$exclusion <- rowSums(is.na(df[,c(IV,"VO2_MAX", "REL_VO2_MAX")]))
df1 <- subset(df, exclusion == 0)
# subsetting data including new IVs
dfm <- subset(df1, Geschlecht == "Men")
dff <- subset(df1, Geschlecht == "Women")
# Regression fitting
QR <- function(dat, outcome, qtile) {
# creating formula
# IV have to be defined!
frm <- as.formula(paste(outcome ,"˜", paste(IV, collapse = "+")))
# fitting quantile regression
fit <- step(rq(frm, data = dat, tau = qtile), direction = "both")
# bootstrapped P values
# NBOOT has to be defined!
set.seed(1)
tab <- summary(fit, se = "boot", R = NBOOT)
# extract all variables that are in the formula of final model and remove dependent var
var <- setdiff(all.vars(tab$call$formula), outcome)
# bottstrapping 95% confidence intervals
set.seed(1)
bt <- boot.rq(cbind(1, dat[, var]), dat[, outcome], tau = qtile, R = NBOOT)
# add bootstrapped 95% CI to table
tab <- cbind(
tab$coefficients[, c(1,4)],
t(apply(bt$B, 2, quantile, c(0.025,0.975))))
# are coefficients within ci bounds?
tab <- as.data.frame(tab)




# do 95% CI and P value lead to the same conclusion (sig. yes/no)?
sig <- data.frame(
pval = tab[,4] < 0.05,
ci = (tab[,2] > 0) == (tab[,3] > 0)
)
sig$SAME_CONCLUSION <- sig$pval == sig$ci
# calculation of Rˆ2 according to
# Hao, 2007, p. 52
# https://stat.ethz.ch/pipermail/r-help/2006-August/110386.html
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# http://stats.stackexchange.com/questions/129200/r-squared-in-quantile-regression
fit0 <- rq(REL_VO2_MAX ˜ 1, tau = qtile, data = dat)
rho <- function(u,tau=qtile)u*(tau - (u < 0))
R1 <- round(1 - fit$rho/fit0$rho, digits = 3)
# creating name for coefficient plot
# sex
if(dat[3,"Geschlecht"] == "Men") sex <- "Men"
if(dat[3,"Geschlecht"] == "Women") sex <- "Women"
# return the name VO2_MAX
out <- colnames(dat)[which(colnames(dat) %in% outcome)]
# build name
if(out == "REL_VO2_MAX") {
lab <- bquote(atop(.(paste0(sex))*";"
˜Dependent˜variable˜"="
˜Relative˜dot('V')*O['2peak']˜ "[mL" * O["2"]*"/min/kg"*"]",
Quantile˜"="˜.(qtile)*";"
˜Pseudo*"-"*Rˆ2˜"="˜ .(R1)))}
if(out == "VO2_MAX") {
lab <- bquote(atop(.(paste0(sex))*";"
˜Dependent˜variable˜"="
˜Absolute˜dot('V')*O['2peak']˜ "[L" * O["2"]*"/min"*"]",
Quantile˜"="˜.(qtile)*";"
˜Pseudo*"-"*Rˆ2˜"="˜ .(R1)))}





plt <-ggplot(data = tab2[2:nrow(tab2),]) +
geom_point(aes(x = name, y = Value)) +
theme(panel.background = element_rect(fill = "white"),
panel.grid.major = element_line(linetype = "dotted", colour = "grey60", size = 0.3),
plot.title = element_text(size = 10)) +
geom_hline(yintercept = 0, lty = 2) +
geom_linerange(aes(x = name, ymin = `2.5%`, ymax = `97.5%`)) +
labs(x = "", y = "") +
ggtitle(lab) +
scale_y_continuous(expand = c(0.1,0.1), breaks = ) +
coord_flip()
l <- list(tab, plt, R1, coef_in_ci, sig)
return(l)}
# males
rm25 <- QR(dfm, "REL_VO2_MAX", 0.25)
rm50 <- QR(dfm, "REL_VO2_MAX", 0.50)
rm75 <- QR(dfm, "REL_VO2_MAX", 0.75)
# females
rf25 <- QR(dff, "REL_VO2_MAX", 0.25)
rf50 <- QR(dff, "REL_VO2_MAX", 0.50)
rf75 <- QR(dff, "REL_VO2_MAX", 0.75)
# arranging coefficient plots
rm <- grid.arrange(rm25[[2]], rm50[[2]], rm75[[2]], ncol = 1)
rf <- grid.arrange(rf25[[2]], rf50[[2]], rf75[[2]], ncol = 1)
# absolute VO2peak
# males
am25 <- QR(dfm, "VO2_MAX", 0.25)
am50 <- QR(dfm, "VO2_MAX", 0.50)
am75 <- QR(dfm, "VO2_MAX", 0.75)
# females
af25 <- QR(dff, "VO2_MAX", 0.25)
af50 <- QR(dff, "VO2_MAX", 0.50)
af75 <- QR(dff, "VO2_MAX", 0.75)
# arranging coefficient plots
am <- grid.arrange(am25[[2]], am50[[2]], am75[[2]], ncol = 1)
af <- grid.arrange(af25[[2]], af50[[2]], af75[[2]], ncol = 1)
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print(xtable(rbind(rm25[[1]], rm50[[1]], rm75[[1]]), digits=c(2,2,2,2,3)))
print(xtable(rbind(rf25[[1]], rf50[[1]], rf75[[1]]), digits=c(2,2,2,2,3)))
print(xtable(rbind(am25[[1]], am50[[1]], am75[[1]]), digits=c(2,2,2,2,3)))
print(xtable(rbind(af25[[1]], af50[[1]], af75[[1]]), digits=c(2,2,2,2,3)))
7.3.9 Comparison of reference values
# SHIP Study (Koch, 2009)
# CODING
# m=1, f=2
# age groups: 25-34, 35-44, 45-54, 55-64, >=64
# bmi: <25 = 0, >=25 = 1
# VO2peak 5%
v.05 <- function(sex, Age, bmi){











v.95 <- function(sex, Age, bmi){











v.50 <- function(sex, Age, bmi){











# prediction data set
ship_m <- data.frame(Age = 1:5)
ship_f <- data.frame(Age = 1:5)
own_m <- data.frame(Age = 25:70)
own_f <- data.frame(Age = 25:70)
# males
ship_m$m.05 <- v.05(1, ship_m$Age, 0)
ship_m$m.50 <- v.50(1, ship_m$Age, 0)
ship_m$m.95 <- v.95(1, ship_m$Age, 0)
# females
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ship_f$f.05 <- v.05(2, ship_f$Age, 0)
ship_f$f.50 <- v.50(2, ship_f$Age, 0)
ship_f$f.95 <- v.95(2, ship_f$Age, 0)
ship_m$Age <- ship_f$Age <- factor(
ship_m$Age,
levels = 1:5,
labels = c("25-34", "35-44", "45-54", "55-64", ">=64"))
ship_m_long <- melt(ship_m, id.vars = "Age")
ship_f_long <- melt(ship_f, id.vars = "Age")
# FRIEND Study (Kaminsky, 2015)
# Age groups (6): 20-29, 30-39, 40-49, 50-59, 60-69, 70-79
kaminsky_m <- data.frame(
Age = rep(1:6, 3),
variable = c(rep("m.05",6), rep("m.50",6), rep("m.95",6)),
value = c(
# m.50
41.9, 30.1, 27.1, 24.8, 22.4, 19.5))
kaminsky_f <- data.frame(
Age = rep(1:6, 3),
variable = c(rep("f.05",6), rep("f.50",6), rep("f.95",6)),
value = c(
# f.50
31.0, 21.6, 19.4, 17.3, 16.0, 14.8))
# recoding age
kaminsky_m$Age <- kaminsky_f$Age <- factor(
kaminsky_m$Age,
levels = 1:6,





fitm.05 <- rq(REL_VO2_MAX ˜ Age + I(Ageˆ2), data = dfm_FR, tau = 0.05)
fitm.50 <- rq(REL_VO2_MAX ˜ Age + I(Ageˆ2), data = dfm_FR, tau = 0.50)
fitm.95 <- rq(REL_VO2_MAX ˜ Age + I(Ageˆ2), data = dfm_FR, tau = 0.95)
own_m$m.05 <- predict(fitm.05, newdata = own_m)
own_m$m.50 <- predict(fitm.50, newdata = own_m)
own_m$m.95 <- predict(fitm.95, newdata = own_m)
own_m_long <- melt(own_m, id.vars = "Age")
# females
fitf.05 <- rq(REL_VO2_MAX ˜ Age + I(Ageˆ2), data = dff_FR, tau = 0.05)
fitf.50 <- rq(REL_VO2_MAX ˜ Age + I(Ageˆ2), data = dff_FR, tau = 0.50)
fitf.95 <- rq(REL_VO2_MAX ˜ Age + I(Ageˆ2), data = dff_FR, tau = 0.95)
own_f$f.05 <- predict(fitf.05, newdata = own_f)
own_f$f.50 <- predict(fitf.50, newdata = own_f)
own_f$f.95 <- predict(fitf.95, newdata = own_f)
own_f_long <- melt(own_f, id.vars = "Age")
g <- function(dat, tit, xtit, ytit, class = T){
# plot
gp <- ggplot(data = dat, aes(x = Age, y = value, group = factor(variable))) +
geom_line() +
theme(panel.grid.major = element_line(colour = "grey60", size = 0.3),
panel.background = element_rect(fill = "white")) +
scale_y_continuous(limits = c(10,55), breaks = seq(from=10, to = 55, by = 5)) +
labs(title = tit, x = xtit, y = ytit)
# modifying x axis
if(class == F){
gp <- gp + scale_x_continuous(limits = c(25,70), breaks = seq(from= 25, to = 70, by = 5))
}else{
gp <- gp + geom_point()
}
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g1 <- g(own_m_long, "Prevention First", "Age [years]", REL_LAB, class = F)
g2 <- g(ship_m_long, "SHIP Study", "Age class [years]", "")
g3 <- g(kaminsky_m, "FRIEND Study", "Age class [years]", "")
# agganging plots
gm <- grid.arrange(g1, g2, g3, ncol = 3, top = "Men")
# plotting females
g1 <- g(own_f_long, "Prevention First", "Age [years]", REL_LAB, class = F)
g2 <- g(ship_f_long, "SHIP Study", "Age class [years]", "")
g3 <- g(kaminsky_f, "FRIEND Study", "Age class [years]", "")
# agganging plots
gf <- grid.arrange(g1, g2, g3, ncol = 3, top = "Women")









# see separate code
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Table A.1: Bivariate descriptive table of the full dataset and random sample.




Relative [mLO2/min/kg] 32.8 [27.7;38.4] 31.9 [27.2;37.5] 0.211
Absolute [LO2/min] 2.63 [2.06;3.18] 2.56 [1.97;3.13] 0.218
Anthropometric
Age [years] 45.0 [41.0;50.0] 45.0 [40.0;50.0] 0.546
Weight [kg] 80.0 [69.0;90.0] 79.0 [67.5;89.0] 0.615
Height [cm] 177 [170;183] 177 [168;183] 0.459
BMI [kg/m2] 25.1 [22.9;27.7] 24.7 [22.7;28.0] 0.713
Sex: 0.756
Men 5916 (64.8%) 147 (63.6%)
Women 3207 (35.2%) 84 (36.4%)
Smoker 0.374
no 7810 (86.1%) 192 (83.8%)
yes 1258 (13.9%) 37 (16.2%)
Overweight 0.234
no 4434 (48.6%) 122 (52.8%)
yes 4684 (51.4%) 109 (47.2%)
Study center
City 0.628
Frankfurt/Ruedesheim 7327 (80.3%) 189 (81.8%)
Munich 1796 (19.7%) 42 (18.2%)
Note: Full data denotes the overall dataset (n=10,189) excluding participants
who were selected for the random sample (n=252). The random sample was
drawn from the original dataset including 10,189 participants before exclusion
of participants (fig. 3.2).
None of the obtained P values was < 0.05. Consequently, there were no statisti-
cally significant differences between the full data and the random sample. The
random sample was hence assumed to represent the full dataset adequately.
Quantitative variables are displayed as median [1st quartile; 3rd quartile],
qualitative characteristics as n (percent).
Overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥ 30 kg/m2.
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A.2 Selective dropout analysis
Table A.2: Bivariate descriptive table of the final dataset and excluded cases.




Relative [mLO2/min/kg] 32.8 [27.7;38.4] 31.6 [26.4;36.8] <0.001
Absolute [LO2/min] 2.63 [2.06;3.18] 2.29 [1.84;2.94] <0.001
Anthropometric
Age [years] 45.0 [41.0;50.0] 46.0 [41.0;51.0] <0.001
Weight [kg] 80.0 [69.0;90.0] 75.0 [65.0;86.0] <0.001
Height [cm] 177 [170;183] 173 [166;181] <0.001
BMI [kg/m2] 25.1 [22.9;27.7] 24.5 [22.2;27.2] <0.001
Sex <0.001
Men 6063 (64.8%) 449 (53.8%)
Women 3291 (35.2%) 386 (46.2%)
Smoker 0.722
no 8002 (86.1%) 710 (86.6%)
yes 1295 (13.9%) 110 (13.4%)
Overweight <0.001
no 4556 (48.7%) 463 (55.7%)
yes 4793 (51.3%) 368 (44.3%)
Study center
City 0.805
Frankfurt/Ruedesheim 7516 (80.4%) 126 (79.2%)
Munich 1838 (19.6%) 33 (20.8%)
Note: Final dataset denotes the main study dataset (n=9,354) excluding
participants who were excluded due to missing values (n=835) (fig. 3.2).
Quantitative variables are displayed as median [1st quartile; 3rd quartile],
qualitative characteristics as n (percent).
Overweight: BMI ≥ 25 kg/m2, obesity: BMI ≥ 30 kg/m2.
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Figure A.1: Histograms of continuous variables for men.
Note: Men from Frankfurt/Rüdesheim and Munich were included (n=6,063).
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Figure A.2: Histograms of continuous variables for women.
Note: Women from Frankfurt/Rüdesheim and Munich were included (n=3,291).
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Figure A.3: Correlation matrix of continuous variables for men.
Note: Scatter plots including ellipsoids and Loess curves are plotted on the bottom-left, his-
tograms on the diagonal and Spearman correlation coefficients on the top-right.
All 6,063 men from Frankfurt/Rüdesheim and Munich were included.
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Figure A.4: Correlation matrix of continuous variables for women.
Note: Scatter plots including ellipsoids and Loess curves are plotted on the bottom-left, his-
tograms on the diagonal and Spearman correlation coefficients on the top-right.
All 3,291 women from Frankfurt/Rüdesheim and Munich were included.
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Table A.3: Skewness and quantile-based skewness of all eligible quantitative variables
Men Women
Skewness QSK Skewness QSK
Outcome measures
Relative V̇O2peak [mLO2/min/kg] 0.19 0.06 0.30 0.09
Absolute V̇O2peak [LO2/min] 0.09 0.08 0.43 0.04
Anthropometrics
Age [years] 0.50 0.83 0.60 1.00
Weight [kg] 0.96 0.31 1.30 0.82
Height [cm] -0.01 0.12 -0.10 0.03
BMI [kg/m2] 1.27 0.53 1.42 0.93
Body fat (Caliper) [%] 1.15 0.04 0.64 0.00
Body fat (Tanita) [%] 0.55 0.13 0.16 0.11
Waist circumference [cm] 0.86 0.36 0.82 0.58
Blood pressure
Systolic [mmHg] 0.82 0.38 1.04 0.00
Diastolic [mmHg] 0.57 0.30 0.52 -0.17
Glucose metabolism
Blood glucose [mg/dL] 5.72 0.40 13.63 0.30
HbA1c [%] 41.38 -0.00 25.73 0.33
Lipid metabolism
Total cholesterol [mg/dL] 0.31 0.13 0.66 0.30
HDL Cholesterol [mg/dL] 0.98 0.50 0.56 0.38
LDL Cholesterol [mg/dL] 2.29 0.18 11.75 0.28
Triglycerides [mg/dL] 3.89 1.22 10.65 1.37
Quantile-based skewness (QSK) was calculated according to [22, p. 14]. All
3,291 women and all 6,063 men from Frankfurt/Rüdesheim and Munich were
included.
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A.3 Regression modelling
Figure A.5: Apparent validation box plots: Comparing regression models.
Note: Quantiles are displayed as ● = 0.25, ▴ = 0.5, ◾ = 0.75. For apparent validation, the box
plots as well as the regression predictions were based on participants from Frankruft/Rüdesheim.
Age was modelled in classes.
Green: quantile regression using b-spline smoothing
Red: linear quantile regression model
Blue: polynomial quantile regression model
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Figure A.6: Apparent validation calibration plots.
Note: Quantiles are displayed as ● = 0.25, ▴ = 0.5, ◾ = 0.75.
For apparent validation, the observed values as well as the regression predictions were based on
participants from Frankruft/Rüdesheim.
Green: quantile regression using b-spline smoothing
Red: linear quantile regression model






























Table A.4: Regression coefficients and R squared for linear regression in calibration data for apparent validation. Comparison of three regression models.
Absolute V̇O2peak Relative V̇O2peak
Linear Spline Polynomial Linear Spline Polynomial
Women
Intercept 0.09 [-0.1 to 0.27] 0.01 [-0.19 to 0.19] 0.11 [-0.12 to 0.33] 2.03 [-0.35 to 4.13] 0.27 [-2.12 to 2.96] 1.06 [-1.29 to 3.35]
Slope 0.94 [0.86 to 1.04] 1 [0.9 to 1.1] 0.94 [0.83 to 1.05] 0.93 [0.85 to 1.01] 1 [0.91 to 1.09] 0.97 [0.88 to 1.05]
R squared 0.96 [0.92 to 0.99] 0.96 [0.92 to 0.98] 0.95 [0.92 to 0.99] 0.95 [0.89 to 0.98] 0.92 [0.79 to 0.98] 0.95 [0.9 to 0.98]
Men
Intercept 0.32 [0.02 to 0.64] 0.02 [-0.08 to 0.13] 0.26 [0.07 to 0.45] 6.21 [0.99 to 11.11] 1.16 [-0.62 to 3] 5.94 [1.35 to 9.91]
Slope 0.87 [0.76 to 0.98] 0.99 [0.96 to 1.03] 0.91 [0.84 to 0.97] 0.8 [0.65 to 0.96] 0.97 [0.92 to 1.02] 0.83 [0.71 to 0.96]
R squared 0.94 [0.88 to 0.99] 0.99 [0.99 to 1] 0.97 [0.95 to 0.99] 0.89 [0.8 to 0.96] 0.98 [0.96 to 0.99] 0.92 [0.85 to 0.97]
95% confidence intervals in square brackets.
Table A.5: Akaike Information Criterion AIC for different regression models.
Absolute V̇O2peak Relative V̇O2peak
Quantile Linear Spline Polynomial Linear Spline Polynomial
Female
.25 18562.02 18562.13 18563.99 2832.95 2830.88 2831.54
.50 18357.10 18358.27 18357.55 2623.22 2623.27 2623.08
.75 18794.05 18791.95 18790.79 3205.03 3201.94 3200.07
Male
.25 32693.45 32659.89 32672.15 8611.33 8597.82 8604.32
.50 32425.59 32388.06 32406.82 8175.13 8145.55 8152.83
.75 33269.80 33219.23 33242.66 8975.45 8954.71 8957.62
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A.4 Informed consent
Figure A.7: Informed consent
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herzlich bei Chrisi, Jakob, Karin und Walde bedanken. Besonders dankbar bin ich auch
meiner Freundin Frauke, die trotz der vielen Stunden Arbeit an dieser Dissertation immer
ein offenes Ohr für Probleme hatte und mich immer unterstützte. Ungleich dankbarer
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